data_2mz7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mz7 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.489 ' O ' ' CD2' ' A' ' 268' ' ' HIS . 19.2 t-160 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 19.8 mp0 -54.48 -34.54 23.6 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.934 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 32.4 Cg_exo -63.18 -8.78 15.15 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 118.624 0.544 . . . . 0.0 112.016 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.89 4.52 55.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 275' ' ' VAL . . . 165.91 120.92 0.54 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -51.9 -36.44 42.1 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -61.45 -34.44 75.42 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.7 t -111.25 129.45 66.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -118.31 132.2 56.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.402 . . . . 0.0 111.029 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 279' ' ' ASN . 84.7 mt -99.64 7.9 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.863 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 278' ' ' ILE . 21.1 mm 70.12 -24.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.287 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.584 ' H ' ' C ' ' A' ' 277' ' ' ILE . 4.0 m120 -56.69 -22.28 33.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.02 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -48.85 -41.92 34.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -58.89 -38.12 78.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 57.8 mt -71.02 -35.5 72.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.698 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -79.84 140.47 36.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.029 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 285' ' ' SER . 48.5 mt -68.63 -26.45 65.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.69 ' HG ' ' N ' ' A' ' 286' ' ' ASN . 21.8 p 100.26 -134.52 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.727 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.69 ' N ' ' HG ' ' A' ' 285' ' ' SER . 22.9 m120 -59.18 -32.27 69.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.794 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 270' ' ' PRO . 24.3 t60 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.781 0.324 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 0.0 OUTLIER -34.42 -33.82 0.1 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.139 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.459 ' N ' ' O ' ' A' ' 268' ' ' HIS . 6.4 Cg_endo -112.84 89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.171 1.247 . . . . 0.0 112.285 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -54.5 -38.36 62.82 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -66.08 -40.12 94.97 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.63 110.66 3.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -59.74 -37.31 78.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 9.4 p -145.21 0.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.552 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -94.43 144.7 25.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 6.6 pt -99.25 123.81 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.497 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 279' ' ' ASN . 32.9 mm -117.0 106.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER 18.61 -112.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.752 0.657 . . . . 0.0 111.736 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 279' ' ' ASN . 10.9 mmtp 37.84 23.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 279' ' ' ASN . 23.2 tptp -55.46 -25.95 39.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.068 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.83 -28.69 61.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.413 ' HB2' HE21 ' A' ' 269' ' ' GLN . 92.0 m-20 -74.93 152.33 38.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.451 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 44.5 mt -95.33 155.42 16.74 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.651 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 284' ' ' LEU . 8.1 t -58.77 -142.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -12.67 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 110.101 179.785 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.901 0.381 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.711 ' NE2' ' HZ3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -80.36 144.42 57.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.327 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 272' ' ' GLY . 90.0 Cg_endo -57.22 -12.11 9.46 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.348 2.032 . . . . 0.0 112.174 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . -37.29 -25.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -97.81 -106.03 2.47 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -85.72 169.83 43.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -97.37 120.35 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 50.3 t -150.56 -15.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.416 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 1.6 pp0? -137.83 172.8 12.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.642 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.598 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 59.5 mt -72.36 136.39 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.649 ' C ' ' H ' ' A' ' 280' ' ' LYS . 84.9 mt -53.86 -17.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.213 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 281' ' ' LYS . 42.1 t-20 -51.76 -1.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.711 ' HZ3' ' NE2' ' A' ' 269' ' ' GLN . 0.0 OUTLIER -38.11 -11.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 279' ' ' ASN . 10.6 mptt -45.17 -37.05 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.229 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.5 -30.42 68.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.215 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 280' ' ' LYS . 88.3 m-20 -92.67 140.63 29.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.188 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 285' ' ' SER . 74.1 mt -112.89 160.89 17.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.588 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 287' ' ' VAL . 1.0 OUTLIER -55.6 -155.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.263 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.533 ' N ' ' OG ' ' A' ' 285' ' ' SER . 45.9 t-20 -43.35 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 285' ' ' SER . 60.0 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.602 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.558 ' O ' ' CD2' ' A' ' 268' ' ' HIS . 17.6 t-160 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.112 0.482 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 3.2 mp0 -43.35 -40.9 6.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.026 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 7.6 Cg_endo -86.25 137.93 5.42 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 120.786 0.99 . . . . 0.0 111.853 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -102.69 -15.89 23.49 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.51 -38.23 86.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.84 -139.79 6.84 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 276' ' ' GLN . 41.6 mtmt -95.99 147.19 23.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 277' ' ' ILE . 2.1 t 61.84 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.345 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' A' ' 274' ' ' LYS . 92.7 mm-40 -72.4 24.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.312 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 275' ' ' VAL . 93.3 mt -39.67 -26.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.96 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 276' ' ' GLN . 79.5 mt -51.6 -37.68 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.151 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.698 HD21 ' N ' ' A' ' 279' ' ' ASN . 0.6 OUTLIER -82.04 -1.1 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.026 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 277' ' ' ILE . 30.7 ttpt -54.61 -34.08 61.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.422 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.2 OUTLIER -56.09 -32.7 64.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.483 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 282' ' ' LEU . 9.7 mp -62.38 -37.04 84.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 85.9 m-20 -109.72 160.38 16.36 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.415 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' A' ' 284' ' ' LEU . 2.9 mp -92.38 148.71 21.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.3 m -57.26 72.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.346 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 284' ' ' LEU . 29.4 m120 61.42 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.97 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.618 ' H ' ' C ' ' A' ' 285' ' ' SER . 20.8 m . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.587 ' O ' ' CD2' ' A' ' 268' ' ' HIS . 16.8 t-160 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.473 0.654 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.653 ' NE2' ' ND2' ' A' ' 286' ' ' ASN . 52.3 mt-30 -41.62 -36.66 1.11 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.969 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 271' ' ' GLY . 14.1 Cg_endo -100.62 143.41 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 118.965 0.666 . . . . 0.0 112.246 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . 33.1 -106.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.46 71.51 0.44 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 76.81 33.61 45.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.98 147.32 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.143 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.668 ' C ' ' H ' ' A' ' 277' ' ' ILE . 16.2 m -63.42 -9.19 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.164 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 278' ' ' ILE . 93.1 mt-30 -57.24 12.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.668 ' H ' ' C ' ' A' ' 275' ' ' VAL . 17.4 tt -42.87 -21.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.579 0.228 . . . . 0.0 110.812 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 276' ' ' GLN . 21.9 pt -53.98 -26.2 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.872 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.576 ' C ' HD21 ' A' ' 279' ' ' ASN . 0.4 OUTLIER -115.93 38.54 3.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.515 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.414 ' HD3' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -61.84 -18.94 61.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.732 -179.421 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.58 ' HZ2' ' CD2' ' A' ' 282' ' ' LEU . 0.0 OUTLIER -57.68 -23.58 52.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.724 -178.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.58 ' CD2' ' HZ2' ' A' ' 281' ' ' LYS . 84.0 mt -56.8 -37.89 71.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.58 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -127.59 116.45 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.44 11.14 5.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 87.1 p -44.21 -35.95 2.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.3 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.733 ' ND2' ' H ' ' A' ' 287' ' ' VAL . 0.0 OUTLIER -62.86 -42.42 99.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.073 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.733 ' H ' ' ND2' ' A' ' 286' ' ' ASN . 76.1 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.249 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.402 ' HE2' HG12 ' A' ' 277' ' ' ILE . 2.5 p-80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.535 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 0.5 OUTLIER -112.91 100.09 50.11 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.464 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -68.94 -18.78 40.77 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.801 1.667 . . . . 0.0 112.064 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.86 -34.75 4.59 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.58 -32.62 65.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.29 -63.34 3.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.3 -35.71 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.84 129.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.775 0.321 . . . . 0.0 110.808 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.05 -31.24 69.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 279' ' ' ASN . 40.7 mt -140.89 -119.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.016 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.467 ' H ' ' CG2' ' A' ' 277' ' ' ILE . 69.2 mt 55.66 -74.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.014 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.747 HD21 ' N ' ' A' ' 279' ' ' ASN . 0.6 OUTLIER -76.48 2.32 14.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -51.48 -27.07 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.645 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.21 -35.1 48.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 282' ' ' LEU . 10.0 mp -66.68 -32.83 74.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.233 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -82.96 119.59 24.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.663 ' CD2' ' H ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER -70.72 -25.28 62.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.2 t 93.46 -139.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.216 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -57.09 -30.55 64.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.148 179.572 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 1.1 p80 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.705 0.288 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 0.0 OUTLIER 79.3 143.67 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 272' ' ' GLY . 60.7 Cg_endo -53.55 -36.73 81.48 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.29 1.993 . . . . 0.0 112.435 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 55.62 -78.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -56.78 -30.9 60.29 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 86.12 21.28 52.97 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -58.32 -41.88 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.582 ' CG1' ' H ' ' A' ' 276' ' ' GLN . 1.6 p 176.55 -97.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.425 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.582 ' H ' ' CG1' ' A' ' 275' ' ' VAL . 67.3 mm-40 37.39 -126.7 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.4 110.81 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.575 ' CD1' ' H ' ' A' ' 278' ' ' ILE . 3.2 mp -66.23 -29.55 47.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.631 HD21 ' H ' ' A' ' 282' ' ' LEU . 0.2 OUTLIER -74.4 69.38 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.904 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -55.28 -37.2 66.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.477 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 10.4 mptt -56.12 -30.42 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.131 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.631 ' H ' HD21 ' A' ' 279' ' ' ASN . 35.9 tp -61.67 -37.14 82.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -106.03 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 286' ' ' ASN . 23.7 mt -99.88 148.85 24.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.106 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.645 ' C ' ' H ' ' A' ' 287' ' ' VAL . 1.1 m -61.66 67.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.364 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 284' ' ' LEU . 42.9 t-20 60.94 -25.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.699 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.645 ' H ' ' C ' ' A' ' 285' ' ' SER . 8.4 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.778 0.323 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 271' ' ' GLY . 7.7 t60 . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.498 ' O ' ' OD2' ' A' ' 283' ' ' ASP . 7.5 mt-30 -38.27 -39.72 0.78 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.974 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.06 -28.13 49.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.424 1.416 . . . . 0.0 112.575 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 268' ' ' HIS . . . 98.26 71.06 1.01 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 156.49 15.64 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 69.53 -59.19 0.67 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -72.38 146.29 47.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.683 0.278 . . . . 0.0 110.332 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.1 p -69.71 128.76 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.15 0.5 . . . . 0.0 110.749 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -120.64 161.95 20.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.418 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.77 -17.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 85.6 mt -57.15 140.08 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.699 ' N ' ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -66.04 112.91 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 110.354 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -57.98 -34.02 69.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.776 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.678 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -57.82 -22.42 47.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.63 -36.94 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.328 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.498 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 39.0 m-20 -104.71 163.85 12.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.389 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 286' ' ' ASN . 24.6 mt -81.6 154.55 26.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.663 ' C ' ' H ' ' A' ' 287' ' ' VAL . 2.6 m -56.34 69.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.663 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 284' ' ' LEU . 14.4 m120 58.73 -22.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.663 ' H ' ' C ' ' A' ' 285' ' ' SER . 9.4 p . . . . . 0 C--N 1.328 -0.342 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.91 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.564 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 4.1 m170 . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.721 0.296 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.579 ' OE1' ' ND2' ' A' ' 286' ' ' ASN . 30.6 tt0 93.26 71.4 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.207 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -52.27 134.42 50.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.497 2.131 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -59.96 -32.22 74.67 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -168.67 21.85 0.09 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.16 35.68 33.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.423 ' O ' ' CG2' ' A' ' 275' ' ' VAL . 86.4 mttt -59.1 -39.54 82.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.35 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 274' ' ' LYS . 71.5 t -156.94 -41.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.376 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.514 ' CD ' ' H ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -65.54 163.61 15.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 110.579 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.571 ' C ' ' H ' ' A' ' 279' ' ' ASN . 68.3 mt -72.7 141.53 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.86 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.643 ' C ' ' H ' ' A' ' 280' ' ' LYS . 48.9 mm -62.82 6.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 277' ' ' ILE . 87.0 m-20 -61.97 13.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.643 ' H ' ' C ' ' A' ' 278' ' ' ILE . 54.2 pttt -40.76 -37.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.667 0.27 . . . . 0.0 111.126 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.538 ' HZ2' ' CB ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -54.92 -30.92 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.427 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 279' ' ' ASN . 31.9 tp -57.02 -37.75 72.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.442 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.59 ' O ' ' ND2' ' A' ' 286' ' ' ASN . 44.1 t0 -149.95 33.6 0.67 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.841 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' LYS . 7.4 tt -57.94 -36.95 73.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 87.4 p -57.27 -24.01 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.081 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.739 HD21 ' H ' ' A' ' 287' ' ' VAL . 0.0 OUTLIER -53.32 -36.44 61.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.916 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.739 ' H ' HD21 ' A' ' 286' ' ' ASN . 54.7 t . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.789 0.328 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -63.3 148.27 93.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.185 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.98 151.29 58.71 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.855 1.703 . . . . 0.0 112.321 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.1 35.16 1.38 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 97.0 -0.19 60.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -114.05 -49.26 0.54 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 150.27 20.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.379 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 10.1 p -133.89 3.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.874 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -57.68 -39.65 77.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.231 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.09 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.15 -38.42 82.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.763 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.584 ' C ' HD21 ' A' ' 279' ' ' ASN . 0.3 OUTLIER -82.58 1.6 37.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.565 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.692 ' C ' ' H ' ' A' ' 282' ' ' LEU . 39.7 mtmt 40.03 -149.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 55.79 -19.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.089 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.692 ' H ' ' C ' ' A' ' 280' ' ' LYS . 35.8 tp -64.67 -39.68 94.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 283' ' ' ASP . 51.8 p30 -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.7 mt -106.39 147.47 29.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.099 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.637 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.2 m -63.01 86.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 63.08 -29.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.397 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 285' ' ' SER . 54.3 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.017 0.437 . . . . 0.0 110.029 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.624 ' O ' ' N ' ' A' ' 270' ' ' PRO . 71.8 t60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.42 0.152 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.4 OUTLIER -29.34 -30.58 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.949 -178.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.624 ' N ' ' O ' ' A' ' 268' ' ' HIS . 4.4 Cg_endo -112.26 122.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.082 1.188 . . . . 0.0 111.662 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 282' ' ' LEU . . . -55.11 -27.84 47.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.39 -32.57 30.47 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.5 -82.71 1.55 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.4 -23.46 62.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.28 133.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -106.93 149.48 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.004 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 279' ' ' ASN . 16.4 mm 41.46 -120.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.403 HD13 HG22 ' A' ' 278' ' ' ILE . 74.8 mt 38.89 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.128 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.745 ' H ' HD21 ' A' ' 279' ' ' ASN . 0.0 OUTLIER -94.1 19.72 8.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.7 OUTLIER -40.73 -20.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.648 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.9 OUTLIER -54.87 -29.86 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.487 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 84.3 mt -58.05 -37.77 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.503 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 280' ' ' LYS . 92.4 m-20 -137.94 162.64 33.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.316 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.669 ' H ' ' CD2' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -105.71 171.15 7.49 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 287' ' ' VAL . 35.8 m -45.84 172.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.577 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -45.69 -6.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.423 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 285' ' ' SER . 4.7 p . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.32 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.901 0.382 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.428 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 1.3 tt0 -82.6 138.63 44.12 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.836 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 272' ' ' GLY . 17.9 Cg_endo -59.9 -25.94 80.88 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 120.404 0.736 . . . . 0.0 112.283 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.428 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 45.34 -86.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -55.94 -32.97 59.8 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.7 76.18 0.55 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.426 ' H ' ' CB ' ' A' ' 270' ' ' PRO . 68.4 mttm -90.51 16.95 8.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 110.442 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 277' ' ' ILE . 2.4 t 73.06 3.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.669 ' C ' ' H ' ' A' ' 278' ' ' ILE . 26.1 mt-30 -74.16 32.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.468 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 279' ' ' ASN . 20.4 pt -48.77 -1.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.603 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.669 ' H ' ' C ' ' A' ' 276' ' ' GLN . 15.4 mm -43.82 -12.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.828 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 277' ' ' ILE . 6.8 t-20 101.15 28.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.922 0.764 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.444 ' HZ3' ' CG2' ' A' ' 278' ' ' ILE . 1.2 mptt -57.48 -11.91 2.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.331 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -48.46 -30.87 5.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 72.2 mt -62.6 -29.7 70.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 110.028 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 280' ' ' LYS . 91.3 m-20 -80.17 151.24 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 285' ' ' SER . 75.1 mt -97.82 161.37 13.78 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 287' ' ' VAL . 22.6 t -51.45 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.435 ' O ' ' ND2' ' A' ' 286' ' ' ASN . 0.7 OUTLIER -44.3 -12.65 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.748 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 285' ' ' SER . 6.3 p . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.926 0.393 . . . . 0.0 110.249 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.596 ' ND1' ' OE1' ' A' ' 269' ' ' GLN . 85.8 t60 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.596 ' OE1' ' ND1' ' A' ' 268' ' ' HIS . 0.1 OUTLIER -63.57 146.15 96.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.268 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -57.58 150.15 62.66 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.865 1.71 . . . . 0.0 111.957 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -56.22 -33.89 61.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 274' ' ' LYS . . . 143.31 -39.64 1.29 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -72.19 9.55 5.41 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 272' ' ' GLY . 2.5 ttmp? 66.64 44.92 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.546 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.407 ' HB ' HE21 ' A' ' 276' ' ' GLN . 63.9 t -62.09 -36.1 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.407 HE21 ' HB ' ' A' ' 275' ' ' VAL . 0.9 OUTLIER -113.1 144.13 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.53 -20.45 26.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.23 130.84 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.216 0.531 . . . . 0.0 110.663 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -87.14 143.68 27.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.519 ' CD ' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -51.9 -34.78 42.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.476 -179.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER -58.78 -39.03 79.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.876 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.1 -30.13 70.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.354 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.47 ' OD2' ' NE2' ' A' ' 269' ' ' GLN . 65.4 t0 -77.61 116.67 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 0.0 110.934 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 285' ' ' SER . 54.7 mt -65.12 -38.12 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.338 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.567 ' C ' ' H ' ' A' ' 287' ' ' VAL . 2.8 m 152.08 57.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.79 -22.45 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.148 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 285' ' ' SER . 75.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.016 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -66.0 139.74 96.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.41 -23.99 76.47 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 120.225 0.617 . . . . 0.0 112.205 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.52 41.67 50.7 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.16 20.67 29.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 84.05 45.99 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.478 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -57.61 -48.33 79.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.576 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 276' ' ' GLN . 4.4 p 173.43 -23.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.538 HE21 ' CA ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -55.08 -153.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.306 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 279' ' ' ASN . 64.8 mt -57.88 -16.19 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.566 0.222 . . . . 0.0 110.771 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 278' ' ' ILE . 91.8 mt 65.1 -19.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.52 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 277' ' ' ILE . 74.9 m-20 -89.96 79.56 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.512 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.407 ' HE3' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -58.65 -24.62 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.333 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 280' ' ' LYS . 15.4 mtpp -54.88 -38.38 67.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.77 -35.87 81.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.274 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.13 127.05 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 285' ' ' SER . 5.7 mp -70.84 -24.75 62.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 9.7 p 95.8 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.947 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 65.34 -52.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.752 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 110.14 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.47 151.31 88.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.343 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.38 150.17 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.746 1.63 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.07 48.35 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.07 -37.03 36.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.57 177.81 45.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -114.41 121.65 44.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.172 0.511 . . . . 0.0 110.933 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.13 -13.31 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.613 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 1.6 pp0? -138.91 176.25 8.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.613 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 31.9 mm -67.62 130.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.599 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.401 ' HA ' HE22 ' A' ' 276' ' ' GLN . 42.8 mm -70.73 92.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.362 0.601 . . . . 0.0 110.905 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.49 39.86 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.704 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 283' ' ' ASP . 30.9 mtmt -50.88 -39.16 53.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.734 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -59.66 -37.9 80.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.059 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 48.7 mt -72.91 -35.24 67.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.179 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 280' ' ' LYS . 46.1 p30 -113.01 170.78 7.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.256 0.55 . . . . 0.0 111.982 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 285' ' ' SER . 15.6 tp -153.43 64.91 0.75 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.414 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 43.82 -173.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.963 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -68.95 -16.81 63.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.294 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.713 -178.856 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.803 0.335 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.55 147.68 91.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.26 155.58 50.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.827 1.685 . . . . 0.0 111.933 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -52.34 -16.58 3.53 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 99.79 0.8 56.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.81 23.16 1.02 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -91.13 -78.29 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.795 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 277' ' ' ILE . 9.2 p -176.05 -39.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.431 ' N ' ' CG1' ' A' ' 275' ' ' VAL . 96.5 mt-30 -67.4 9.24 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.778 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 275' ' ' VAL . 91.6 mt -47.52 -41.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.829 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 2.3 pt -52.41 -35.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.695 HD21 ' N ' ' A' ' 279' ' ' ASN . 0.8 OUTLIER -85.49 0.14 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.568 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 16.2 ttmt -55.13 -50.96 67.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -31.18 72.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 282' ' ' LEU . 3.1 mm? -68.1 -34.25 76.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 283' ' ' ASP . 50.2 p30 -106.6 155.52 19.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.161 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 286' ' ' ASN . 22.3 mt -109.22 153.31 23.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.081 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.656 ' C ' ' H ' ' A' ' 287' ' ' VAL . 0.5 OUTLIER -56.75 73.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.029 0.442 . . . . 0.0 110.505 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 55.01 -6.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.656 ' H ' ' C ' ' A' ' 285' ' ' SER . 61.0 t . . . . . 0 CA--C 1.515 -0.365 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.871 0.367 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 146.13 77.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.993 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.33 -27.97 77.88 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.183 1.922 . . . . 0.0 112.338 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.24 -1.89 86.49 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.46 0.43 70.02 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -90.69 -82.7 1.4 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.87 -33.3 73.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 275' ' ' VAL . 37.0 t 51.85 19.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.53 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -54.75 -39.14 68.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.222 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 279' ' ' ASN . 32.3 mm -67.22 -20.59 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.782 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 64.8 mt 64.63 -65.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.836 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 277' ' ' ILE . 2.5 m120 -95.4 95.56 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 281' ' ' LYS . 4.8 ptpp? -61.41 -42.69 99.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.013 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.611 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.1 OUTLIER -59.88 -30.11 68.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.93 -36.4 79.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.503 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 284' ' ' LEU . 59.8 t0 -101.01 141.35 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 79.7 mt -102.73 146.91 27.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.009 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 287' ' ' VAL . 44.8 m -55.72 -167.58 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -49.99 -3.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.664 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.648 ' H ' ' C ' ' A' ' 285' ' ' SER . 76.2 t . . . . . 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.774 0.321 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.93 147.72 98.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.408 ' HB3' HE21 ' A' ' 276' ' ' GLN . 19.8 Cg_endo -59.2 157.12 31.47 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.543 1.495 . . . . 0.0 112.081 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -87.0 81.93 1.65 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 95.46 4.12 60.98 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.83 5.9 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.463 ' O ' ' CG2' ' A' ' 275' ' ' VAL . 55.1 mttp -54.93 -70.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 276' ' ' GLN . 49.6 t -161.82 -15.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 110.458 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 275' ' ' VAL . 30.3 mt-30 -56.14 -131.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 279' ' ' ASN . 75.4 mt -59.59 -35.78 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.407 ' H ' ' HG3' ' A' ' 270' ' ' PRO . 97.9 mt 62.79 -32.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.853 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 277' ' ' ILE . 8.2 m120 -71.99 58.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.874 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -49.37 -38.85 29.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.549 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.416 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 8.6 mptt -56.76 -28.31 60.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 279' ' ' ASN . 9.5 tp -67.34 -40.2 85.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.648 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -98.85 139.55 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.638 ' CD2' ' H ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -91.96 -0.26 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.9 t 93.21 -171.11 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.746 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.584 ' C ' HD21 ' A' ' 286' ' ' ASN . 0.2 OUTLIER -50.98 -22.64 2.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.495 ' N ' ' ND2' ' A' ' 286' ' ' ASN . 4.8 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.693 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.587 ' CD2' ' H ' ' A' ' 268' ' ' HIS . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.422 ' CB ' ' CD ' ' A' ' 270' ' ' PRO . 4.4 mt-30 -41.37 -39.62 2.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 272' ' ' GLY . 3.2 Cg_endo -83.84 91.99 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.689 1.593 . . . . 0.0 111.748 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.67 30.34 2.27 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 270' ' ' PRO . . . 96.34 3.18 60.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -83.4 -171.13 47.21 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -55.32 -31.24 61.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.612 ' C ' ' H ' ' A' ' 277' ' ' ILE . 99.2 t -57.95 -12.82 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.923 0.392 . . . . 0.0 110.058 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.651 ' C ' ' H ' ' A' ' 278' ' ' ILE . 19.7 pt20 -44.2 -8.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.546 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.612 ' H ' ' C ' ' A' ' 275' ' ' VAL . 37.4 mm -48.33 -3.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.651 ' H ' ' C ' ' A' ' 276' ' ' GLN . 8.2 mt 65.96 7.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.133 0.492 . . . . 0.0 110.277 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.615 ' C ' ' H ' ' A' ' 281' ' ' LYS . 15.3 t-20 -57.2 -18.4 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 283' ' ' ASP . 0.0 OUTLIER -46.85 -1.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.176 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 279' ' ' ASN . 23.4 mmtm -42.39 -31.84 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.142 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.82 -35.64 77.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 280' ' ' LYS . 60.2 t0 -75.22 139.47 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.973 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 285' ' ' SER . 13.5 mt -62.7 -29.13 70.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER 89.95 -134.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.78 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -31.4 67.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.09 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 84.6 t60 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.563 0.22 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 268' ' ' HIS . 18.9 tt0 84.94 125.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.184 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -58.31 138.29 85.09 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.688 0.925 . . . . 0.0 112.16 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -133.48 40.32 1.61 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 103.16 -26.34 24.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -59.23 -35.38 84.23 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 61.59 37.0 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.405 ' HB ' ' NE2' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -115.49 2.65 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.405 ' NE2' ' HB ' ' A' ' 275' ' ' VAL . 2.9 mm-40 -110.67 170.35 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.188 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -69.0 123.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.653 ' C ' ' H ' ' A' ' 280' ' ' LYS . 46.7 mm -62.48 -25.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.488 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 281' ' ' LYS . 79.2 m-20 -67.13 23.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.322 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.653 ' H ' ' C ' ' A' ' 278' ' ' ILE . 2.6 ptpt -38.75 -15.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.834 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 279' ' ' ASN . 6.4 mptt -47.97 -37.53 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.23 -34.33 70.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.061 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 280' ' ' LYS . 90.7 m-20 -91.07 128.74 37.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.932 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 285' ' ' SER . 0.4 OUTLIER -102.66 4.1 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.2 t 87.11 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.653 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -49.22 -24.78 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.391 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' A' ' 280' ' ' LYS . 54.4 mttp . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' A' ' 268' ' ' HIS . 19.2 t-160 -98.36 -12.85 21.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.709 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 19.8 mp0 -54.48 -34.54 23.6 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.934 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 32.4 Cg_exo -63.18 -8.78 15.15 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 118.624 0.544 . . . . 0.0 112.016 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.89 4.52 55.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 275' ' ' VAL . . . 165.91 120.92 0.54 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -51.9 -36.44 42.1 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -61.45 -34.44 75.42 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.7 t -111.25 129.45 66.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -118.31 132.2 56.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.402 . . . . 0.0 111.029 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 279' ' ' ASN . 84.7 mt -99.64 7.9 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.863 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.425 HD12 HG23 ' A' ' 278' ' ' ILE . 21.1 mm 70.12 -24.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.287 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.584 ' H ' ' C ' ' A' ' 277' ' ' ILE . 4.0 m120 -56.69 -22.28 33.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.02 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.632 ' CD ' ' N ' ' A' ' 267' ' ' LYS . 32.9 ttpt -48.85 -41.92 34.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -58.89 -38.12 78.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 57.8 mt -71.02 -35.5 72.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.698 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -79.84 140.47 36.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.029 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 285' ' ' SER . 48.5 mt -68.63 -26.45 65.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.69 ' HG ' ' N ' ' A' ' 286' ' ' ASN . 21.8 p 100.26 -134.52 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.727 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.69 ' N ' ' HG ' ' A' ' 285' ' ' SER . 22.9 m120 -59.18 -32.27 69.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.403 HG12 ' HZ2' ' A' ' 294' ' ' LYS . 75.9 t -59.39 -34.95 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.631 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.8 tt0 -57.75 -36.05 71.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 288' ' ' GLN . 7.6 t 33.17 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.919 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' A' ' 288' ' ' GLN . 69.2 mttt -59.91 165.96 2.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.314 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 76.5 m -51.37 -31.97 24.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.221 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -127.97 -178.13 15.2 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.643 ' H ' ' CG1' ' A' ' 297' ' ' ILE . 6.2 t -68.63 -171.92 0.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.788 0.328 . . . . 0.0 110.31 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.612 ' H ' ' HG ' ' A' ' 293' ' ' SER . 21.4 mmtm -60.17 138.99 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.919 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 58.58 40.73 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.946 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 298' ' ' LYS . 18.3 m120 53.5 46.72 25.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.45 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.643 ' CG1' ' H ' ' A' ' 293' ' ' SER . 57.4 mt 49.87 6.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.31 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 296' ' ' ASN . 49.6 mtmt 51.97 22.88 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 109.899 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' A' ' 300' ' ' VAL . 2.3 p80 -88.81 10.62 20.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.055 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 308' ' ' ILE . 96.5 t -25.64 111.87 0.21 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.257 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -87.5 -23.05 1.47 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.517 1.478 . . . . 0.0 111.493 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 306' ' ' VAL . . . 171.32 -84.52 0.08 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -50.33 -28.26 13.56 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.449 ' O ' ' OG ' ' A' ' 305' ' ' SER . . . -53.16 -38.1 55.72 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 304' ' ' GLY . 3.0 m 173.88 -5.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 110.512 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 302' ' ' GLY . 4.7 t 51.28 81.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.789 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.429 HE21 HG23 ' A' ' 300' ' ' VAL . 39.9 mt-30 -137.36 -75.64 0.41 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 300' ' ' VAL . 11.7 pt -70.39 -27.42 31.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.346 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.2 m 37.75 41.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.916 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.631 ' O ' ' CG ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -149.63 51.69 0.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.458 0.647 . . . . 0.0 111.401 179.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -9.18 108.69 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.349 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo . . . . . 0 C--N 1.305 -1.738 0 C-N-CA 121.58 1.52 . . . . 0.0 112.4 178.053 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.723 0.296 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 270' ' ' PRO . 24.3 t60 -88.41 -35.05 17.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 0.0 OUTLIER -34.42 -33.82 0.1 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.139 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.459 ' N ' ' O ' ' A' ' 268' ' ' HIS . 6.4 Cg_endo -112.84 89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.171 1.247 . . . . 0.0 112.285 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -54.5 -38.36 62.82 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -66.08 -40.12 94.97 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.63 110.66 3.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -59.74 -37.31 78.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 9.4 p -145.21 0.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.552 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -94.43 144.7 25.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 6.6 pt -99.25 123.81 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.497 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 279' ' ' ASN . 32.9 mm -117.0 106.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER 18.61 -112.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.752 0.657 . . . . 0.0 111.736 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 279' ' ' ASN . 10.9 mmtp 37.84 23.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 279' ' ' ASN . 23.2 tptp -55.46 -25.95 39.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.068 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.83 -28.69 61.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.413 ' HB2' HE21 ' A' ' 269' ' ' GLN . 92.0 m-20 -74.93 152.33 38.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.451 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 44.5 mt -95.33 155.42 16.74 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.651 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 284' ' ' LEU . 8.1 t -58.77 -142.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -12.67 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 289' ' ' SER . 70.3 t -63.76 -35.39 72.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 110.101 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.406 HE22 ' HB3' ' A' ' 283' ' ' ASP . 7.3 tt0 -52.12 -14.32 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.615 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 287' ' ' VAL . 29.9 t -47.42 -29.26 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.623 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 292' ' ' GLY . 53.7 mttm -55.48 -29.82 59.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.013 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 290' ' ' LYS . 5.2 t 30.77 33.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.135 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 290' ' ' LYS . . . -165.91 -79.38 0.04 OUTLIER Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 295' ' ' ASP . 29.2 m -55.49 -31.17 61.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.665 -0.268 . . . . 0.0 111.547 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -45.93 -12.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.094 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 293' ' ' SER . 54.2 t0 -46.34 -37.68 7.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.427 ' OD1' ' C ' ' A' ' 296' ' ' ASN . 35.6 p-10 -179.87 16.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.497 ' O ' ' CG2' ' A' ' 297' ' ' ILE . 85.5 mt 62.02 52.04 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.513 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.407 ' HE2' HE22 ' A' ' 307' ' ' GLN . 16.4 ptmt -77.73 20.41 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.917 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.59 ' ND1' ' C ' ' A' ' 299' ' ' HIS . 0.5 OUTLIER -99.97 149.83 23.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.597 ' O ' ' N ' ' A' ' 302' ' ' GLY . 74.7 t -63.54 -36.57 23.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 52.2 Cg_exo -45.85 -10.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 CA-C-N 119.648 0.91 . . . . 0.0 111.689 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -150.37 -32.99 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 299' ' ' HIS . . . 169.48 96.02 0.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -156.06 -166.39 15.92 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 307' ' ' GLN . 23.0 t -125.55 92.98 3.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t 40.76 14.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.262 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' A' ' 305' ' ' SER . 2.7 tt0 -115.24 115.62 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.538 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.586 ' CG2' ' H ' ' A' ' 311' ' ' LYS . 1.1 mp -131.99 146.2 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.0 111.431 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 76.1 t -71.16 -28.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.307 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.562 ' OH ' ' NZ ' ' A' ' 290' ' ' LYS . 1.1 p90 -138.9 -7.08 1.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.586 ' H ' ' CG2' ' A' ' 308' ' ' ILE . 25.3 mttm 62.94 112.36 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.495 1.57 0 C-N-CA 121.039 1.16 . . . . 0.0 112.233 -178.805 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -113.25 150.37 32.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.537 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.711 ' NE2' ' HZ3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -80.36 144.42 57.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.327 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 272' ' ' GLY . 90.0 Cg_endo -57.22 -12.11 9.46 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.348 2.032 . . . . 0.0 112.174 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . -37.29 -25.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -97.81 -106.03 2.47 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -85.72 169.83 43.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -97.37 120.35 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 50.3 t -150.56 -15.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.416 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 1.6 pp0? -137.83 172.8 12.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.642 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.598 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 59.5 mt -72.36 136.39 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.649 ' C ' ' H ' ' A' ' 280' ' ' LYS . 84.9 mt -53.86 -17.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.213 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 281' ' ' LYS . 42.1 t-20 -51.76 -1.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.711 ' HZ3' ' NE2' ' A' ' 269' ' ' GLN . 0.0 OUTLIER -38.11 -11.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 279' ' ' ASN . 10.6 mptt -45.17 -37.05 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.229 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.5 -30.42 68.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.215 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 280' ' ' LYS . 88.3 m-20 -92.67 140.63 29.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.188 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 285' ' ' SER . 74.1 mt -112.89 160.89 17.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.588 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 287' ' ' VAL . 1.0 OUTLIER -55.6 -155.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.263 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 288' ' ' GLN . 45.9 t-20 -43.35 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 289' ' ' SER . 60.0 t -52.33 -7.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.602 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 286' ' ' ASN . 98.8 mm-40 -41.2 -14.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.619 ' N ' ' O ' ' A' ' 287' ' ' VAL . 12.5 t -45.5 -21.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.464 ' N ' ' C ' ' A' ' 288' ' ' GLN . 16.1 pttp -75.34 136.0 40.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.911 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 78.8 m -84.27 -38.9 19.91 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -101.12 -76.08 1.18 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.53 ' O ' ' C ' ' A' ' 294' ' ' LYS . 3.7 p -164.67 -28.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.587 ' C ' ' H ' ' A' ' 296' ' ' ASN . 55.8 mttp 13.99 -130.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.988 0.805 . . . . 0.0 111.944 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.463 ' O ' ' CG ' ' A' ' 296' ' ' ASN . 79.8 m-20 44.81 10.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.128 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 294' ' ' LYS . 1.9 m120 -177.98 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.918 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.61 ' O ' ' N ' ' A' ' 299' ' ' HIS . 31.5 pt -90.68 54.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 297' ' ' ILE . 82.6 tttt -37.49 88.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.497 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.61 ' N ' ' O ' ' A' ' 297' ' ' ILE . 0.3 OUTLIER -131.73 156.09 46.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.234 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.676 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 2.7 t -85.3 -53.48 0.46 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 56.9 Cg_endo -46.06 144.56 6.11 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.244 1.296 . . . . 0.0 111.906 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 100.2 15.94 29.03 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.71 28.64 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -81.7 -169.15 42.16 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.474 ' O ' ' CG1' ' A' ' 300' ' ' VAL . 4.4 m -60.16 -172.28 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 111.037 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.04 30.88 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.751 0.31 . . . . 0.0 110.944 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -65.77 -122.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 310' ' ' TYR . 0.2 OUTLIER -61.22 -24.67 34.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.914 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 308' ' ' ILE . 5.2 p 25.22 36.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 123.521 0.513 . . . . 0.0 112.315 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.615 ' CD2' ' O ' ' A' ' 310' ' ' TYR . 1.6 p90 -96.69 15.92 20.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.859 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 312' ' ' PRO . 24.7 tttt 67.72 62.87 0.72 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.944 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 311' ' ' LYS . 54.0 Cg_exo . . . . . 0 C--N 1.307 -1.611 0 C-N-CA 122.248 1.965 . . . . 0.0 112.288 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 59.5 tttm . . . . . 0 C--O 1.231 0.109 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 268' ' ' HIS . 17.6 t-160 -93.05 -22.35 19.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 109.993 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 3.2 mp0 -43.35 -40.9 6.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.026 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 7.6 Cg_endo -86.25 137.93 5.42 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 120.786 0.99 . . . . 0.0 111.853 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -102.69 -15.89 23.49 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.51 -38.23 86.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.84 -139.79 6.84 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 276' ' ' GLN . 41.6 mtmt -95.99 147.19 23.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 277' ' ' ILE . 2.1 t 61.84 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.345 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' A' ' 274' ' ' LYS . 92.7 mm-40 -72.4 24.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.312 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 275' ' ' VAL . 93.3 mt -39.67 -26.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.96 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 276' ' ' GLN . 79.5 mt -51.6 -37.68 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.151 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.698 HD21 ' N ' ' A' ' 279' ' ' ASN . 0.6 OUTLIER -82.04 -1.1 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.026 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 277' ' ' ILE . 30.7 ttpt -54.61 -34.08 61.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.422 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.2 OUTLIER -56.09 -32.7 64.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.483 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 282' ' ' LEU . 9.7 mp -62.38 -37.04 84.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 85.9 m-20 -109.72 160.38 16.36 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.415 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 284' ' ' LEU . 2.9 mp -92.38 148.71 21.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.3 m -57.26 72.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.346 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 284' ' ' LEU . 29.4 m120 61.42 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.97 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.618 ' H ' ' C ' ' A' ' 285' ' ' SER . 20.8 m -59.03 -7.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 286' ' ' ASN . 38.6 tt0 -46.82 -28.89 1.7 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.247 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.513 ' O ' ' SG ' ' A' ' 291' ' ' CYS . 68.0 p -53.26 -19.78 3.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.211 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.504 ' C ' ' SG ' ' A' ' 291' ' ' CYS . 18.8 ptmt -54.09 -18.74 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.264 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 289' ' ' SER . 1.3 p 34.48 62.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.944 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 76.18 -117.94 5.19 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 3.1 p -35.78 118.53 0.5 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.266 0.555 . . . . 0.0 112.482 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 45.6 tttp 179.11 -73.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.02 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -94.17 -70.08 0.72 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -150.32 -0.57 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.78 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 299' ' ' HIS . 6.3 mm -69.96 -4.82 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -44.49 -12.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.565 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.744 ' HD1' ' N ' ' A' ' 300' ' ' VAL . 2.8 p80 -75.11 -173.36 1.95 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.573 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.744 ' N ' ' HD1' ' A' ' 299' ' ' HIS . 1.9 m -178.13 80.66 0.23 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.623 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.445 ' CD ' ' ND1' ' A' ' 299' ' ' HIS . 8.3 Cg_exo -41.43 136.54 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.108 1.205 . . . . 0.0 111.956 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.72 5.48 62.94 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 175.42 -7.63 0.03 OUTLIER Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -83.98 -171.29 47.67 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 307' ' ' GLN . 0.1 OUTLIER -71.82 18.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.589 ' H ' ' C ' ' A' ' 304' ' ' GLY . 13.8 p 41.86 20.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.869 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 305' ' ' SER . 3.1 pt20 -60.08 -42.61 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.9 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.464 ' CD1' ' CD2' ' A' ' 299' ' ' HIS . 0.1 OUTLIER -124.32 164.23 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 310' ' ' TYR . 5.7 p -129.9 98.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 0.0 OUTLIER 168.35 -20.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.006 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 301' ' ' PRO . 19.5 tttt 66.26 68.99 0.6 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 111.129 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.415 ' HD2' ' CE1' ' A' ' 299' ' ' HIS . 80.7 Cg_exo . . . . . 0 C--N 1.306 -1.691 0 C-N-CA 122.14 1.893 . . . . 0.0 112.115 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.478 ' CG ' ' H ' ' A' ' 268' ' ' HIS . 16.2 tptp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.793 0.33 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 268' ' ' HIS . 16.8 t-160 -87.23 -17.97 31.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.473 0.654 . . . . 0.0 109.326 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.653 ' NE2' ' ND2' ' A' ' 286' ' ' ASN . 52.3 mt-30 -41.62 -36.66 1.11 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.969 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 271' ' ' GLY . 14.1 Cg_endo -100.62 143.41 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 118.965 0.666 . . . . 0.0 112.246 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . 33.1 -106.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.46 71.51 0.44 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 76.81 33.61 45.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.98 147.32 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.143 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.668 ' C ' ' H ' ' A' ' 277' ' ' ILE . 16.2 m -63.42 -9.19 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.164 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 278' ' ' ILE . 93.1 mt-30 -57.24 12.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.668 ' H ' ' C ' ' A' ' 275' ' ' VAL . 17.4 tt -42.87 -21.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.579 0.228 . . . . 0.0 110.812 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 276' ' ' GLN . 21.9 pt -53.98 -26.2 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.872 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.576 ' C ' HD21 ' A' ' 279' ' ' ASN . 0.4 OUTLIER -115.93 38.54 3.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.515 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.414 ' HD3' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -61.84 -18.94 61.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.732 -179.421 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.58 ' HZ2' ' CD2' ' A' ' 282' ' ' LEU . 0.0 OUTLIER -57.68 -23.58 52.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.724 -178.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.58 ' CD2' ' HZ2' ' A' ' 281' ' ' LYS . 84.0 mt -56.8 -37.89 71.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.58 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -127.59 116.45 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.44 11.14 5.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.403 ' HA ' ' NE2' ' A' ' 288' ' ' GLN . 87.1 p -44.21 -35.95 2.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.3 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.733 ' ND2' ' H ' ' A' ' 287' ' ' VAL . 0.0 OUTLIER -62.86 -42.42 99.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.073 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.733 ' H ' ' ND2' ' A' ' 286' ' ' ASN . 76.1 t -72.63 -35.61 51.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.249 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 290' ' ' LYS . 61.5 mt-30 -55.74 -42.84 75.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.593 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 288' ' ' GLN . 5.8 t 22.3 35.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.902 0.751 . . . . 0.0 112.785 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 288' ' ' GLN . 80.1 mttt -146.25 141.61 27.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 71.9 m -70.09 -38.38 75.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.775 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.401 ' HA3' ' HZ3' ' A' ' 298' ' ' LYS . . . -164.49 93.54 0.11 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.33 -31.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.092 0.472 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 296' ' ' ASN . 65.1 tttm -137.39 123.14 19.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.39 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 297' ' ' ILE . 60.4 t0 60.6 -68.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.651 ' C ' ' H ' ' A' ' 298' ' ' LYS . 92.5 m-20 -70.84 12.35 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.574 ' H ' ' C ' ' A' ' 295' ' ' ASP . 0.7 OUTLIER -47.01 -4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.351 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.651 ' H ' ' C ' ' A' ' 296' ' ' ASN . 52.6 mttp 64.84 36.48 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.472 ' HD1' ' CG ' ' A' ' 301' ' ' PRO . 0.2 OUTLIER -125.8 153.27 44.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.367 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.684 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 62.1 t -103.77 -25.8 0.21 Allowed Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -48.53 140.01 22.33 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 CA-C-N 119.331 0.797 . . . . 0.0 111.774 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.62 11.62 57.88 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.46 49.09 4.78 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -91.93 -114.58 2.02 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 26.0 m -101.51 -116.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.646 0.26 . . . . 0.0 110.819 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 6.2 p -163.59 8.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.754 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.414 HE22 ' HA ' ' A' ' 298' ' ' LYS . 16.6 pt20 -61.52 -44.63 96.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.052 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' ' 308' ' ' ILE . 1.8 pp -128.91 168.73 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.772 0.32 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.32 -23.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 43.9 p90 -88.31 130.28 35.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.95 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.21 131.54 58.81 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 N--CA 1.489 1.257 0 C-N-CA 121.021 1.147 . . . . 0.0 112.296 178.781 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.79 0.329 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.402 ' HE2' HG12 ' A' ' 277' ' ' ILE . 2.5 p-80 -103.1 157.5 16.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.535 ' N ' ' CD ' ' A' ' 269' ' ' GLN . 0.5 OUTLIER -112.91 100.09 50.11 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.464 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -68.94 -18.78 40.77 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.801 1.667 . . . . 0.0 112.064 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.86 -34.75 4.59 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.58 -32.62 65.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.29 -63.34 3.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.3 -35.71 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.84 129.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.775 0.321 . . . . 0.0 110.808 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.05 -31.24 69.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 279' ' ' ASN . 40.7 mt -140.89 -119.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.016 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.467 ' H ' ' CG2' ' A' ' 277' ' ' ILE . 69.2 mt 55.66 -74.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.014 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.747 HD21 ' N ' ' A' ' 279' ' ' ASN . 0.6 OUTLIER -76.48 2.32 14.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -51.48 -27.07 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.645 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.21 -35.1 48.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 282' ' ' LEU . 10.0 mp -66.68 -32.83 74.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.233 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -82.96 119.59 24.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.663 ' H ' ' CD2' ' A' ' 284' ' ' LEU . 1.0 OUTLIER -70.72 -25.28 62.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.2 t 93.46 -139.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.216 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -57.09 -30.55 64.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.7 -32.45 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.148 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.615 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.4 tt0 -52.36 -40.55 62.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 288' ' ' GLN . 18.9 t 11.42 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.175 0.922 . . . . 0.0 112.375 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 288' ' ' GLN . 23.3 mtpp 58.26 58.67 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.384 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 288' ' ' GLN . 93.3 m -37.97 -34.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -137.5 -34.24 0.2 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 294' ' ' LYS . 1.0 OUTLIER 173.51 9.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 293' ' ' SER . 14.9 tptp 92.41 -48.13 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 296' ' ' ASN . 53.8 p30 -67.58 -23.02 65.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.642 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 63.9 t30 -55.25 -36.23 65.83 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.836 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 297' ' ' ILE . 0.2 OUTLIER -63.41 -33.57 62.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -102.37 45.79 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.378 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.681 ' H ' ' HD1' ' A' ' 299' ' ' HIS . 0.0 OUTLIER -111.78 132.67 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.473 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 302' ' ' GLY . 42.4 t -34.57 -49.89 1.0 Allowed Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.595 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 9.1 Cg_endo -60.33 81.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 120.778 0.985 . . . . 0.0 110.31 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 106.76 1.38 36.82 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 299' ' ' HIS . . . 123.72 121.91 2.67 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 170.79 -172.78 44.41 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.2 m -86.88 -79.63 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 0.0 110.7 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 306' ' ' VAL . 3.6 p -179.87 7.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.348 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -52.91 -43.93 66.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.507 ' CD1' ' C ' ' A' ' 308' ' ' ILE . 1.7 pp -131.13 167.69 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 311' ' ' LYS . 11.4 p -161.31 -4.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.22 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -53.78 -8.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 309' ' ' VAL . 21.5 ttmt 68.19 64.48 0.63 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo . . . . . 0 C--N 1.306 -1.696 0 C-N-CA 122.513 2.142 . . . . 0.0 112.148 179.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -64.52 -23.58 67.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 0.0 OUTLIER 79.3 143.67 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 272' ' ' GLY . 60.7 Cg_endo -53.55 -36.73 81.48 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.29 1.993 . . . . 0.0 112.435 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 55.62 -78.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -56.78 -30.9 60.29 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 86.12 21.28 52.97 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -58.32 -41.88 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.582 ' CG1' ' H ' ' A' ' 276' ' ' GLN . 1.6 p 176.55 -97.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.425 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.582 ' H ' ' CG1' ' A' ' 275' ' ' VAL . 67.3 mm-40 37.39 -126.7 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.4 110.81 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.575 ' CD1' ' H ' ' A' ' 278' ' ' ILE . 3.2 mp -66.23 -29.55 47.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.631 HD21 ' H ' ' A' ' 282' ' ' LEU . 0.2 OUTLIER -74.4 69.38 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.904 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -55.28 -37.2 66.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.477 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 10.4 mptt -56.12 -30.42 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.131 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.631 ' H ' HD21 ' A' ' 279' ' ' ASN . 35.9 tp -61.67 -37.14 82.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -106.03 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 286' ' ' ASN . 23.7 mt -99.88 148.85 24.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.106 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.645 ' C ' ' H ' ' A' ' 287' ' ' VAL . 1.1 m -61.66 67.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.364 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 288' ' ' GLN . 42.9 t-20 60.94 -25.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.699 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.645 ' H ' ' C ' ' A' ' 285' ' ' SER . 8.4 p -50.68 -8.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.778 0.323 . . . . 0.0 110.19 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.582 ' H ' ' C ' ' A' ' 286' ' ' ASN . 88.7 mt-30 -40.57 -18.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 287' ' ' VAL . 25.4 t -48.41 -9.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.555 ' H ' ' C ' ' A' ' 288' ' ' GLN . 41.1 mttp -51.41 -29.73 16.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.681 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 2.2 t 63.72 -67.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.679 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 290' ' ' LYS . . . -161.84 127.6 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.635 ' H ' ' CD2' ' A' ' 299' ' ' HIS . 31.9 m 30.44 97.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -138.75 -79.87 0.33 Allowed 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.164 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.61 -50.84 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -176.67 -13.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.607 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.639 ' O ' ' N ' ' A' ' 299' ' ' HIS . 46.6 pt -57.31 -24.63 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 297' ' ' ILE . 55.3 pttt 27.21 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.874 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.639 ' N ' ' O ' ' A' ' 297' ' ' ILE . 0.3 OUTLIER -68.14 169.03 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.153 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.652 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 93.9 t -80.27 -53.31 0.92 Allowed Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 52.5 Cg_endo -50.09 141.96 28.94 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.554 1.503 . . . . 0.0 112.269 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.22 57.14 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.25 21.12 57.64 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 305' ' ' SER . . . -81.63 -158.92 22.83 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 306' ' ' VAL . 28.4 t -49.98 -170.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 111.102 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.525 ' N ' ' OG ' ' A' ' 305' ' ' SER . 17.0 m -119.38 23.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.21 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.559 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 3.7 pt20 -85.19 -104.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 111.79 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.554 ' O ' ' CD1' ' A' ' 308' ' ' ILE . 0.0 OUTLIER -90.24 136.51 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.302 0.572 . . . . 0.0 112.306 -178.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 13.8 p -107.8 -5.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.509 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -60.4 -11.0 5.56 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.959 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 72.1 tttt 67.41 104.38 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo . . . . . 0 C--N 1.31 -1.485 0 C-N-CA 122.035 1.824 . . . . 0.0 112.191 178.303 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 271' ' ' GLY . 7.7 t60 -72.59 -32.23 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.498 ' O ' ' OD2' ' A' ' 283' ' ' ASP . 7.5 mt-30 -38.27 -39.72 0.78 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.974 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.06 -28.13 49.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.424 1.416 . . . . 0.0 112.575 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 268' ' ' HIS . . . 98.26 71.06 1.01 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 156.49 15.64 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 69.53 -59.19 0.67 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -72.38 146.29 47.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.683 0.278 . . . . 0.0 110.332 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.1 p -69.71 128.76 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.15 0.5 . . . . 0.0 110.749 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -120.64 161.95 20.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.418 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.77 -17.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 85.6 mt -57.15 140.08 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.699 ' N ' ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -66.04 112.91 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 110.354 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -57.98 -34.02 69.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.776 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.678 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -57.82 -22.42 47.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.63 -36.94 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.328 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.498 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 39.0 m-20 -104.71 163.85 12.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.389 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 286' ' ' ASN . 24.6 mt -81.6 154.55 26.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.663 ' C ' ' H ' ' A' ' 287' ' ' VAL . 2.6 m -56.34 69.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.663 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 284' ' ' LEU . 14.4 m120 58.73 -22.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.663 ' H ' ' C ' ' A' ' 285' ' ' SER . 9.4 p -58.64 -22.26 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.91 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 290' ' ' LYS . 1.4 pt20 -51.12 -112.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.01 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.51 ' O ' ' OG ' ' A' ' 293' ' ' SER . 43.9 t 36.11 -89.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 288' ' ' GLN . 11.9 ptmm? -63.17 -37.59 87.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.404 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . 0.547 ' O ' ' N ' ' A' ' 296' ' ' ASN . 7.2 m -77.42 -80.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.45 5.01 57.72 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.025 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -135.07 25.47 3.57 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.733 0.766 . . . . 0.0 111.534 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -170.49 -53.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.748 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -93.15 -74.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.066 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.547 ' N ' ' O ' ' A' ' 291' ' ' CYS . 83.9 m-20 -58.08 -32.6 68.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.788 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.507 ' C ' ' H ' ' A' ' 299' ' ' HIS . 0.0 OUTLIER -50.8 -20.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -50.8 -13.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.585 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.777 ' HD1' ' N ' ' A' ' 300' ' ' VAL . 1.4 p80 -89.29 -170.71 2.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.001 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.777 ' N ' ' HD1' ' A' ' 299' ' ' HIS . 1.9 p 176.39 80.46 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.06 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -40.37 136.58 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.371 1.38 . . . . 0.0 111.877 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 92.36 5.93 64.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 175.02 -6.59 0.03 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -83.06 -169.93 45.37 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.705 ' HG ' HE21 ' A' ' 307' ' ' GLN . 18.7 p -70.11 5.35 1.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.0 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 304' ' ' GLY . 2.2 t 59.3 13.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.705 HE21 ' HG ' ' A' ' 305' ' ' SER . 11.6 pt20 -60.38 -38.88 85.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 110.003 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 299' ' ' HIS . 2.3 pp -129.11 168.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.883 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 18.0 m -127.44 4.23 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.1 OUTLIER -91.38 -7.67 50.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.092 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 310' ' ' TYR . 12.4 pttt 35.59 64.99 1.99 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 110.694 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 98.5 Cg_exo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.309 2.006 . . . . 0.0 112.33 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.745 0.307 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.564 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 4.1 m170 -134.07 177.41 7.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.608 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.61 ' NE2' HE22 ' A' ' 288' ' ' GLN . 30.6 tt0 93.26 71.4 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.207 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -52.27 134.42 50.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.497 2.131 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -59.96 -32.22 74.67 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -168.67 21.85 0.09 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.16 35.68 33.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.423 ' O ' ' CG2' ' A' ' 275' ' ' VAL . 86.4 mttt -59.1 -39.54 82.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.35 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 274' ' ' LYS . 71.5 t -156.94 -41.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.376 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.514 ' CD ' ' H ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -65.54 163.61 15.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 110.579 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.571 ' C ' ' H ' ' A' ' 279' ' ' ASN . 68.3 mt -72.7 141.53 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.86 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.643 ' C ' ' H ' ' A' ' 280' ' ' LYS . 48.9 mm -62.82 6.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 277' ' ' ILE . 87.0 m-20 -61.97 13.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.643 ' H ' ' C ' ' A' ' 278' ' ' ILE . 54.2 pttt -40.76 -37.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.667 0.27 . . . . 0.0 111.126 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.538 ' HZ2' ' CB ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -54.92 -30.92 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.427 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 279' ' ' ASN . 31.9 tp -57.02 -37.75 72.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.442 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.59 ' O ' ' ND2' ' A' ' 286' ' ' ASN . 44.1 t0 -149.95 33.6 0.67 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.841 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.56 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 7.4 tt -57.94 -36.95 73.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 289' ' ' SER . 87.4 p -57.27 -24.01 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.081 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.739 HD21 ' H ' ' A' ' 287' ' ' VAL . 0.0 OUTLIER -53.32 -36.44 61.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.916 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.739 ' H ' HD21 ' A' ' 286' ' ' ASN . 54.7 t -75.76 -53.66 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.61 HE22 ' NE2' ' A' ' 269' ' ' GLN . 0.4 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.706 -178.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.609 ' N ' ' O ' ' A' ' 285' ' ' SER . 3.6 t 67.33 -8.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 110.102 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.564 ' H ' ' C ' ' A' ' 288' ' ' GLN . 38.2 tptt -118.98 132.47 56.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.82 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . 0.682 ' CB ' HD21 ' A' ' 296' ' ' ASN . 50.9 t -127.7 141.08 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.149 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.6 11.48 60.64 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.709 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 294' ' ' LYS . 26.8 t -167.01 6.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.303 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 296' ' ' ASN . 85.4 mttt -158.86 126.81 5.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.4 t70 59.57 -69.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.682 HD21 ' CB ' ' A' ' 291' ' ' CYS . 87.2 m-20 -49.17 -28.51 4.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.584 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . . . . . . . . . 2.5 pp -49.89 -11.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 109.995 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 296' ' ' ASN . 1.0 OUTLIER -56.62 -14.65 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.894 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.799 ' HD1' ' N ' ' A' ' 300' ' ' VAL . 4.0 p80 -67.77 -165.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.799 ' N ' ' HD1' ' A' ' 299' ' ' HIS . 2.3 p 173.58 78.39 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.231 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -40.04 133.74 1.9 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.376 1.384 . . . . 0.0 111.784 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.42 1.56 66.34 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -171.16 -16.96 0.02 OUTLIER Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -80.6 -174.9 48.72 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.81 ' H ' HE22 ' A' ' 307' ' ' GLN . 69.7 m -76.66 8.93 3.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.0 110.187 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 304' ' ' GLY . 16.6 t 63.39 26.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.695 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.81 HE22 ' H ' ' A' ' 305' ' ' SER . 0.0 OUTLIER -60.44 -44.31 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.669 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.46 ' CD1' ' CD2' ' A' ' 299' ' ' HIS . 0.1 OUTLIER -123.57 167.42 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.27 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.86 9.75 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.898 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -106.22 3.86 28.25 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.025 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 310' ' ' TYR . 6.7 ptmt 34.12 56.16 1.79 Allowed Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.644 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.441 ' C ' ' O ' ' A' ' 311' ' ' LYS . 90.4 Cg_exo . . . . . 0 C--N 1.307 -1.642 0 C-N-CA 122.666 2.244 . . . . 0.0 112.394 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 53.3 tttp . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.756 0.312 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -81.78 143.62 31.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -63.3 148.27 93.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.185 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.98 151.29 58.71 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.855 1.703 . . . . 0.0 112.321 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.1 35.16 1.38 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 97.0 -0.19 60.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -114.05 -49.26 0.54 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 150.27 20.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.379 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 10.1 p -133.89 3.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.874 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -57.68 -39.65 77.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.231 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.09 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.15 -38.42 82.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.763 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.584 ' C ' HD21 ' A' ' 279' ' ' ASN . 0.3 OUTLIER -82.58 1.6 37.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.565 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.692 ' C ' ' H ' ' A' ' 282' ' ' LEU . 39.7 mtmt 40.03 -149.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 55.79 -19.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.089 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.692 ' H ' ' C ' ' A' ' 280' ' ' LYS . 35.8 tp -64.67 -39.68 94.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 283' ' ' ASP . 51.8 p30 -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.7 mt -106.39 147.47 29.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.099 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.637 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.2 m -63.01 86.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 63.08 -29.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.397 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 285' ' ' SER . 54.3 t -57.49 -26.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.017 0.437 . . . . 0.0 110.029 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.547 ' C ' ' N ' ' A' ' 290' ' ' LYS . 2.3 pt20 -44.19 -10.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.234 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.593 ' N ' ' O ' ' A' ' 287' ' ' VAL . 8.7 t -46.4 -19.79 0.09 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.547 ' N ' ' C ' ' A' ' 288' ' ' GLN . 48.8 mttm -81.47 145.89 30.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.668 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 79.9 m -61.04 -31.51 71.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.701 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -132.7 -73.7 0.1 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 7.2 t 174.49 75.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.424 ' H ' ' HD3' ' A' ' 290' ' ' LYS . 67.2 mttm -54.3 -30.94 52.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -51.51 -43.2 62.19 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.617 ' O ' ' CG2' ' A' ' 297' ' ' ILE . 15.5 m120 -92.17 -30.71 15.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.617 ' CG2' ' O ' ' A' ' 296' ' ' ASN . 19.8 tt 120.06 63.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 125.238 1.586 . . . . 0.0 109.61 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.542 ' C ' ' O ' ' A' ' 297' ' ' ILE . 10.2 ptmm? 1.17 66.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.809 0.693 . . . . 0.0 112.633 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.605 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 0.5 OUTLIER -126.5 135.97 52.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.794 179.07 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 302' ' ' GLY . 94.0 t -50.74 -34.28 11.44 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 121.47 -0.769 . . . . 0.0 112.026 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.661 ' CB ' ' HH ' ' A' ' 310' ' ' TYR . 46.9 Cg_exo -45.15 -12.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 CA-C-N 119.025 0.688 . . . . 0.0 111.697 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -143.72 30.35 1.95 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.95 14.25 79.8 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 299' ' ' HIS . . . -89.04 -168.75 44.09 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 14.5 m -69.68 159.8 32.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.5 p -63.66 -7.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.128 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 297' ' ' ILE . 12.5 pt20 -46.18 -23.58 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.772 0.32 . . . . 0.0 111.505 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.506 ' CD1' ' C ' ' A' ' 308' ' ' ILE . 0.0 OUTLIER -42.78 154.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 110.816 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.408 ' N ' HG12 ' A' ' 308' ' ' ILE . 14.4 m -133.76 -13.56 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.661 ' HH ' ' CB ' ' A' ' 301' ' ' PRO . 47.4 p90 -106.39 -10.8 16.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 310' ' ' TYR . 9.8 pttp 31.66 97.29 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 122.966 0.166 . . . . 0.0 111.045 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo . . . . . 0 N--CA 1.491 1.344 0 C-N-CA 120.937 1.091 . . . . 0.0 112.212 -178.896 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.406 ' O ' ' CD ' ' A' ' 270' ' ' PRO . 62.6 mttp . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.584 0.23 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.624 ' O ' ' N ' ' A' ' 270' ' ' PRO . 71.8 t60 -64.75 -13.53 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.214 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.4 OUTLIER -29.34 -30.58 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.949 -178.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.624 ' N ' ' O ' ' A' ' 268' ' ' HIS . 4.4 Cg_endo -112.26 122.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.082 1.188 . . . . 0.0 111.662 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 282' ' ' LEU . . . -55.11 -27.84 47.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.39 -32.57 30.47 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.5 -82.71 1.55 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.4 -23.46 62.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.28 133.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -106.93 149.48 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.004 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 279' ' ' ASN . 16.4 mm 41.46 -120.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.403 HD13 HG22 ' A' ' 278' ' ' ILE . 74.8 mt 38.89 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.128 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.745 ' H ' HD21 ' A' ' 279' ' ' ASN . 0.0 OUTLIER -94.1 19.72 8.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.7 OUTLIER -40.73 -20.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.648 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.9 OUTLIER -54.87 -29.86 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.487 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 84.3 mt -58.05 -37.77 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.503 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.506 ' O ' ' O ' ' A' ' 280' ' ' LYS . 92.4 m-20 -137.94 162.64 33.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.316 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.669 ' H ' ' CD2' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -105.71 171.15 7.49 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 287' ' ' VAL . 35.8 m -45.84 172.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.577 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -45.69 -6.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.423 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 285' ' ' SER . 4.7 p -51.39 -25.92 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.32 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 290' ' ' LYS . 97.2 mt-30 -36.12 -77.15 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 33.3 t 43.33 11.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.161 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 288' ' ' GLN . 59.9 mttp -135.45 131.41 36.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 77.6 m -72.73 -32.29 65.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.45 55.16 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.934 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.467 ' O ' ' CG1' ' A' ' 297' ' ' ILE . 70.0 m -85.73 18.07 3.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.88 -77.86 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 -43.48 98.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.155 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.613 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 64.5 m-20 -92.71 2.01 56.97 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.829 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.518 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 0.4 OUTLIER -52.37 -19.76 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 299' ' ' HIS . 37.8 mmtm -83.02 1.69 38.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.649 ' ND1' ' N ' ' A' ' 299' ' ' HIS . 0.0 OUTLIER -54.3 -121.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.195 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 301' ' ' PRO . 2.8 p -175.63 31.97 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.994 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.544 ' C ' ' N ' ' A' ' 303' ' ' GLY . 14.2 Cg_exo 19.25 -120.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 113.871 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 301' ' ' PRO . . . 44.16 21.41 0.24 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . 0.544 ' N ' ' C ' ' A' ' 301' ' ' PRO . . . 151.18 -36.61 0.88 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.23 94.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 306' ' ' VAL . 14.1 t 171.8 -125.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.583 ' N ' ' OG ' ' A' ' 305' ' ' SER . 11.8 m -161.56 61.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.206 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -110.54 -112.84 0.32 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.925 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -31.38 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.421 ' H ' ' HG2' ' A' ' 301' ' ' PRO . 33.3 t 46.33 45.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.306 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.615 ' O ' ' CG ' ' A' ' 310' ' ' TYR . 0.8 OUTLIER -175.25 33.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.125 0.488 . . . . 0.0 110.276 178.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 310' ' ' TYR . 14.8 pttm 34.43 77.91 0.35 Allowed Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.102 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 C-N-CA 121.387 1.391 . . . . 0.0 112.35 -178.008 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 69.0 tttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.793 0.33 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -110.83 159.79 17.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.719 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.428 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 1.3 tt0 -82.6 138.63 44.12 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.836 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 272' ' ' GLY . 17.9 Cg_endo -59.9 -25.94 80.88 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 120.404 0.736 . . . . 0.0 112.283 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.428 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 45.34 -86.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -55.94 -32.97 59.8 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.7 76.18 0.55 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.426 ' H ' ' CB ' ' A' ' 270' ' ' PRO . 68.4 mttm -90.51 16.95 8.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 110.442 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 277' ' ' ILE . 2.4 t 73.06 3.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.669 ' C ' ' H ' ' A' ' 278' ' ' ILE . 26.1 mt-30 -74.16 32.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.468 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 279' ' ' ASN . 20.4 pt -48.77 -1.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.603 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.669 ' H ' ' C ' ' A' ' 276' ' ' GLN . 15.4 mm -43.82 -12.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.828 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 277' ' ' ILE . 6.8 t-20 101.15 28.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.922 0.764 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.444 ' HZ3' ' CG2' ' A' ' 278' ' ' ILE . 1.2 mptt -57.48 -11.91 2.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.331 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -48.46 -30.87 5.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 72.2 mt -62.6 -29.7 70.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 110.028 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 280' ' ' LYS . 91.3 m-20 -80.17 151.24 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 285' ' ' SER . 75.1 mt -97.82 161.37 13.78 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 287' ' ' VAL . 22.6 t -51.45 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 286' ' ' ASN . 0.7 OUTLIER -44.3 -12.65 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.748 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 285' ' ' SER . 6.3 p -61.48 -27.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.926 0.393 . . . . 0.0 110.249 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.5 tt0 -53.63 -30.3 42.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 288' ' ' GLN . 1.0 OUTLIER 35.75 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.609 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 288' ' ' GLN . 65.8 mmtt -88.65 151.46 22.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 86.9 m -56.97 -30.85 64.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.574 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -172.72 92.51 0.09 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.671 ' C ' ' H ' ' A' ' 295' ' ' ASP . 24.1 t -179.96 110.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt 61.78 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.579 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.671 ' H ' ' C ' ' A' ' 293' ' ' SER . 78.7 m-20 -56.2 -37.32 69.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 0.0 110.657 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -168.11 -34.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.737 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.676 ' O ' ' N ' ' A' ' 299' ' ' HIS . 28.9 pt -69.54 -27.36 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 297' ' ' ILE . 0.0 OUTLIER 28.93 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.93 0.769 . . . . 0.0 110.828 -178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.772 ' CD2' ' H ' ' A' ' 300' ' ' VAL . 0.3 OUTLIER -49.85 -49.5 48.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.217 -179.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.772 ' H ' ' CD2' ' A' ' 299' ' ' HIS . 15.5 t 134.06 -48.99 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 124.561 1.163 . . . . 0.0 109.695 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 302' ' ' GLY . 25.7 Cg_exo -51.84 -30.18 37.47 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.196 1.264 . . . . 0.0 111.618 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.76 ' H ' ' NE2' ' A' ' 299' ' ' HIS . . . -47.06 -91.31 0.01 OUTLIER Glycine 0 C--N 1.333 0.416 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -58.15 -29.23 62.39 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 84.61 147.16 8.36 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.342 -0.929 . . . . 0.0 112.032 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.0 t -176.59 -20.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.2 t 74.44 35.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.386 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -79.03 -65.93 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 310' ' ' TYR . 24.4 pt -74.37 -19.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 1.5 t 66.65 -28.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.45 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.614 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 20.9 p90 -108.37 133.37 52.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.744 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.441 ' O ' ' OXT' ' A' ' 312' ' ' PRO . 1.9 ptmm? -98.28 124.28 47.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.628 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.441 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 75.4 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 C-N-CA 121.075 1.183 . . . . 0.0 112.201 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.405 ' CG ' ' H ' ' A' ' 268' ' ' HIS . 30.0 tptt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.596 ' ND1' ' OE1' ' A' ' 269' ' ' GLN . 85.8 t60 -91.97 147.14 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.241 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.596 ' OE1' ' ND1' ' A' ' 268' ' ' HIS . 0.1 OUTLIER -63.57 146.15 96.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.268 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -57.58 150.15 62.66 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.865 1.71 . . . . 0.0 111.957 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -56.22 -33.89 61.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 274' ' ' LYS . . . 143.31 -39.64 1.29 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -72.19 9.55 5.41 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 272' ' ' GLY . 2.5 ttmp? 66.64 44.92 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.546 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.407 ' HB ' HE21 ' A' ' 276' ' ' GLN . 63.9 t -62.09 -36.1 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.407 HE21 ' HB ' ' A' ' 275' ' ' VAL . 0.9 OUTLIER -113.1 144.13 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.53 -20.45 26.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.23 130.84 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.216 0.531 . . . . 0.0 110.663 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -87.14 143.68 27.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.519 ' CD ' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -51.9 -34.78 42.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.476 -179.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER -58.78 -39.03 79.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.876 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.1 -30.13 70.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.354 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.47 ' OD2' ' NE2' ' A' ' 269' ' ' GLN . 65.4 t0 -77.61 116.67 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 0.0 110.934 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 285' ' ' SER . 54.7 mt -65.12 -38.12 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.338 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.567 ' C ' ' H ' ' A' ' 287' ' ' VAL . 2.8 m 152.08 57.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.79 -22.45 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.148 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 289' ' ' SER . 75.1 t -60.78 -28.68 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.016 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.5 tt0 -45.05 -9.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 287' ' ' VAL . 32.1 t -35.02 -30.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.016 0.436 . . . . 0.0 109.961 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.584 ' NZ ' ' OD2' ' A' ' 295' ' ' ASP . 12.9 tptm -114.57 147.93 38.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 290' ' ' LYS . 20.8 p -68.86 125.04 25.36 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.317 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . 99.18 -35.61 4.57 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 292' ' ' GLY . 2.4 m 153.7 -86.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.834 0.35 . . . . 0.0 110.095 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -149.06 31.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.592 ' O ' ' ND2' ' A' ' 296' ' ' ASN . 87.1 m-20 55.82 45.22 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 295' ' ' ASP . 29.0 m120 -152.63 -15.72 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.006 0.432 . . . . 0.0 109.967 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 299' ' ' HIS . 13.1 pt -140.8 7.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.677 ' HZ3' HE22 ' A' ' 307' ' ' GLN . 22.1 ttpp -46.59 87.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.606 ' N ' ' O ' ' A' ' 297' ' ' ILE . 4.0 p80 -174.96 154.85 1.92 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.621 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.557 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 1.6 t -58.85 -66.87 1.16 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.743 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 32.8 Cg_endo -52.01 105.21 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.756 1.637 . . . . 0.0 111.516 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 103.18 -1.0 47.17 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 100.19 131.76 7.48 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 178.66 -167.54 38.02 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 91.7 p -63.24 -14.55 50.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 t 75.83 75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.677 HE22 ' HZ3' ' A' ' 298' ' ' LYS . 2.2 pt20 -136.09 -69.96 0.48 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.454 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.496 ' O ' ' CD1' ' A' ' 308' ' ' ILE . 2.7 pp -110.36 131.57 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.27 0.557 . . . . 0.0 112.029 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.638 ' C ' ' H ' ' A' ' 311' ' ' LYS . 17.6 m -85.92 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.773 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -49.35 0.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.51 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.638 ' H ' ' C ' ' A' ' 309' ' ' VAL . 13.0 pttt 34.96 93.37 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.744 0.307 . . . . 0.0 111.242 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo . . . . . 0 C--N 1.309 -1.525 0 C-N-CA 122.11 1.874 . . . . 0.0 112.32 179.379 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 66.8 mttt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.524 ' HD1' ' NE2' ' A' ' 288' ' ' GLN . 23.2 t-160 -58.8 -37.91 77.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.453 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -66.0 139.74 96.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.41 -23.99 76.47 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 120.225 0.617 . . . . 0.0 112.205 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.52 41.67 50.7 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.16 20.67 29.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 84.05 45.99 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.478 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -57.61 -48.33 79.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.576 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 276' ' ' GLN . 4.4 p 173.43 -23.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.538 ' CA ' HE21 ' A' ' 276' ' ' GLN . 0.0 OUTLIER -55.08 -153.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.306 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 279' ' ' ASN . 64.8 mt -57.88 -16.19 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.566 0.222 . . . . 0.0 110.771 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 278' ' ' ILE . 91.8 mt 65.1 -19.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.52 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 277' ' ' ILE . 74.9 m-20 -89.96 79.56 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.512 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.407 ' H ' ' HE3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -58.65 -24.62 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.333 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 280' ' ' LYS . 15.4 mtpp -54.88 -38.38 67.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.77 -35.87 81.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.274 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.13 127.05 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 285' ' ' SER . 5.7 mp -70.84 -24.75 62.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 9.7 p 95.8 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.947 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 65.34 -52.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.752 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 289' ' ' SER . 9.4 p -56.89 -21.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 110.14 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.524 ' NE2' ' HD1' ' A' ' 268' ' ' HIS . 7.7 tt0 -44.25 -13.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.108 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 287' ' ' VAL . 37.5 m -40.43 -23.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.569 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 288' ' ' GLN . 39.2 mmtm -55.58 -31.78 62.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 2.0 t 72.5 -60.02 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 179.02 -170.06 41.68 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 19.8 t 59.07 16.29 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.754 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -146.18 -90.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.0 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.49 -43.16 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 22.2 m120 -85.54 -3.97 59.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.521 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 299' ' ' HIS . 0.2 OUTLIER -49.89 -26.31 2.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.41 ' O ' ' CA ' ' A' ' 304' ' ' GLY . 14.9 ptpt -71.01 18.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.453 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 296' ' ' ASN . 0.0 OUTLIER -104.14 148.11 26.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 302' ' ' GLY . 70.2 t -48.18 -43.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.87 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 300' ' ' VAL . 26.4 Cg_exo -46.49 -11.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 120.609 0.873 . . . . 0.0 111.304 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -156.62 32.58 0.57 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 86.67 86.18 1.07 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.41 ' CA ' ' O ' ' A' ' 298' ' ' LYS . . . -133.27 176.45 19.6 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.719 ' N ' HE22 ' A' ' 307' ' ' GLN . 43.0 p -87.93 10.6 18.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.406 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.697 ' H ' HE22 ' A' ' 307' ' ' GLN . 2.7 t 79.75 82.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.947 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.719 HE22 ' N ' ' A' ' 305' ' ' SER . 0.0 OUTLIER -123.33 -91.92 0.54 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.147 179.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.639 ' O ' ' N ' ' A' ' 310' ' ' TYR . 2.7 pp -61.18 -47.63 92.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.62 ' N ' ' CD1' ' A' ' 308' ' ' ILE . 21.6 t 39.86 13.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.833 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.639 ' N ' ' O ' ' A' ' 308' ' ' ILE . 0.2 OUTLIER -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.142 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 310' ' ' TYR . 34.1 tttp 75.22 95.79 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.998 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.086 179.817 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.841 0.353 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -67.51 153.86 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.47 151.31 88.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.343 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.38 150.17 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.746 1.63 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.07 48.35 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.07 -37.03 36.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.57 177.81 45.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -114.41 121.65 44.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.172 0.511 . . . . 0.0 110.933 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.13 -13.31 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.613 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 1.6 pp0? -138.91 176.25 8.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.613 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 31.9 mm -67.62 130.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.599 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.401 ' HA ' HE22 ' A' ' 276' ' ' GLN . 42.8 mm -70.73 92.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.362 0.601 . . . . 0.0 110.905 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.49 39.86 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.704 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 283' ' ' ASP . 30.9 mtmt -50.88 -39.16 53.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.734 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -59.66 -37.9 80.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.059 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 48.7 mt -72.91 -35.24 67.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.179 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 280' ' ' LYS . 46.1 p30 -113.01 170.78 7.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.256 0.55 . . . . 0.0 111.982 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.733 ' N ' HE21 ' A' ' 288' ' ' GLN . 15.6 tp -153.43 64.91 0.75 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.414 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 43.82 -173.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.963 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -68.95 -16.81 63.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.294 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.12 -11.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.713 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.733 HE21 ' N ' ' A' ' 284' ' ' LEU . 92.2 mt-30 -52.52 -41.92 63.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.294 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 288' ' ' GLN . 10.0 t 25.19 30.04 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 288' ' ' GLN . 52.4 mttm -143.68 138.41 28.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 110.988 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 89.2 m -98.73 -22.14 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -93.1 -74.73 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.331 -0.707 . . . . 0.0 111.331 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.58 ' HG ' ' NE2' ' A' ' 307' ' ' GLN . 53.0 m -116.24 150.34 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.022 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 296' ' ' ASN . 32.0 mmtp -99.4 135.75 40.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.992 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 295' ' ' ASP . 59.2 t0 51.68 6.54 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 294' ' ' LYS . 77.7 m-20 62.22 26.13 15.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.132 0.491 . . . . 0.0 110.639 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.5 ' CD1' ' C ' ' A' ' 297' ' ' ILE . 1.7 pp -113.46 -7.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.509 ' C ' ' CG ' ' A' ' 299' ' ' HIS . 50.3 tttp -101.11 116.47 32.9 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.265 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.509 ' CG ' ' C ' ' A' ' 298' ' ' LYS . 1.5 p80 162.27 165.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.82 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.53 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 0.2 OUTLIER -52.15 -67.55 0.52 Allowed Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 61.2 Cg_endo -52.53 101.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.05 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 101.39 1.95 53.74 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 299' ' ' HIS . . . 98.43 128.44 6.12 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.386 -0.685 . . . . 0.0 111.386 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.461 ' HA3' ' H ' ' A' ' 299' ' ' HIS . . . 170.85 -107.52 0.26 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 9.3 m -133.15 -128.36 0.18 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 111.377 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.2 6.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.521 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.58 ' NE2' ' HG ' ' A' ' 293' ' ' SER . 13.0 pt20 -55.27 -40.41 70.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.372 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.412 ' CD1' ' C ' ' A' ' 308' ' ' ILE . 2.3 pp -128.78 -175.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 11.0 p -171.55 -0.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.086 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.442 ' O ' ' C ' ' A' ' 311' ' ' LYS . 1.0 OUTLIER -85.87 28.78 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 310' ' ' TYR . 9.6 pttm 33.16 68.63 0.97 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.078 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 C--N 1.306 -1.681 0 C-N-CA 122.514 2.143 . . . . 0.0 112.184 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -69.1 149.83 48.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.191 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.55 147.68 91.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.26 155.58 50.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.827 1.685 . . . . 0.0 111.933 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -52.34 -16.58 3.53 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 99.79 0.8 56.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.81 23.16 1.02 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -91.13 -78.29 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.795 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 277' ' ' ILE . 9.2 p -176.05 -39.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.431 ' N ' ' CG1' ' A' ' 275' ' ' VAL . 96.5 mt-30 -67.4 9.24 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.778 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 275' ' ' VAL . 91.6 mt -47.52 -41.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.829 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 2.3 pt -52.41 -35.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.695 HD21 ' N ' ' A' ' 279' ' ' ASN . 0.8 OUTLIER -85.49 0.14 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.568 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 16.2 ttmt -55.13 -50.96 67.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -31.18 72.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 282' ' ' LEU . 3.1 mm? -68.1 -34.25 76.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 283' ' ' ASP . 50.2 p30 -106.6 155.52 19.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.161 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 286' ' ' ASN . 22.3 mt -109.22 153.31 23.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.081 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.656 ' C ' ' H ' ' A' ' 287' ' ' VAL . 0.5 OUTLIER -56.75 73.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.029 0.442 . . . . 0.0 110.505 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 55.01 -6.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.656 ' H ' ' C ' ' A' ' 285' ' ' SER . 61.0 t -60.99 -27.03 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.424 ' CD ' ' H ' ' A' ' 284' ' ' LEU . 13.0 pt20 -87.64 -160.83 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.207 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.31 -51.21 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.136 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -97.47 155.33 16.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.157 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 74.2 m -53.74 -33.46 55.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.125 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . -71.24 0.1 33.82 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 292' ' ' GLY . 1.4 t 89.71 -167.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.45 -38.86 72.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.988 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 297' ' ' ILE . 61.3 t0 -166.09 72.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.897 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.601 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 74.8 m-20 39.3 20.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.313 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 295' ' ' ASP . 1.4 pp -60.65 -17.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.123 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.47 -1.12 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.42 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.694 ' HD1' ' C ' ' A' ' 299' ' ' HIS . 0.1 OUTLIER -93.47 168.7 10.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.043 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 304' ' ' GLY . 0.0 OUTLIER -127.04 104.91 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.519 ' CD ' ' ND1' ' A' ' 299' ' ' HIS . 0.3 OUTLIER -68.25 -12.69 35.79 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 C-N-CA 120.488 0.792 . . . . 0.0 112.819 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -55.93 -28.96 54.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 304' ' ' GLY . . . -149.57 4.43 0.67 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 50.64 108.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 308' ' ' ILE . 73.9 m -66.76 160.72 25.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 110.331 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 6.8 p -53.66 -28.8 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.075 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -61.04 -36.65 80.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.187 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 309' ' ' VAL . 2.9 pp -132.51 -152.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.576 ' N ' ' CD1' ' A' ' 308' ' ' ILE . 0.6 OUTLIER 166.27 -5.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -83.02 11.16 6.58 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 309' ' ' VAL . 0.0 OUTLIER 39.66 56.16 6.4 Favored Pre-proline 0 N--CA 1.435 -1.193 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.786 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.409 ' HG2' ' NE2' ' A' ' 299' ' ' HIS . 55.7 Cg_exo . . . . . 0 C--N 1.311 -1.419 0 C-N-CA 121.768 1.646 . . . . 0.0 112.43 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 268' ' ' HIS . 18.2 ttpp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.733 0.301 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.483 ' O ' ' O ' ' A' ' 267' ' ' LYS . 83.0 t60 57.16 146.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 146.13 77.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.993 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.33 -27.97 77.88 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.183 1.922 . . . . 0.0 112.338 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.24 -1.89 86.49 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.46 0.43 70.02 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -90.69 -82.7 1.4 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.87 -33.3 73.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 275' ' ' VAL . 37.0 t 51.85 19.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.53 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -54.75 -39.14 68.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.222 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 279' ' ' ASN . 32.3 mm -67.22 -20.59 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.782 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 64.8 mt 64.63 -65.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.836 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 277' ' ' ILE . 2.5 m120 -95.4 95.56 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 281' ' ' LYS . 4.8 ptpp? -61.41 -42.69 99.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.013 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.611 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.1 OUTLIER -59.88 -30.11 68.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.93 -36.4 79.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.503 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 284' ' ' LEU . 59.8 t0 -101.01 141.35 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 79.7 mt -102.73 146.91 27.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.009 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 287' ' ' VAL . 44.8 m -55.72 -167.58 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -49.99 -3.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.664 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.648 ' H ' ' C ' ' A' ' 285' ' ' SER . 76.2 t -57.76 -37.28 58.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 290' ' ' LYS . 9.9 pt20 -55.9 -38.65 70.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 15.4 t 41.87 11.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.497 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 288' ' ' GLN . 87.4 mttt -130.21 141.2 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 77.8 m -94.3 -20.35 19.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.936 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -101.15 -130.34 7.01 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 24.7 p -70.05 158.67 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.49 ' HG3' ' H ' ' A' ' 296' ' ' ASN . 36.9 pttt -166.83 -129.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.161 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.408 ' N ' ' HG3' ' A' ' 294' ' ' LYS . 88.9 m-20 -81.97 -3.9 55.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.514 ' O ' ' C ' ' A' ' 297' ' ' ILE . 25.6 t30 -99.44 -26.88 13.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 299' ' ' HIS . 1.6 pt 12.94 -98.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.819 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 297' ' ' ILE . 93.5 mttt 35.34 29.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.524 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.678 ' H ' ' CD2' ' A' ' 299' ' ' HIS . 0.2 OUTLIER -50.68 -61.67 2.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.129 -178.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.725 ' H ' ' CD ' ' A' ' 301' ' ' PRO . 77.5 t -154.28 -8.27 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.725 ' CD ' ' H ' ' A' ' 300' ' ' VAL . 59.5 Cg_endo -56.72 106.16 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 CA-C-N 120.393 1.176 . . . . 0.0 112.117 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.49 72.29 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.6 63.32 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.39 -25.0 29.6 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.0 m -60.58 -38.94 86.26 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 307' ' ' GLN . 39.2 t -66.95 -42.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.817 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 307' ' ' GLN . 0.0 OUTLIER 47.14 100.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.931 0.872 . . . . 0.0 109.779 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.569 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 3.3 pt -124.59 20.77 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.057 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 1.8 t 69.76 -50.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.66 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 308' ' ' ILE . 8.8 p90 -95.35 144.31 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.026 0.441 . . . . 0.0 110.657 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.47 116.94 65.3 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.019 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.313 -1.302 0 C-N-CA 121.274 1.316 . . . . 0.0 112.333 178.34 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 9.2 pttm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -72.05 155.81 39.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.405 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.93 147.72 98.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.408 ' HB3' HE21 ' A' ' 276' ' ' GLN . 19.8 Cg_endo -59.2 157.12 31.47 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.543 1.495 . . . . 0.0 112.081 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -87.0 81.93 1.65 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 95.46 4.12 60.98 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.83 5.9 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.463 ' O ' ' CG2' ' A' ' 275' ' ' VAL . 55.1 mttp -54.93 -70.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 276' ' ' GLN . 49.6 t -161.82 -15.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 110.458 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 275' ' ' VAL . 30.3 mt-30 -56.14 -131.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 279' ' ' ASN . 75.4 mt -59.59 -35.78 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.407 ' H ' ' HG3' ' A' ' 270' ' ' PRO . 97.9 mt 62.79 -32.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.853 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 277' ' ' ILE . 8.2 m120 -71.99 58.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.874 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -49.37 -38.85 29.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.549 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.416 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 8.6 mptt -56.76 -28.31 60.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 279' ' ' ASN . 9.5 tp -67.34 -40.2 85.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.648 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -98.85 139.55 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.638 ' H ' ' CD2' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -91.96 -0.26 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.9 t 93.21 -171.11 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.746 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.584 ' C ' HD21 ' A' ' 286' ' ' ASN . 0.2 OUTLIER -50.98 -22.64 2.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.495 ' N ' ' ND2' ' A' ' 286' ' ' ASN . 4.8 m -61.55 -21.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.693 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.648 ' C ' ' H ' ' A' ' 290' ' ' LYS . 2.4 pt20 -53.63 -41.96 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.501 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 288' ' ' GLN . 1.5 t 59.82 -26.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.199 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.648 ' H ' ' C ' ' A' ' 288' ' ' GLN . 43.6 tttp -90.67 148.74 22.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.827 0.346 . . . . 0.0 110.803 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.17 147.18 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 71.28 -125.95 12.6 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -117.02 148.05 41.81 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 297' ' ' ILE . 18.5 tttm -106.25 -53.5 2.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 294' ' ' LYS . 85.2 m-20 38.17 37.73 0.17 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 298' ' ' LYS . 37.5 t30 73.67 46.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.667 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 294' ' ' LYS . 11.1 tt 34.6 32.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.699 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.595 ' O ' ' NE2' ' A' ' 307' ' ' GLN . 14.3 pttp -74.55 -0.61 18.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.529 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.627 ' HE2' ' CE ' ' A' ' 290' ' ' LYS . 3.7 p80 -80.24 149.41 30.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.556 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 0.6 OUTLIER -55.78 -67.55 0.72 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.316 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.557 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 95.1 Cg_endo -51.6 108.27 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.87 1.713 . . . . 0.0 111.379 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 99.72 -1.04 56.7 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 299' ' ' HIS . . . 107.6 128.71 5.95 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 171.54 -169.89 42.88 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.9 m -71.61 -84.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.761 0.315 . . . . 0.0 110.851 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.639 ' N ' ' NE2' ' A' ' 307' ' ' GLN . 2.1 p 178.27 80.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.221 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -120.24 -100.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.928 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.6 ' H ' ' CD1' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -104.5 127.17 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.714 0.768 . . . . 0.0 112.347 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 311' ' ' LYS . 16.3 m -84.83 -7.29 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 1.2 t80 -43.3 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.805 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 309' ' ' VAL . 27.5 ttmt 56.21 65.65 4.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.003 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 C--N 1.304 -1.781 0 C-N-CA 122.656 2.238 . . . . 0.0 112.21 179.468 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 268' ' ' HIS . 48.6 mttp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.587 ' H ' ' CD2' ' A' ' 268' ' ' HIS . 0.1 OUTLIER -57.1 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.062 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.422 ' CB ' ' CD ' ' A' ' 270' ' ' PRO . 4.4 mt-30 -41.37 -39.62 2.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 272' ' ' GLY . 3.2 Cg_endo -83.84 91.99 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.689 1.593 . . . . 0.0 111.748 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.67 30.34 2.27 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 270' ' ' PRO . . . 96.34 3.18 60.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -83.4 -171.13 47.21 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -55.32 -31.24 61.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.612 ' C ' ' H ' ' A' ' 277' ' ' ILE . 99.2 t -57.95 -12.82 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.923 0.392 . . . . 0.0 110.058 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.651 ' C ' ' H ' ' A' ' 278' ' ' ILE . 19.7 pt20 -44.2 -8.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.546 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.612 ' H ' ' C ' ' A' ' 275' ' ' VAL . 37.4 mm -48.33 -3.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.651 ' H ' ' C ' ' A' ' 276' ' ' GLN . 8.2 mt 65.96 7.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.133 0.492 . . . . 0.0 110.277 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.615 ' C ' ' H ' ' A' ' 281' ' ' LYS . 15.3 t-20 -57.2 -18.4 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 283' ' ' ASP . 0.0 OUTLIER -46.85 -1.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.176 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 279' ' ' ASN . 23.4 mmtm -42.39 -31.84 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.142 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.82 -35.64 77.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.577 ' OD1' ' NE2' ' A' ' 288' ' ' GLN . 60.2 t0 -75.22 139.47 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.973 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 285' ' ' SER . 13.5 mt -62.7 -29.13 70.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER 89.95 -134.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.78 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -31.4 67.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.09 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.65 -32.26 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 290' ' ' LYS . 6.8 tt0 -51.28 -21.63 2.27 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.674 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.3 t 50.76 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.628 ' N ' ' O ' ' A' ' 288' ' ' GLN . 19.3 tttm -130.84 148.33 52.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.697 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 52.8 t -97.88 140.57 32.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.898 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . 98.42 42.85 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER 163.16 107.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.622 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.601 ' C ' ' H ' ' A' ' 296' ' ' ASN . 64.8 tttt 44.97 18.05 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 293' ' ' SER . 61.4 m-20 52.5 8.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 294' ' ' LYS . 79.7 m-20 -144.8 -65.72 0.34 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.795 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.491 ' CG2' ' O ' ' A' ' 296' ' ' ASN . 23.7 pt -159.31 50.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.494 ' HB2' ' N ' ' A' ' 294' ' ' LYS . 78.2 tttt -57.41 -27.0 61.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.443 ' CG ' ' HD2' ' A' ' 301' ' ' PRO . 0.3 OUTLIER -69.3 156.16 39.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.146 -178.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.637 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 84.5 t -74.45 -60.07 1.45 Allowed Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 45.9 Cg_endo -48.09 142.05 16.59 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.153 1.902 . . . . 0.0 112.262 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.84 18.15 38.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 85.54 26.67 34.94 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -86.67 -162.04 36.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 304' ' ' GLY . 19.1 m -55.49 -131.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.681 0.277 . . . . 0.0 111.168 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 305' ' ' SER . 18.6 m -159.58 26.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.863 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.477 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 1.7 pt20 -84.84 -70.87 0.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.636 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.509 ' O ' ' CD1' ' A' ' 308' ' ' ILE . 2.7 pp -113.94 134.65 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.484 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 311' ' ' LYS . 14.4 m -118.17 5.99 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.512 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 311' ' ' LYS . 2.8 p90 -70.29 20.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.073 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 309' ' ' VAL . 9.7 pttp 32.31 98.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.595 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.484 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 94.2 Cg_exo . . . . . 0 N--CA 1.493 1.478 0 C-N-CA 121.652 1.568 . . . . 0.0 112.223 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 31.3 mttp . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.783 0.325 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 84.6 t60 -58.47 -36.67 74.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.61 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 268' ' ' HIS . 18.9 tt0 84.94 125.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.184 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -58.31 138.29 85.09 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.688 0.925 . . . . 0.0 112.16 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -133.48 40.32 1.61 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 103.16 -26.34 24.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -59.23 -35.38 84.23 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 61.59 37.0 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.405 ' HB ' ' NE2' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -115.49 2.65 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.405 ' NE2' ' HB ' ' A' ' 275' ' ' VAL . 2.9 mm-40 -110.67 170.35 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.188 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -69.0 123.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.653 ' C ' ' H ' ' A' ' 280' ' ' LYS . 46.7 mm -62.48 -25.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.488 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 281' ' ' LYS . 79.2 m-20 -67.13 23.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.322 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.653 ' H ' ' C ' ' A' ' 278' ' ' ILE . 2.6 ptpt -38.75 -15.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.834 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 279' ' ' ASN . 6.4 mptt -47.97 -37.53 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.23 -34.33 70.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.061 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 280' ' ' LYS . 90.7 m-20 -91.07 128.74 37.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.932 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 285' ' ' SER . 0.4 OUTLIER -102.66 4.1 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.2 t 87.11 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.653 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -49.22 -24.78 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.391 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.17 -35.89 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.598 ' O ' ' N ' ' A' ' 290' ' ' LYS . 2.8 pt20 -58.15 -36.59 73.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.13 -68.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.309 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 288' ' ' GLN . 90.6 mttt -75.75 161.99 28.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.615 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 83.4 m -50.9 -36.09 36.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.549 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -92.32 -167.78 39.88 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 294' ' ' LYS . 21.8 t -62.36 -141.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.542 ' N ' ' OG ' ' A' ' 293' ' ' SER . 17.8 mmtm -53.44 -30.29 39.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -161.99 -120.93 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.6 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . 0.623 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 35.6 p30 -83.19 0.05 47.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.923 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.587 ' CD1' ' H ' ' A' ' 297' ' ' ILE . 2.4 mp -59.31 -19.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.431 ' HB3' ' H ' ' A' ' 293' ' ' SER . 4.3 pttm -41.24 -21.37 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.545 0.688 . . . . 0.0 109.416 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' HIS . . . . . 0.809 ' HD1' ' N ' ' A' ' 300' ' ' VAL . 1.2 p80 -86.67 -162.95 0.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.216 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.809 ' N ' ' HD1' ' A' ' 299' ' ' HIS . 1.7 p 172.35 74.44 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.958 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . 0.584 ' C ' ' H ' ' A' ' 303' ' ' GLY . 12.0 Cg_exo -31.32 -28.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.608 1.539 . . . . 0.0 113.205 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -66.39 4.14 2.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 301' ' ' PRO . . . 168.08 7.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -87.42 -170.34 46.39 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.433 ' OG ' ' CG ' ' A' ' 307' ' ' GLN . 24.7 p -79.38 8.92 5.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.175 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 35.4 t 55.19 58.57 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.552 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.433 ' CG ' ' OG ' ' A' ' 305' ' ' SER . 62.4 mt-30 -82.2 -72.41 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -72.13 -2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.09 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 308' ' ' ILE . 2.0 t 33.97 40.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.536 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' TYR . . . . . 0.497 ' O ' ' O ' ' A' ' 311' ' ' LYS . 7.0 t80 -146.4 -14.33 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.686 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 310' ' ' TYR . 28.0 pttt 31.96 96.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.298 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.494 1.516 0 C-N-CA 121.612 1.542 . . . . 0.0 112.004 179.62 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 1.2 t60 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 19.8 mp0 -54.48 -34.54 23.6 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.934 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 32.4 Cg_exo -63.18 -8.78 15.15 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 118.624 0.544 . . . . 0.0 112.016 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.89 4.52 55.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 275' ' ' VAL . . . 165.91 120.92 0.54 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -51.9 -36.44 42.1 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -61.45 -34.44 75.42 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.7 t -111.25 129.45 66.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -118.31 132.2 56.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.402 . . . . 0.0 111.029 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 277' ' ' ILE . 84.7 mt -99.64 7.9 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.863 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.1 mm 70.12 -24.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.287 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.548 ' H ' ' C ' ' A' ' 277' ' ' ILE . 64.1 m-20 -56.69 -22.28 33.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.02 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -48.85 -41.92 34.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -58.89 -38.12 78.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 57.8 mt -71.02 -35.5 72.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.698 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -79.84 140.47 36.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.029 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 285' ' ' SER . 48.5 mt -68.63 -26.45 65.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 21.8 p 100.26 -134.52 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.727 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.521 ' N ' ' OG ' ' A' ' 285' ' ' SER . 22.9 m120 -59.18 -32.27 69.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.794 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 268' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 270' ' ' PRO . 44.0 t-80 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.781 0.324 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.724 HE22 ' N ' ' A' ' 285' ' ' SER . 1.1 mm-40 -34.42 -33.82 0.1 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.139 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.459 ' N ' ' O ' ' A' ' 268' ' ' HIS . 6.4 Cg_endo -112.84 89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.171 1.247 . . . . 0.0 112.285 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -54.5 -38.36 62.82 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -66.08 -40.12 94.97 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.63 110.66 3.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -59.74 -37.31 78.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 275' ' ' VAL . 9.4 p -145.21 0.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -94.43 144.7 25.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 6.6 pt -99.25 123.81 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.497 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 279' ' ' ASN . 32.9 mm -117.0 106.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 281' ' ' LYS . 49.3 t-20 18.61 -112.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.752 0.657 . . . . 0.0 111.736 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 279' ' ' ASN . 10.9 mmtp 37.84 23.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 279' ' ' ASN . 23.2 tptp -55.46 -25.95 39.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.068 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.83 -28.69 61.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -74.93 152.33 38.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.451 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.572 ' C ' HE22 ' A' ' 269' ' ' GLN . 44.5 mt -95.33 155.42 16.74 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.651 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.724 ' N ' HE22 ' A' ' 269' ' ' GLN . 8.1 t -58.77 -142.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -58.37 -12.67 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.726 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 110.101 179.785 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.901 0.381 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -80.36 144.42 57.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.327 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 272' ' ' GLY . 90.0 Cg_endo -57.22 -12.11 9.46 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.348 2.032 . . . . 0.0 112.174 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . -37.29 -25.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -97.81 -106.03 2.47 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -85.72 169.83 43.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -97.37 120.35 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 275' ' ' VAL . 50.3 t -150.56 -15.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.416 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.648 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 0.0 OUTLIER -137.83 172.8 12.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.642 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.648 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 59.5 mt -72.36 136.39 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.642 ' C ' ' H ' ' A' ' 280' ' ' LYS . 84.9 mt -53.86 -17.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.213 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 281' ' ' LYS . 42.1 t-20 -51.76 -1.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 278' ' ' ILE . 0.0 OUTLIER -38.11 -11.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 279' ' ' ASN . 10.6 mptt -45.17 -37.05 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.229 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 282' ' ' LEU . 6.8 mp -69.5 -30.42 68.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.215 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 280' ' ' LYS . 88.3 m-20 -92.67 140.63 29.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.188 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 285' ' ' SER . 74.1 mt -112.89 160.89 17.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.588 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 287' ' ' VAL . 1.0 OUTLIER -55.6 -155.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.263 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.533 ' N ' ' OG ' ' A' ' 285' ' ' SER . 45.9 t-20 -43.35 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 285' ' ' SER . 60.0 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.602 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.112 0.482 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 3.2 mp0 -43.35 -40.9 6.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.026 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 7.6 Cg_endo -86.25 137.93 5.42 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 120.786 0.99 . . . . 0.0 111.853 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -102.69 -15.89 23.49 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.51 -38.23 86.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.84 -139.79 6.84 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 276' ' ' GLN . 41.6 mtmt -95.99 147.19 23.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 277' ' ' ILE . 2.1 t 61.84 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.345 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 274' ' ' LYS . 92.7 mm-40 -72.4 24.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.312 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 275' ' ' VAL . 93.3 mt -39.67 -26.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.96 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 276' ' ' GLN . 79.5 mt -51.6 -37.68 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.151 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.04 -1.1 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.026 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 277' ' ' ILE . 30.7 ttpt -54.61 -34.08 61.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.479 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.2 OUTLIER -56.09 -32.7 64.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.483 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 282' ' ' LEU . 9.7 mp -62.38 -37.04 84.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 85.9 m-20 -109.72 160.38 16.36 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.415 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.836 ' N ' HD12 ' A' ' 284' ' ' LEU . 2.9 mp -92.38 148.71 21.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.591 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.3 m -57.26 72.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.346 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 284' ' ' LEU . 29.4 m120 61.42 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.97 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.591 ' H ' ' C ' ' A' ' 285' ' ' SER . 20.8 m . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.473 0.654 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.411 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 42.7 mt-30 -41.62 -36.66 1.11 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.969 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 271' ' ' GLY . 14.1 Cg_endo -100.62 143.41 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 118.965 0.666 . . . . 0.0 112.246 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . 33.1 -106.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.46 71.51 0.44 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 76.81 33.61 45.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.98 147.32 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.143 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.657 ' C ' ' H ' ' A' ' 277' ' ' ILE . 16.2 m -63.42 -9.19 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.164 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 278' ' ' ILE . 93.1 mt-30 -57.24 12.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.657 ' H ' ' C ' ' A' ' 275' ' ' VAL . 17.4 tt -42.87 -21.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.579 0.228 . . . . 0.0 110.812 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 276' ' ' GLN . 21.9 pt -53.98 -26.2 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.872 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.604 HD22 ' C ' ' A' ' 279' ' ' ASN . 0.4 OUTLIER -115.93 38.54 3.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.515 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -61.84 -18.94 61.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.732 -179.421 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.495 ' NZ ' HD21 ' A' ' 282' ' ' LEU . 0.0 OUTLIER -57.68 -23.58 52.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.724 -178.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.495 HD21 ' NZ ' ' A' ' 281' ' ' LYS . 84.0 mt -56.8 -37.89 71.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.58 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -127.59 116.45 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.44 11.14 5.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 87.1 p -44.21 -35.95 2.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.3 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -62.86 -42.42 99.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.073 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 76.1 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.249 179.531 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 268' ' ' HIS . . . . . 0.404 ' NE2' ' HD3' ' A' ' 280' ' ' LYS . 2.5 p-80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.535 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 0.2 OUTLIER -112.91 100.09 50.11 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.464 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -68.94 -18.78 40.77 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.801 1.667 . . . . 0.0 112.064 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.86 -34.75 4.59 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.58 -32.62 65.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.29 -63.34 3.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.3 -35.71 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 275' ' ' VAL . 34.2 m -91.84 129.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.775 0.321 . . . . 0.0 110.808 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.05 -31.24 69.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 279' ' ' ASN . 40.7 mt -140.89 -119.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.016 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 277' ' ' ILE . 69.2 mt 55.66 -74.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.014 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 277' ' ' ILE . 2.0 m-20 -76.48 2.32 14.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.404 ' HD3' ' NE2' ' A' ' 268' ' ' HIS . 31.2 ttpt -51.48 -27.07 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.645 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.21 -35.1 48.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 282' ' ' LEU . 10.0 mp -66.68 -32.83 74.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.233 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -82.96 119.59 24.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 1.034 ' H ' HD22 ' A' ' 284' ' ' LEU . 1.0 OUTLIER -70.72 -25.28 62.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.2 t 93.46 -139.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.216 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -57.09 -30.55 64.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.148 179.572 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.705 0.288 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 0.0 OUTLIER 79.3 143.67 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 272' ' ' GLY . 60.7 Cg_endo -53.55 -36.73 81.48 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.29 1.993 . . . . 0.0 112.435 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.498 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 55.62 -78.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -56.78 -30.9 60.29 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 86.12 21.28 52.97 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -58.32 -41.88 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.818 HG13 ' H ' ' A' ' 276' ' ' GLN . 1.6 p 176.55 -97.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.425 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.818 ' H ' HG13 ' A' ' 275' ' ' VAL . 17.5 mm100 37.39 -126.7 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 277' ' ' ILE . 4.2 mp -103.4 110.81 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.79 HD12 ' H ' ' A' ' 278' ' ' ILE . 3.2 mp -66.23 -29.55 47.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -74.4 69.38 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.904 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -55.28 -37.2 66.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 10.4 mptt -56.12 -30.42 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.131 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 35.9 tp -61.67 -37.14 82.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -106.03 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 286' ' ' ASN . 23.7 mt -99.88 148.85 24.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.106 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.634 ' C ' ' H ' ' A' ' 287' ' ' VAL . 1.1 m -61.66 67.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.364 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 284' ' ' LEU . 42.9 t-20 60.94 -25.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.699 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.634 ' H ' ' C ' ' A' ' 285' ' ' SER . 8.4 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.778 0.323 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 271' ' ' GLY . 15.0 t-80 . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.498 ' O ' ' OD2' ' A' ' 283' ' ' ASP . 7.5 mt-30 -38.27 -39.72 0.78 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.974 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.06 -28.13 49.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.424 1.416 . . . . 0.0 112.575 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 268' ' ' HIS . . . 98.26 71.06 1.01 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 156.49 15.64 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 69.53 -59.19 0.67 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -72.38 146.29 47.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.683 0.278 . . . . 0.0 110.332 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.411 ' H ' HG12 ' A' ' 275' ' ' VAL . 3.1 p -69.71 128.76 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.15 0.5 . . . . 0.0 110.749 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -120.64 161.95 20.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.418 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.77 -17.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 85.6 mt -57.15 140.08 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 0.4 OUTLIER -66.04 112.91 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 110.354 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -57.98 -34.02 69.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.776 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.731 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -57.82 -22.42 47.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.63 -36.94 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.328 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.498 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 39.0 m-20 -104.71 163.85 12.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.389 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 286' ' ' ASN . 24.6 mt -81.6 154.55 26.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.631 ' C ' ' H ' ' A' ' 287' ' ' VAL . 2.6 m -56.34 69.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.663 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 284' ' ' LEU . 14.4 m120 58.73 -22.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.631 ' H ' ' C ' ' A' ' 285' ' ' SER . 9.4 p . . . . . 0 C--N 1.328 -0.342 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.91 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' HIS . . . . . 0.564 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 4.1 m170 . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.721 0.296 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 268' ' ' HIS . 30.6 tt0 93.26 71.4 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.207 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -52.27 134.42 50.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.497 2.131 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -59.96 -32.22 74.67 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -168.67 21.85 0.09 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.16 35.68 33.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 275' ' ' VAL . 86.4 mttt -59.1 -39.54 82.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.35 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 274' ' ' LYS . 71.5 t -156.94 -41.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.376 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' H ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -65.54 163.61 15.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 110.579 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.536 ' C ' ' H ' ' A' ' 279' ' ' ASN . 68.3 mt -72.7 141.53 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.86 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 278' ' ' ILE . 48.9 mm -62.82 6.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 277' ' ' ILE . 87.0 m-20 -61.97 13.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.61 ' H ' ' C ' ' A' ' 278' ' ' ILE . 54.2 pttt -40.76 -37.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.667 0.27 . . . . 0.0 111.126 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.461 ' HZ2' ' CB ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -54.92 -30.92 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.427 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 279' ' ' ASN . 31.9 tp -57.02 -37.75 72.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.442 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.1 t0 -149.95 33.6 0.67 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.841 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' LYS . 7.4 tt -57.94 -36.95 73.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 87.4 p -57.27 -24.01 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.081 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.461 ' OD1' ' N ' ' A' ' 287' ' ' VAL . 43.8 p-10 -53.32 -36.44 61.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.916 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.461 ' N ' ' OD1' ' A' ' 286' ' ' ASN . 54.7 t . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.789 0.328 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -63.3 148.27 93.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.185 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.98 151.29 58.71 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.855 1.703 . . . . 0.0 112.321 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.1 35.16 1.38 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 97.0 -0.19 60.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -114.05 -49.26 0.54 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 150.27 20.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.379 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 275' ' ' VAL . 10.1 p -133.89 3.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.874 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -57.68 -39.65 77.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.231 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 280' ' ' LYS . 55.2 mt -111.09 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.15 -38.42 82.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.763 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 280' ' ' LYS . 21.9 p30 -82.58 1.6 37.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.565 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.654 ' C ' ' H ' ' A' ' 282' ' ' LEU . 39.7 mtmt 40.03 -149.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 55.79 -19.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.089 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 280' ' ' LYS . 35.8 tp -64.67 -39.68 94.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 283' ' ' ASP . 51.8 p30 -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.7 mt -106.39 147.47 29.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.099 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.2 m -63.01 86.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 63.08 -29.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.397 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.614 ' H ' ' C ' ' A' ' 285' ' ' SER . 54.3 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.017 0.437 . . . . 0.0 110.029 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' HIS . . . . . 0.624 ' O ' ' N ' ' A' ' 270' ' ' PRO . 71.8 t60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.42 0.152 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.4 OUTLIER -29.34 -30.58 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.949 -178.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.624 ' N ' ' O ' ' A' ' 268' ' ' HIS . 4.4 Cg_endo -112.26 122.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.082 1.188 . . . . 0.0 111.662 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' A' ' 282' ' ' LEU . . . -55.11 -27.84 47.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.39 -32.57 30.47 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.5 -82.71 1.55 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.4 -23.46 62.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.28 133.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -106.93 149.48 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.004 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 279' ' ' ASN . 16.4 mm 41.46 -120.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.407 ' N ' HG22 ' A' ' 277' ' ' ILE . 74.8 mt 38.89 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.128 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.607 ' N ' ' O ' ' A' ' 277' ' ' ILE . 38.2 p-10 -94.1 19.72 8.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.7 OUTLIER -40.73 -20.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.648 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.9 OUTLIER -54.87 -29.86 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.504 HD12 ' ND2' ' A' ' 279' ' ' ASN . 84.3 mt -58.05 -37.77 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.503 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.786 ' C ' HD13 ' A' ' 284' ' ' LEU . 92.4 m-20 -137.94 162.64 33.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.316 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 1.093 ' H ' HD22 ' A' ' 284' ' ' LEU . 0.0 OUTLIER -105.71 171.15 7.49 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 287' ' ' VAL . 35.8 m -45.84 172.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.577 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -45.69 -6.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.423 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 285' ' ' SER . 4.7 p . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.32 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.901 0.382 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.485 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 2.6 tt0 -82.6 138.63 44.12 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.836 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 272' ' ' GLY . 17.9 Cg_endo -59.9 -25.94 80.88 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 120.404 0.736 . . . . 0.0 112.283 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 45.34 -86.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -55.94 -32.97 59.8 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.7 76.18 0.55 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.514 ' C ' HG23 ' A' ' 275' ' ' VAL . 68.4 mttm -90.51 16.95 8.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 110.442 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.514 HG23 ' C ' ' A' ' 274' ' ' LYS . 2.4 t 73.06 3.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.626 ' C ' ' H ' ' A' ' 278' ' ' ILE . 83.1 mt-30 -74.16 32.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.468 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 279' ' ' ASN . 20.4 pt -48.77 -1.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.603 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.626 ' H ' ' C ' ' A' ' 276' ' ' GLN . 15.4 mm -43.82 -12.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.828 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 277' ' ' ILE . 6.8 t-20 101.15 28.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.922 0.764 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.406 ' HZ1' HG21 ' A' ' 278' ' ' ILE . 1.2 mptt -57.48 -11.91 2.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.331 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -48.46 -30.87 5.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 72.2 mt -62.6 -29.7 70.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 110.028 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -80.17 151.24 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 285' ' ' SER . 75.1 mt -97.82 161.37 13.78 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 287' ' ' VAL . 22.6 t -51.45 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -44.3 -12.65 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.748 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 285' ' ' SER . 6.3 p . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.926 0.393 . . . . 0.0 110.249 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' HIS . . . . . 0.596 ' ND1' ' OE1' ' A' ' 269' ' ' GLN . 85.8 t60 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.62 ' H ' ' CD ' ' A' ' 269' ' ' GLN . 0.1 OUTLIER -63.57 146.15 96.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.268 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -57.58 150.15 62.66 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.865 1.71 . . . . 0.0 111.957 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -56.22 -33.89 61.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 274' ' ' LYS . . . 143.31 -39.64 1.29 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -72.19 9.55 5.41 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 272' ' ' GLY . 2.5 ttmp? 66.64 44.92 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.546 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.09 -36.1 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -113.1 144.13 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.53 -20.45 26.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.23 130.84 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.216 0.531 . . . . 0.0 110.663 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -87.14 143.68 27.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.574 ' CD ' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -51.9 -34.78 42.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.476 -179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.483 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER -58.78 -39.03 79.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.876 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.1 -30.13 70.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.354 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.47 ' OD2' ' NE2' ' A' ' 269' ' ' GLN . 65.4 t0 -77.61 116.67 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 0.0 110.934 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 285' ' ' SER . 54.7 mt -65.12 -38.12 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.338 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.8 m 152.08 57.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 71.79 -22.45 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.148 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 285' ' ' SER . 75.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.016 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -66.0 139.74 96.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.41 -23.99 76.47 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 120.225 0.617 . . . . 0.0 112.205 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.52 41.67 50.7 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.16 20.67 29.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 84.05 45.99 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.478 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.468 ' HG2' HG12 ' A' ' 275' ' ' VAL . 57.8 tttp -57.61 -48.33 79.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.576 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 276' ' ' GLN . 4.4 p 173.43 -23.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 275' ' ' VAL . 0.0 OUTLIER -55.08 -153.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.306 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.544 ' C ' ' H ' ' A' ' 279' ' ' ASN . 64.8 mt -57.88 -16.19 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.566 0.222 . . . . 0.0 110.771 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 278' ' ' ILE . 91.8 mt 65.1 -19.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.52 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 277' ' ' ILE . 74.9 m-20 -89.96 79.56 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.512 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.469 ' HE3' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -58.65 -24.62 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.333 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -54.88 -38.38 67.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.77 -35.87 81.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.274 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.13 127.05 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.783 ' N ' HD12 ' A' ' 284' ' ' LEU . 5.7 mp -70.84 -24.75 62.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 9.7 p 95.8 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.947 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 65.34 -52.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.752 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 285' ' ' SER . 9.4 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 110.14 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.47 151.31 88.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.343 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.38 150.17 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.746 1.63 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.07 48.35 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.07 -37.03 36.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.57 177.81 45.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -114.41 121.65 44.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.172 0.511 . . . . 0.0 110.933 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 275' ' ' VAL . 7.5 p -132.13 -13.31 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.646 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 0.0 OUTLIER -138.91 176.25 8.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.694 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.646 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 31.9 mm -67.62 130.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.599 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 42.8 mm -70.73 92.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.362 0.601 . . . . 0.0 110.905 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.49 39.86 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.704 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 283' ' ' ASP . 30.9 mtmt -50.88 -39.16 53.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.734 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -59.66 -37.9 80.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.059 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 48.7 mt -72.91 -35.24 67.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.179 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 280' ' ' LYS . 46.1 p30 -113.01 170.78 7.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.256 0.55 . . . . 0.0 111.982 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 285' ' ' SER . 15.6 tp -153.43 64.91 0.75 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.414 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 43.82 -173.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.963 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -68.95 -16.81 63.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.294 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 284' ' ' LEU . 35.2 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.713 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.803 0.335 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -62.55 147.68 91.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.26 155.58 50.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.827 1.685 . . . . 0.0 111.933 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -52.34 -16.58 3.53 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 99.79 0.8 56.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.81 23.16 1.02 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -91.13 -78.29 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.795 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 276' ' ' GLN . 9.2 p -176.05 -39.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.491 ' N ' HG13 ' A' ' 275' ' ' VAL . 96.5 mt-30 -67.4 9.24 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.778 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.485 ' H ' ' C ' ' A' ' 275' ' ' VAL . 91.6 mt -47.52 -41.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.829 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 2.3 pt -52.41 -35.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -85.49 0.14 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.568 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 16.2 ttmt -55.13 -50.96 67.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.459 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -64.85 -31.18 72.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 282' ' ' LEU . 3.1 mm? -68.1 -34.25 76.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 283' ' ' ASP . 50.2 p30 -106.6 155.52 19.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.161 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 286' ' ' ASN . 22.3 mt -109.22 153.31 23.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.081 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 287' ' ' VAL . 0.5 OUTLIER -56.75 73.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.029 0.442 . . . . 0.0 110.505 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 284' ' ' LEU . 2.2 p30 55.01 -6.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.632 ' H ' ' C ' ' A' ' 285' ' ' SER . 61.0 t . . . . . 0 CA--C 1.515 -0.365 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.871 0.367 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.95 146.13 77.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.993 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.33 -27.97 77.88 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.183 1.922 . . . . 0.0 112.338 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.24 -1.89 86.49 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.46 0.43 70.02 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 275' ' ' VAL . . . -90.69 -82.7 1.4 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.87 -33.3 73.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 275' ' ' VAL . 37.0 t 51.85 19.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.53 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -54.75 -39.14 68.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.222 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 279' ' ' ASN . 32.3 mm -67.22 -20.59 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.782 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 64.8 mt 64.63 -65.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.836 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 277' ' ' ILE . 33.6 m-20 -95.4 95.56 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 281' ' ' LYS . 4.8 ptpp? -61.41 -42.69 99.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.013 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.684 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.1 OUTLIER -59.88 -30.11 68.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.93 -36.4 79.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.503 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 284' ' ' LEU . 59.8 t0 -101.01 141.35 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 79.7 mt -102.73 146.91 27.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.009 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.603 ' C ' ' H ' ' A' ' 287' ' ' VAL . 44.8 m -55.72 -167.58 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -49.99 -3.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.664 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 285' ' ' SER . 76.2 t . . . . . 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.774 0.321 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.93 147.72 98.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.486 ' HG3' ' H ' ' A' ' 278' ' ' ILE . 19.8 Cg_endo -59.2 157.12 31.47 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.543 1.495 . . . . 0.0 112.081 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -87.0 81.93 1.65 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 95.46 4.12 60.98 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.83 5.9 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 275' ' ' VAL . 55.1 mttp -54.93 -70.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 274' ' ' LYS . 49.6 t -161.82 -15.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 110.458 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 275' ' ' VAL . 58.9 mt-30 -56.14 -131.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 279' ' ' ASN . 75.4 mt -59.59 -35.78 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.486 ' H ' ' HG3' ' A' ' 270' ' ' PRO . 97.9 mt 62.79 -32.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.853 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 277' ' ' ILE . 8.2 m120 -71.99 58.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.874 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -49.37 -38.85 29.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.549 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.497 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 8.6 mptt -56.76 -28.31 60.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.34 -40.2 85.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.648 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -98.85 139.55 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 1.007 ' H ' HD22 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -91.96 -0.26 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.9 t 93.21 -171.11 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.746 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -50.98 -22.64 2.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 284' ' ' LEU . 4.8 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.693 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 269' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.422 ' CB ' ' CD ' ' A' ' 270' ' ' PRO . 4.8 mt-30 -41.37 -39.62 2.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 269' ' ' GLN . 3.2 Cg_endo -83.84 91.99 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.689 1.593 . . . . 0.0 111.748 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.67 30.34 2.27 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.18 60.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -83.4 -171.13 47.21 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -55.32 -31.24 61.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.606 ' O ' ' N ' ' A' ' 277' ' ' ILE . 99.2 t -57.95 -12.82 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.923 0.392 . . . . 0.0 110.058 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.629 ' C ' ' H ' ' A' ' 278' ' ' ILE . 19.7 pt20 -44.2 -8.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.546 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 275' ' ' VAL . 37.4 mm -48.33 -3.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.629 ' H ' ' C ' ' A' ' 276' ' ' GLN . 8.2 mt 65.96 7.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.133 0.492 . . . . 0.0 110.277 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 281' ' ' LYS . 15.3 t-20 -57.2 -18.4 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 283' ' ' ASP . 0.0 OUTLIER -46.85 -1.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.176 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.623 ' H ' ' C ' ' A' ' 279' ' ' ASN . 23.4 mmtm -42.39 -31.84 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.142 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.82 -35.64 77.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 280' ' ' LYS . 60.2 t0 -75.22 139.47 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.973 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 285' ' ' SER . 13.5 mt -62.7 -29.13 70.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER 89.95 -134.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.78 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -58.39 -31.4 67.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.09 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 268' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 84.6 t60 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.563 0.22 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 268' ' ' HIS . 18.9 tt0 84.94 125.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.184 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -58.31 138.29 85.09 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.688 0.925 . . . . 0.0 112.16 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -133.48 40.32 1.61 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 103.16 -26.34 24.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -59.23 -35.38 84.23 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 61.59 37.0 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.415 ' HB ' ' NE2' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -115.49 2.65 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.415 ' NE2' ' HB ' ' A' ' 275' ' ' VAL . 2.9 mm-40 -110.67 170.35 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.188 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.0 123.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.625 ' C ' ' H ' ' A' ' 280' ' ' LYS . 46.7 mm -62.48 -25.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.488 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 281' ' ' LYS . 79.2 m-20 -67.13 23.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.322 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 278' ' ' ILE . 2.6 ptpt -38.75 -15.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.834 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 279' ' ' ASN . 6.4 mptt -47.97 -37.53 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 282' ' ' LEU . 7.6 mp -71.23 -34.33 70.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.061 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 280' ' ' LYS . 90.7 m-20 -91.07 128.74 37.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.932 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 285' ' ' SER . 0.4 OUTLIER -102.66 4.1 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 285' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.2 t 87.11 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.653 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -49.22 -24.78 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.391 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' A' ' 280' ' ' LYS . 54.4 mttp . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -98.36 -12.85 21.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.709 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 19.8 mp0 -54.48 -34.54 23.6 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.934 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 32.4 Cg_exo -63.18 -8.78 15.15 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 118.624 0.544 . . . . 0.0 112.016 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.89 4.52 55.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 275' ' ' VAL . . . 165.91 120.92 0.54 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -51.9 -36.44 42.1 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -61.45 -34.44 75.42 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.7 t -111.25 129.45 66.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -118.31 132.2 56.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.402 . . . . 0.0 111.029 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 277' ' ' ILE . 84.7 mt -99.64 7.9 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.863 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.1 mm 70.12 -24.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.287 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.548 ' H ' ' C ' ' A' ' 277' ' ' ILE . 64.1 m-20 -56.69 -22.28 33.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.02 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.632 ' CD ' ' N ' ' A' ' 267' ' ' LYS . 32.9 ttpt -48.85 -41.92 34.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -58.89 -38.12 78.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 57.8 mt -71.02 -35.5 72.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.698 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -79.84 140.47 36.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.029 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 285' ' ' SER . 48.5 mt -68.63 -26.45 65.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 21.8 p 100.26 -134.52 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.727 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.521 ' N ' ' OG ' ' A' ' 285' ' ' SER . 22.9 m120 -59.18 -32.27 69.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.39 -34.95 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.631 ' O ' ' N ' ' A' ' 290' ' ' LYS . 64.1 tt0 -57.75 -36.05 71.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 288' ' ' GLN . 7.6 t 33.17 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.919 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' A' ' 288' ' ' GLN . 69.2 mttt -59.91 165.96 2.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.314 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 76.5 m -51.37 -31.97 24.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.221 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -127.97 -178.13 15.2 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.679 ' H ' ' CG1' ' A' ' 297' ' ' ILE . 6.2 t -68.63 -171.92 0.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.788 0.328 . . . . 0.0 110.31 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -60.17 138.99 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.919 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 58.58 40.73 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.946 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 298' ' ' LYS . 18.3 m120 53.5 46.72 25.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.45 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.679 ' CG1' ' H ' ' A' ' 293' ' ' SER . 57.4 mt 49.87 6.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.31 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 296' ' ' ASN . 49.6 mtmt 51.97 22.88 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 109.899 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.755 ' C ' HD11 ' A' ' 308' ' ' ILE . 2.3 p80 -88.81 10.62 20.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.055 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 308' ' ' ILE . 96.5 t -25.64 111.87 0.21 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.257 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -87.5 -23.05 1.47 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.517 1.478 . . . . 0.0 111.493 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 306' ' ' VAL . . . 171.32 -84.52 0.08 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -50.33 -28.26 13.56 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.445 ' O ' ' OG ' ' A' ' 305' ' ' SER . . . -53.16 -38.1 55.72 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 304' ' ' GLY . 3.0 m 173.88 -5.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 110.512 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 302' ' ' GLY . 4.7 t 51.28 81.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.789 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -137.36 -75.64 0.41 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.755 HD11 ' C ' ' A' ' 299' ' ' HIS . 11.7 pt -70.39 -27.42 31.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.346 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.413 HG22 ' C ' ' A' ' 308' ' ' ILE . 34.2 m 37.75 41.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.916 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.631 ' O ' ' CG ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -149.63 51.69 0.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.458 0.647 . . . . 0.0 111.401 179.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -9.18 108.69 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.349 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo . . . . . 0 C--N 1.305 -1.738 0 C-N-CA 121.58 1.52 . . . . 0.0 112.4 178.053 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.723 0.296 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 270' ' ' PRO . 44.0 t-80 -88.41 -35.05 17.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.724 HE22 ' N ' ' A' ' 285' ' ' SER . 1.1 mm-40 -34.42 -33.82 0.1 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.139 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.459 ' N ' ' O ' ' A' ' 268' ' ' HIS . 6.4 Cg_endo -112.84 89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.171 1.247 . . . . 0.0 112.285 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -54.5 -38.36 62.82 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -66.08 -40.12 94.97 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.63 110.66 3.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -59.74 -37.31 78.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 275' ' ' VAL . 9.4 p -145.21 0.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -94.43 144.7 25.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 6.6 pt -99.25 123.81 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.497 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 279' ' ' ASN . 32.9 mm -117.0 106.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 281' ' ' LYS . 49.3 t-20 18.61 -112.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.752 0.657 . . . . 0.0 111.736 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 279' ' ' ASN . 10.9 mmtp 37.84 23.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 279' ' ' ASN . 23.2 tptp -55.46 -25.95 39.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.068 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.83 -28.69 61.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -74.93 152.33 38.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.451 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.572 ' C ' HE22 ' A' ' 269' ' ' GLN . 44.5 mt -95.33 155.42 16.74 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.651 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.724 ' N ' HE22 ' A' ' 269' ' ' GLN . 8.1 t -58.77 -142.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -58.37 -12.67 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.726 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.76 -35.39 72.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 110.101 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -52.12 -14.32 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.615 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 29.9 t -47.42 -29.26 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.623 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 292' ' ' GLY . 53.7 mttm -55.48 -29.82 59.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.013 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 290' ' ' LYS . 5.2 t 30.77 33.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.135 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 290' ' ' LYS . . . -165.91 -79.38 0.04 OUTLIER Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 295' ' ' ASP . 29.2 m -55.49 -31.17 61.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.665 -0.268 . . . . 0.0 111.547 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -45.93 -12.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.094 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 293' ' ' SER . 54.2 t0 -46.34 -37.68 7.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.43 ' H ' ' H ' ' A' ' 297' ' ' ILE . 35.6 p-10 -179.87 16.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 297' ' ' ILE . 85.5 mt 62.02 52.04 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.513 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -77.73 20.41 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.917 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.674 ' NE2' HG23 ' A' ' 297' ' ' ILE . 0.5 OUTLIER -99.97 149.83 23.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.597 ' O ' ' N ' ' A' ' 302' ' ' GLY . 74.7 t -63.54 -36.57 23.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 300' ' ' VAL . 52.2 Cg_exo -45.85 -10.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 CA-C-N 119.648 0.91 . . . . 0.0 111.689 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -150.37 -32.99 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 299' ' ' HIS . . . 169.48 96.02 0.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -156.06 -166.39 15.92 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 307' ' ' GLN . 23.0 t -125.55 92.98 3.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t 40.76 14.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.262 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' A' ' 305' ' ' SER . 29.5 tt0 -115.24 115.62 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.538 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.655 ' CG2' ' H ' ' A' ' 311' ' ' LYS . 1.1 mp -131.99 146.2 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.0 111.431 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.558 HG23 ' OG ' ' A' ' 293' ' ' SER . 76.1 t -71.16 -28.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.307 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.562 ' OH ' ' NZ ' ' A' ' 290' ' ' LYS . 1.1 p90 -138.9 -7.08 1.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.655 ' H ' ' CG2' ' A' ' 308' ' ' ILE . 25.3 mttm 62.94 112.36 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.495 1.57 0 C-N-CA 121.039 1.16 . . . . 0.0 112.233 -178.805 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -113.25 150.37 32.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.537 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -80.36 144.42 57.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.327 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 272' ' ' GLY . 90.0 Cg_endo -57.22 -12.11 9.46 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.348 2.032 . . . . 0.0 112.174 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . -37.29 -25.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -97.81 -106.03 2.47 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -85.72 169.83 43.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -97.37 120.35 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 275' ' ' VAL . 50.3 t -150.56 -15.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.416 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.648 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 0.0 OUTLIER -137.83 172.8 12.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.642 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.648 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 59.5 mt -72.36 136.39 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.642 ' C ' ' H ' ' A' ' 280' ' ' LYS . 84.9 mt -53.86 -17.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.213 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 281' ' ' LYS . 42.1 t-20 -51.76 -1.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 278' ' ' ILE . 0.0 OUTLIER -38.11 -11.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 279' ' ' ASN . 10.6 mptt -45.17 -37.05 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.229 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 282' ' ' LEU . 6.8 mp -69.5 -30.42 68.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.215 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 280' ' ' LYS . 88.3 m-20 -92.67 140.63 29.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.188 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 285' ' ' SER . 74.1 mt -112.89 160.89 17.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.588 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 287' ' ' VAL . 1.0 OUTLIER -55.6 -155.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.263 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.533 ' N ' ' OG ' ' A' ' 285' ' ' SER . 45.9 t-20 -43.35 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 289' ' ' SER . 60.0 t -52.33 -7.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.602 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 286' ' ' ASN . 98.8 mm-40 -41.2 -14.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.619 ' N ' ' O ' ' A' ' 287' ' ' VAL . 12.5 t -45.5 -21.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.464 ' N ' ' C ' ' A' ' 288' ' ' GLN . 16.1 pttp -75.34 136.0 40.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.911 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 78.8 m -84.27 -38.9 19.91 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -101.12 -76.08 1.18 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.53 ' O ' ' C ' ' A' ' 294' ' ' LYS . 3.7 p -164.67 -28.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 296' ' ' ASN . 55.8 mttp 13.99 -130.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.988 0.805 . . . . 0.0 111.944 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.463 ' O ' ' CG ' ' A' ' 296' ' ' ASN . 79.8 m-20 44.81 10.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.128 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.582 ' N ' ' O ' ' A' ' 294' ' ' LYS . 30.5 m-20 -177.98 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.918 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.61 ' O ' ' N ' ' A' ' 299' ' ' HIS . 31.5 pt -90.68 54.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 297' ' ' ILE . 82.6 tttt -37.49 88.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.497 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.61 ' N ' ' O ' ' A' ' 297' ' ' ILE . 0.2 OUTLIER -131.73 156.09 46.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.234 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 305' ' ' SER . 2.7 t -85.3 -53.48 0.46 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 56.9 Cg_endo -46.06 144.56 6.11 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.244 1.296 . . . . 0.0 111.906 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 100.2 15.94 29.03 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.71 28.64 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -81.7 -169.15 42.16 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.756 ' O ' HG13 ' A' ' 300' ' ' VAL . 4.4 m -60.16 -172.28 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 111.037 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.04 30.88 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.751 0.31 . . . . 0.0 110.944 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -65.77 -122.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.669 ' N ' HD13 ' A' ' 308' ' ' ILE . 0.2 OUTLIER -61.22 -24.67 34.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.914 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 309' ' ' VAL . 5.2 p 25.22 36.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 123.521 0.513 . . . . 0.0 112.315 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.615 ' CD2' ' O ' ' A' ' 310' ' ' TYR . 1.6 p90 -96.69 15.92 20.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.859 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 312' ' ' PRO . 24.7 tttt 67.72 62.87 0.72 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.944 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 311' ' ' LYS . 54.0 Cg_exo . . . . . 0 C--N 1.307 -1.611 0 C-N-CA 122.248 1.965 . . . . 0.0 112.288 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 59.5 tttm . . . . . 0 C--O 1.231 0.109 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -93.05 -22.35 19.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 109.993 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 6.2 mp0 -43.35 -40.9 6.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.026 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 7.6 Cg_endo -86.25 137.93 5.42 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 120.786 0.99 . . . . 0.0 111.853 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -102.69 -15.89 23.49 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.51 -38.23 86.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.84 -139.79 6.84 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 276' ' ' GLN . 41.6 mtmt -95.99 147.19 23.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 277' ' ' ILE . 2.1 t 61.84 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.345 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 274' ' ' LYS . 92.7 mm-40 -72.4 24.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.312 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 275' ' ' VAL . 93.3 mt -39.67 -26.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.96 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 276' ' ' GLN . 79.5 mt -51.6 -37.68 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.151 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.04 -1.1 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.026 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 277' ' ' ILE . 30.7 ttpt -54.61 -34.08 61.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.479 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.2 OUTLIER -56.09 -32.7 64.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.483 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 282' ' ' LEU . 9.7 mp -62.38 -37.04 84.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 85.9 m-20 -109.72 160.38 16.36 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.415 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 284' ' ' LEU . 2.9 mp -92.38 148.71 21.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.591 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.3 m -57.26 72.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.346 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 284' ' ' LEU . 82.7 m-20 61.42 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.97 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.591 ' H ' ' C ' ' A' ' 285' ' ' SER . 20.8 m -59.03 -7.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 286' ' ' ASN . 38.6 tt0 -46.82 -28.89 1.7 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.247 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 68.0 p -53.26 -19.78 3.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.211 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.504 ' C ' ' SG ' ' A' ' 291' ' ' CYS . 18.8 ptmt -54.09 -18.74 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.264 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' CYS . . . . . 0.504 ' SG ' ' C ' ' A' ' 290' ' ' LYS . 1.3 p 34.48 62.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.944 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 76.18 -117.94 5.19 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 3.1 p -35.78 118.53 0.5 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.266 0.555 . . . . 0.0 112.482 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 45.6 tttp 179.11 -73.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.02 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -94.17 -70.08 0.72 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -150.32 -0.57 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.78 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 299' ' ' HIS . 6.3 mm -69.96 -4.82 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -44.49 -12.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.565 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.919 ' O ' HG13 ' A' ' 300' ' ' VAL . 2.8 p80 -75.11 -173.36 1.95 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.573 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 299' ' ' HIS . 1.9 m -178.13 80.66 0.23 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.623 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.505 ' HG2' ' H ' ' A' ' 311' ' ' LYS . 8.3 Cg_exo -41.43 136.54 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.108 1.205 . . . . 0.0 111.956 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.72 5.48 62.94 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 175.42 -7.63 0.03 OUTLIER Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -83.98 -171.29 47.67 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 307' ' ' GLN . 0.1 OUTLIER -71.82 18.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 306' ' ' VAL . 13.8 p 41.86 20.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.869 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 305' ' ' SER . 3.1 pt20 -60.08 -42.61 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.9 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -124.32 164.23 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 309' ' ' VAL . 5.7 p -129.9 98.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 0.0 OUTLIER 168.35 -20.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.006 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.505 ' H ' ' HG2' ' A' ' 301' ' ' PRO . 19.5 tttt 66.26 68.99 0.6 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 111.129 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.408 ' HG2' ' HE2' ' A' ' 299' ' ' HIS . 80.7 Cg_exo . . . . . 0 C--N 1.306 -1.691 0 C-N-CA 122.14 1.893 . . . . 0.0 112.115 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.45 ' CG ' ' H ' ' A' ' 268' ' ' HIS . 16.2 tptp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.793 0.33 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.45 ' H ' ' CG ' ' A' ' 267' ' ' LYS . 2.1 t60 -87.23 -17.97 31.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.473 0.654 . . . . 0.0 109.326 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.411 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 42.7 mt-30 -41.62 -36.66 1.11 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.969 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 271' ' ' GLY . 14.1 Cg_endo -100.62 143.41 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 118.965 0.666 . . . . 0.0 112.246 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . 33.1 -106.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.46 71.51 0.44 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 76.81 33.61 45.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.98 147.32 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.143 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.657 ' C ' ' H ' ' A' ' 277' ' ' ILE . 16.2 m -63.42 -9.19 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.164 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 278' ' ' ILE . 93.1 mt-30 -57.24 12.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.657 ' H ' ' C ' ' A' ' 275' ' ' VAL . 17.4 tt -42.87 -21.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.579 0.228 . . . . 0.0 110.812 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 276' ' ' GLN . 21.9 pt -53.98 -26.2 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.872 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.604 ' C ' HD22 ' A' ' 279' ' ' ASN . 0.4 OUTLIER -115.93 38.54 3.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.515 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -61.84 -18.94 61.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.732 -179.421 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.495 ' NZ ' HD21 ' A' ' 282' ' ' LEU . 0.0 OUTLIER -57.68 -23.58 52.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.724 -178.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.495 HD21 ' NZ ' ' A' ' 281' ' ' LYS . 84.0 mt -56.8 -37.89 71.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.58 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -127.59 116.45 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.44 11.14 5.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.433 ' HA ' HE21 ' A' ' 288' ' ' GLN . 87.1 p -44.21 -35.95 2.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.3 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -62.86 -42.42 99.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.073 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 76.1 t -72.63 -35.61 51.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.249 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 290' ' ' LYS . 61.5 mt-30 -55.74 -42.84 75.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.593 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 288' ' ' GLN . 5.8 t 22.3 35.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.902 0.751 . . . . 0.0 112.785 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 288' ' ' GLN . 80.1 mttt -146.25 141.61 27.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 71.9 m -70.09 -38.38 75.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.775 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -164.49 93.54 0.11 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.33 -31.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.092 0.472 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 296' ' ' ASN . 65.1 tttm -137.39 123.14 19.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.39 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 297' ' ' ILE . 60.4 t0 60.6 -68.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.617 ' C ' ' H ' ' A' ' 298' ' ' LYS . 92.5 m-20 -70.84 12.35 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.536 ' H ' ' C ' ' A' ' 295' ' ' ASP . 0.7 OUTLIER -47.01 -4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.351 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.617 ' H ' ' C ' ' A' ' 296' ' ' ASN . 52.6 mttp 64.84 36.48 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.449 ' CG ' ' HD2' ' A' ' 301' ' ' PRO . 0.2 OUTLIER -125.8 153.27 44.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.367 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.684 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 62.1 t -103.77 -25.8 0.21 Allowed Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -48.53 140.01 22.33 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 CA-C-N 119.331 0.797 . . . . 0.0 111.774 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.62 11.62 57.88 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.46 49.09 4.78 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -91.93 -114.58 2.02 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.4 ' N ' HG13 ' A' ' 300' ' ' VAL . 26.0 m -101.51 -116.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.646 0.26 . . . . 0.0 110.819 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 306' ' ' VAL . 6.2 p -163.59 8.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.754 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.441 HE22 ' HA ' ' A' ' 298' ' ' LYS . 16.6 pt20 -61.52 -44.63 96.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.052 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 310' ' ' TYR . 1.8 pp -128.91 168.73 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.772 0.32 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.432 ' N ' HD12 ' A' ' 308' ' ' ILE . 1.5 t -124.32 -23.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.78 ' O ' HD13 ' A' ' 308' ' ' ILE . 43.9 p90 -88.31 130.28 35.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.95 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.21 131.54 58.81 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 N--CA 1.489 1.257 0 C-N-CA 121.021 1.147 . . . . 0.0 112.296 178.781 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.79 0.329 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.404 ' NE2' ' HD3' ' A' ' 280' ' ' LYS . 2.5 p-80 -103.1 157.5 16.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.535 ' N ' ' CD ' ' A' ' 269' ' ' GLN . 0.2 OUTLIER -112.91 100.09 50.11 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.464 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -68.94 -18.78 40.77 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.801 1.667 . . . . 0.0 112.064 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.86 -34.75 4.59 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.58 -32.62 65.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.29 -63.34 3.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.3 -35.71 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 275' ' ' VAL . 34.2 m -91.84 129.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.775 0.321 . . . . 0.0 110.808 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.05 -31.24 69.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 279' ' ' ASN . 40.7 mt -140.89 -119.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.016 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 277' ' ' ILE . 69.2 mt 55.66 -74.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.014 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 277' ' ' ILE . 2.0 m-20 -76.48 2.32 14.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.404 ' HD3' ' NE2' ' A' ' 268' ' ' HIS . 31.2 ttpt -51.48 -27.07 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.645 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.21 -35.1 48.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 282' ' ' LEU . 10.0 mp -66.68 -32.83 74.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.233 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -82.96 119.59 24.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 1.034 ' H ' HD22 ' A' ' 284' ' ' LEU . 1.0 OUTLIER -70.72 -25.28 62.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.2 t 93.46 -139.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.216 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -57.09 -30.55 64.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.7 -32.45 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.148 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.615 ' O ' ' N ' ' A' ' 290' ' ' LYS . 61.6 tt0 -52.36 -40.55 62.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 288' ' ' GLN . 18.9 t 11.42 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.175 0.922 . . . . 0.0 112.375 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 288' ' ' GLN . 23.3 mtpp 58.26 58.67 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.384 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 288' ' ' GLN . 93.3 m -37.97 -34.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -137.5 -34.24 0.2 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 294' ' ' LYS . 1.0 OUTLIER 173.51 9.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 293' ' ' SER . 14.9 tptp 92.41 -48.13 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 296' ' ' ASN . 53.8 p30 -67.58 -23.02 65.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.642 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 63.9 t30 -55.25 -36.23 65.83 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.836 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 297' ' ' ILE . 0.2 OUTLIER -63.41 -33.57 62.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -102.37 45.79 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.378 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.682 ' HB2' HD11 ' A' ' 308' ' ' ILE . 0.0 OUTLIER -111.78 132.67 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.473 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 302' ' ' GLY . 42.4 t -34.57 -49.89 1.0 Allowed Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.595 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 9.1 Cg_endo -60.33 81.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 120.778 0.985 . . . . 0.0 110.31 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 106.76 1.38 36.82 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 299' ' ' HIS . . . 123.72 121.91 2.67 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 170.79 -172.78 44.41 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.2 m -86.88 -79.63 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 0.0 110.7 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 306' ' ' VAL . 3.6 p -179.87 7.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.348 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -52.91 -43.93 66.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.764 HD12 ' C ' ' A' ' 308' ' ' ILE . 1.7 pp -131.13 167.69 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.529 ' N ' HD12 ' A' ' 308' ' ' ILE . 11.4 p -161.31 -4.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.22 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -53.78 -8.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 309' ' ' VAL . 21.5 ttmt 68.19 64.48 0.63 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo . . . . . 0 C--N 1.306 -1.696 0 C-N-CA 122.513 2.142 . . . . 0.0 112.148 179.875 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -64.52 -23.58 67.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 0.0 OUTLIER 79.3 143.67 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 272' ' ' GLY . 60.7 Cg_endo -53.55 -36.73 81.48 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.29 1.993 . . . . 0.0 112.435 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.498 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 55.62 -78.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -56.78 -30.9 60.29 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 86.12 21.28 52.97 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -58.32 -41.88 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.818 HG13 ' H ' ' A' ' 276' ' ' GLN . 1.6 p 176.55 -97.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.425 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.818 ' H ' HG13 ' A' ' 275' ' ' VAL . 17.5 mm100 37.39 -126.7 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 277' ' ' ILE . 4.2 mp -103.4 110.81 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.79 HD12 ' H ' ' A' ' 278' ' ' ILE . 3.2 mp -66.23 -29.55 47.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -74.4 69.38 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.904 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -55.28 -37.2 66.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 10.4 mptt -56.12 -30.42 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.131 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 35.9 tp -61.67 -37.14 82.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -106.03 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 286' ' ' ASN . 23.7 mt -99.88 148.85 24.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.106 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.634 ' C ' ' H ' ' A' ' 287' ' ' VAL . 1.1 m -61.66 67.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.364 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 288' ' ' GLN . 42.9 t-20 60.94 -25.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.699 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.634 ' H ' ' C ' ' A' ' 285' ' ' SER . 8.4 p -50.68 -8.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.778 0.323 . . . . 0.0 110.19 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 286' ' ' ASN . 88.7 mt-30 -40.57 -18.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 287' ' ' VAL . 25.4 t -48.41 -9.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 288' ' ' GLN . 41.1 mttp -51.41 -29.73 16.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.681 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 2.2 t 63.72 -67.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.679 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 290' ' ' LYS . . . -161.84 127.6 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.699 ' H ' ' CD2' ' A' ' 299' ' ' HIS . 31.9 m 30.44 97.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -138.75 -79.87 0.33 Allowed 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.164 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.61 -50.84 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 297' ' ' ILE . 28.8 t30 -176.67 -13.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.607 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.639 ' O ' ' N ' ' A' ' 299' ' ' HIS . 46.6 pt -57.31 -24.63 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.596 ' HE3' HE22 ' A' ' 307' ' ' GLN . 55.3 pttt 27.21 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.874 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.699 ' CD2' ' H ' ' A' ' 293' ' ' SER . 0.3 OUTLIER -68.14 169.03 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.153 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.652 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 93.9 t -80.27 -53.31 0.92 Allowed Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 52.5 Cg_endo -50.09 141.96 28.94 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.554 1.503 . . . . 0.0 112.269 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.22 57.14 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.25 21.12 57.64 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 305' ' ' SER . . . -81.63 -158.92 22.83 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 306' ' ' VAL . 28.4 t -49.98 -170.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 111.102 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.525 ' N ' ' OG ' ' A' ' 305' ' ' SER . 17.0 m -119.38 23.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.21 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.596 HE22 ' HE3' ' A' ' 298' ' ' LYS . 0.8 OUTLIER -85.19 -104.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 111.79 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 308' ' ' ILE . 0.0 OUTLIER -90.24 136.51 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.302 0.572 . . . . 0.0 112.306 -178.243 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 309' ' ' VAL . 13.8 p -107.8 -5.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.509 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 308' ' ' ILE . 15.8 p90 -60.4 -11.0 5.56 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.959 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 72.1 tttt 67.41 104.38 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo . . . . . 0 C--N 1.31 -1.485 0 C-N-CA 122.035 1.824 . . . . 0.0 112.191 178.303 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 271' ' ' GLY . 15.0 t-80 -72.59 -32.23 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.498 ' O ' ' OD2' ' A' ' 283' ' ' ASP . 7.5 mt-30 -38.27 -39.72 0.78 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.974 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.06 -28.13 49.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.424 1.416 . . . . 0.0 112.575 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 268' ' ' HIS . . . 98.26 71.06 1.01 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 156.49 15.64 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 69.53 -59.19 0.67 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -72.38 146.29 47.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.683 0.278 . . . . 0.0 110.332 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.411 ' H ' HG12 ' A' ' 275' ' ' VAL . 3.1 p -69.71 128.76 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.15 0.5 . . . . 0.0 110.749 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -120.64 161.95 20.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.418 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.77 -17.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 85.6 mt -57.15 140.08 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 0.4 OUTLIER -66.04 112.91 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 110.354 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -57.98 -34.02 69.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.776 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.731 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -57.82 -22.42 47.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.63 -36.94 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.328 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.498 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 39.0 m-20 -104.71 163.85 12.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.389 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 286' ' ' ASN . 24.6 mt -81.6 154.55 26.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.631 ' C ' ' H ' ' A' ' 287' ' ' VAL . 2.6 m -56.34 69.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.663 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 284' ' ' LEU . 14.4 m120 58.73 -22.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.631 ' H ' ' C ' ' A' ' 285' ' ' SER . 9.4 p -58.64 -22.26 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.91 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 290' ' ' LYS . 11.2 pt20 -51.12 -112.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.01 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.51 ' O ' ' OG ' ' A' ' 293' ' ' SER . 43.9 t 36.11 -89.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 288' ' ' GLN . 11.9 ptmm? -63.17 -37.59 87.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.404 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' CYS . . . . . 0.547 ' O ' ' N ' ' A' ' 296' ' ' ASN . 7.2 m -77.42 -80.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.45 5.01 57.72 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.025 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -135.07 25.47 3.57 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.733 0.766 . . . . 0.0 111.534 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -170.49 -53.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.748 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -93.15 -74.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.066 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.547 ' N ' ' O ' ' A' ' 291' ' ' CYS . 83.9 m-20 -58.08 -32.6 68.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.788 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.488 ' C ' ' N ' ' A' ' 299' ' ' HIS . 0.0 OUTLIER -50.8 -20.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -50.8 -13.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.585 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.623 ' ND1' ' C ' ' A' ' 299' ' ' HIS . 1.4 p80 -89.29 -170.71 2.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.001 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 300' ' ' VAL . 1.9 p 176.39 80.46 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.06 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.448 ' HG2' ' H ' ' A' ' 311' ' ' LYS . 20.3 Cg_exo -40.37 136.58 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.371 1.38 . . . . 0.0 111.877 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 92.36 5.93 64.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.423 ' H ' ' H ' ' A' ' 304' ' ' GLY . . . 175.02 -6.59 0.03 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -83.06 -169.93 45.37 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 18.7 p -70.11 5.35 1.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.0 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 304' ' ' GLY . 2.2 t 59.3 13.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -60.38 -38.88 85.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 110.003 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.551 HD11 ' CE1' ' A' ' 299' ' ' HIS . 2.3 pp -129.11 168.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.883 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 18.0 m -127.44 4.23 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.1 OUTLIER -91.38 -7.67 50.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.092 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 310' ' ' TYR . 12.4 pttt 35.59 64.99 1.99 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 110.694 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 98.5 Cg_exo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.309 2.006 . . . . 0.0 112.33 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.745 0.307 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.564 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 4.1 m170 -134.07 177.41 7.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.608 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 268' ' ' HIS . 30.6 tt0 93.26 71.4 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.207 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -52.27 134.42 50.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.497 2.131 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -59.96 -32.22 74.67 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -168.67 21.85 0.09 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.16 35.68 33.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 275' ' ' VAL . 86.4 mttt -59.1 -39.54 82.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.35 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 274' ' ' LYS . 71.5 t -156.94 -41.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.376 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' H ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -65.54 163.61 15.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 110.579 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.536 ' C ' ' H ' ' A' ' 279' ' ' ASN . 68.3 mt -72.7 141.53 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.86 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 278' ' ' ILE . 48.9 mm -62.82 6.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 277' ' ' ILE . 87.0 m-20 -61.97 13.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.61 ' H ' ' C ' ' A' ' 278' ' ' ILE . 54.2 pttt -40.76 -37.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.667 0.27 . . . . 0.0 111.126 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.461 ' HZ2' ' CB ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -54.92 -30.92 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.427 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 279' ' ' ASN . 31.9 tp -57.02 -37.75 72.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.442 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 286' ' ' ASN . 44.1 t0 -149.95 33.6 0.67 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.841 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' LYS . 7.4 tt -57.94 -36.95 73.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 289' ' ' SER . 87.4 p -57.27 -24.01 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.081 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.461 ' OD1' ' N ' ' A' ' 287' ' ' VAL . 43.8 p-10 -53.32 -36.44 61.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.916 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.461 ' N ' ' OD1' ' A' ' 286' ' ' ASN . 54.7 t -75.76 -53.66 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.531 ' C ' ' H ' ' A' ' 290' ' ' LYS . 0.0 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.706 -178.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.609 ' N ' ' O ' ' A' ' 285' ' ' SER . 3.6 t 67.33 -8.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 110.102 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 288' ' ' GLN . 38.2 tptt -118.98 132.47 56.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.82 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' CYS . . . . . 0.716 ' CB ' HD22 ' A' ' 296' ' ' ASN . 50.9 t -127.7 141.08 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.149 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.6 11.48 60.64 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.709 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 294' ' ' LYS . 26.8 t -167.01 6.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.303 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 296' ' ' ASN . 85.4 mttt -158.86 126.81 5.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.4 t70 59.57 -69.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.716 HD22 ' CB ' ' A' ' 291' ' ' CYS . 87.2 m-20 -49.17 -28.51 4.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.584 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 294' ' ' LYS . 2.5 pp -49.89 -11.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 109.995 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 296' ' ' ASN . 1.0 OUTLIER -56.62 -14.65 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.894 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.584 ' ND1' ' C ' ' A' ' 299' ' ' HIS . 4.0 p80 -67.77 -165.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 300' ' ' VAL . 2.3 p 173.58 78.39 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.231 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 311' ' ' LYS . 6.3 Cg_exo -40.04 133.74 1.9 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.376 1.384 . . . . 0.0 111.784 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.42 1.56 66.34 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -171.16 -16.96 0.02 OUTLIER Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -80.6 -174.9 48.72 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.415 ' HB2' ' NE2' ' A' ' 307' ' ' GLN . 69.7 m -76.66 8.93 3.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.0 110.187 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 306' ' ' VAL . 16.6 t 63.39 26.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.695 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.415 ' NE2' ' HB2' ' A' ' 305' ' ' SER . 0.0 OUTLIER -60.44 -44.31 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.669 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.651 HD13 ' H ' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -123.57 167.42 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.27 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.86 9.75 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.898 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -106.22 3.86 28.25 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.025 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 310' ' ' TYR . 6.7 ptmt 34.12 56.16 1.79 Allowed Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.644 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.441 ' C ' ' O ' ' A' ' 311' ' ' LYS . 90.4 Cg_exo . . . . . 0 C--N 1.307 -1.642 0 C-N-CA 122.666 2.244 . . . . 0.0 112.394 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 53.3 tttp . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.756 0.312 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -81.78 143.62 31.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -63.3 148.27 93.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.185 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.98 151.29 58.71 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.855 1.703 . . . . 0.0 112.321 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.1 35.16 1.38 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 97.0 -0.19 60.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -114.05 -49.26 0.54 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 150.27 20.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.379 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 275' ' ' VAL . 10.1 p -133.89 3.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.874 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -57.68 -39.65 77.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.231 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 280' ' ' LYS . 55.2 mt -111.09 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.15 -38.42 82.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.763 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 280' ' ' LYS . 21.9 p30 -82.58 1.6 37.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.565 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.654 ' C ' ' H ' ' A' ' 282' ' ' LEU . 39.7 mtmt 40.03 -149.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 55.79 -19.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.089 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 280' ' ' LYS . 35.8 tp -64.67 -39.68 94.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 283' ' ' ASP . 51.8 p30 -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.7 mt -106.39 147.47 29.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.099 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.2 m -63.01 86.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 63.08 -29.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.397 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.614 ' H ' ' C ' ' A' ' 285' ' ' SER . 54.3 t -57.49 -26.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.017 0.437 . . . . 0.0 110.029 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.547 ' C ' ' N ' ' A' ' 290' ' ' LYS . 2.3 pt20 -44.19 -10.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.234 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.593 ' N ' ' O ' ' A' ' 287' ' ' VAL . 8.7 t -46.4 -19.79 0.09 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.547 ' N ' ' C ' ' A' ' 288' ' ' GLN . 48.8 mttm -81.47 145.89 30.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.668 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 79.9 m -61.04 -31.51 71.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.701 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -132.7 -73.7 0.1 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 7.2 t 174.49 75.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.479 ' H ' ' HD3' ' A' ' 290' ' ' LYS . 67.2 mttm -54.3 -30.94 52.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -51.51 -43.2 62.19 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.797 ' O ' HG22 ' A' ' 297' ' ' ILE . 15.5 m120 -92.17 -30.71 15.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 296' ' ' ASN . 19.8 tt 120.06 63.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 125.238 1.586 . . . . 0.0 109.61 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.542 ' C ' ' O ' ' A' ' 297' ' ' ILE . 10.2 ptmm? 1.17 66.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.809 0.693 . . . . 0.0 112.633 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.605 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 0.5 OUTLIER -126.5 135.97 52.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.794 179.07 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 302' ' ' GLY . 94.0 t -50.74 -34.28 11.44 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 121.47 -0.769 . . . . 0.0 112.026 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 300' ' ' VAL . 46.9 Cg_exo -45.15 -12.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 CA-C-N 119.025 0.688 . . . . 0.0 111.697 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -143.72 30.35 1.95 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.95 14.25 79.8 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 299' ' ' HIS . . . -89.04 -168.75 44.09 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 299' ' ' HIS . 14.5 m -69.68 159.8 32.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.5 p -63.66 -7.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.128 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 297' ' ' ILE . 12.5 pt20 -46.18 -23.58 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.772 0.32 . . . . 0.0 111.505 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 308' ' ' ILE . 0.0 OUTLIER -42.78 154.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 110.816 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 308' ' ' ILE . 14.4 m -133.76 -13.56 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.525 ' O ' ' O ' ' A' ' 311' ' ' LYS . 47.4 p90 -106.39 -10.8 16.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 310' ' ' TYR . 9.8 pttp 31.66 97.29 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 122.966 0.166 . . . . 0.0 111.045 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo . . . . . 0 N--CA 1.491 1.344 0 C-N-CA 120.937 1.091 . . . . 0.0 112.212 -178.896 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.406 ' O ' ' CD ' ' A' ' 270' ' ' PRO . 62.6 mttp . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.584 0.23 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.624 ' O ' ' N ' ' A' ' 270' ' ' PRO . 71.8 t60 -64.75 -13.53 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.214 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.4 OUTLIER -29.34 -30.58 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.949 -178.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.624 ' N ' ' O ' ' A' ' 268' ' ' HIS . 4.4 Cg_endo -112.26 122.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.082 1.188 . . . . 0.0 111.662 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' A' ' 282' ' ' LEU . . . -55.11 -27.84 47.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.39 -32.57 30.47 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.5 -82.71 1.55 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.4 -23.46 62.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.28 133.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -106.93 149.48 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.004 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 279' ' ' ASN . 16.4 mm 41.46 -120.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.407 ' N ' HG22 ' A' ' 277' ' ' ILE . 74.8 mt 38.89 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.128 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.607 ' N ' ' O ' ' A' ' 277' ' ' ILE . 38.2 p-10 -94.1 19.72 8.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.7 OUTLIER -40.73 -20.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.648 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.9 OUTLIER -54.87 -29.86 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.504 HD12 ' ND2' ' A' ' 279' ' ' ASN . 84.3 mt -58.05 -37.77 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.503 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.786 ' C ' HD13 ' A' ' 284' ' ' LEU . 92.4 m-20 -137.94 162.64 33.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.316 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 1.093 ' H ' HD22 ' A' ' 284' ' ' LEU . 0.0 OUTLIER -105.71 171.15 7.49 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 287' ' ' VAL . 35.8 m -45.84 172.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.577 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -45.69 -6.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.423 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 285' ' ' SER . 4.7 p -51.39 -25.92 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.32 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 290' ' ' LYS . 97.2 mt-30 -36.12 -77.15 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 33.3 t 43.33 11.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.161 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 288' ' ' GLN . 59.9 mttp -135.45 131.41 36.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 77.6 m -72.73 -32.29 65.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.45 55.16 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.934 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.467 ' O ' ' CG1' ' A' ' 297' ' ' ILE . 70.0 m -85.73 18.07 3.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.88 -77.86 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 -43.48 98.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.155 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.613 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 64.5 m-20 -92.71 2.01 56.97 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.829 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.518 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 0.4 OUTLIER -52.37 -19.76 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.515 ' HZ3' HG22 ' A' ' 297' ' ' ILE . 37.8 mmtm -83.02 1.69 38.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.657 ' CE1' HD11 ' A' ' 308' ' ' ILE . 0.0 OUTLIER -54.3 -121.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.195 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 300' ' ' VAL . 2.8 p -175.63 31.97 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.994 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.544 ' C ' ' N ' ' A' ' 303' ' ' GLY . 14.2 Cg_exo 19.25 -120.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 113.871 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 301' ' ' PRO . . . 44.16 21.41 0.24 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.544 ' N ' ' C ' ' A' ' 301' ' ' PRO . . . 151.18 -36.61 0.88 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.23 94.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.625 ' O ' HG13 ' A' ' 306' ' ' VAL . 14.1 t 171.8 -125.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 305' ' ' SER . 11.8 m -161.56 61.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.206 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 309' ' ' VAL . 91.1 mm-40 -110.54 -112.84 0.32 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.925 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.8 HD12 ' H ' ' A' ' 309' ' ' VAL . 0.6 OUTLIER -59.7 -31.38 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.8 ' H ' HD12 ' A' ' 308' ' ' ILE . 33.3 t 46.33 45.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.306 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.615 ' O ' ' CG ' ' A' ' 310' ' ' TYR . 0.8 OUTLIER -175.25 33.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.125 0.488 . . . . 0.0 110.276 178.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 310' ' ' TYR . 14.8 pttm 34.43 77.91 0.35 Allowed Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.102 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 C-N-CA 121.387 1.391 . . . . 0.0 112.35 -178.008 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 69.0 tttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.793 0.33 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -110.83 159.79 17.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.719 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.485 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 2.6 tt0 -82.6 138.63 44.12 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.836 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 272' ' ' GLY . 17.9 Cg_endo -59.9 -25.94 80.88 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 120.404 0.736 . . . . 0.0 112.283 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 45.34 -86.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -55.94 -32.97 59.8 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.7 76.18 0.55 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.514 ' C ' HG23 ' A' ' 275' ' ' VAL . 68.4 mttm -90.51 16.95 8.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 110.442 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.514 HG23 ' C ' ' A' ' 274' ' ' LYS . 2.4 t 73.06 3.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.626 ' C ' ' H ' ' A' ' 278' ' ' ILE . 83.1 mt-30 -74.16 32.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.468 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 279' ' ' ASN . 20.4 pt -48.77 -1.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.603 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.626 ' H ' ' C ' ' A' ' 276' ' ' GLN . 15.4 mm -43.82 -12.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.828 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 277' ' ' ILE . 6.8 t-20 101.15 28.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.922 0.764 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.406 ' HZ1' HG21 ' A' ' 278' ' ' ILE . 1.2 mptt -57.48 -11.91 2.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.331 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -48.46 -30.87 5.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 72.2 mt -62.6 -29.7 70.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 110.028 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -80.17 151.24 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 285' ' ' SER . 75.1 mt -97.82 161.37 13.78 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 287' ' ' VAL . 22.6 t -51.45 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -44.3 -12.65 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.748 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 285' ' ' SER . 6.3 p -61.48 -27.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.926 0.393 . . . . 0.0 110.249 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 290' ' ' LYS . 60.9 tt0 -53.63 -30.3 42.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 288' ' ' GLN . 1.0 OUTLIER 35.75 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.609 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 288' ' ' GLN . 65.8 mmtt -88.65 151.46 22.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 86.9 m -56.97 -30.85 64.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.574 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -172.72 92.51 0.09 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.643 ' C ' ' H ' ' A' ' 295' ' ' ASP . 24.1 t -179.96 110.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt 61.78 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.579 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.643 ' H ' ' C ' ' A' ' 293' ' ' SER . 78.7 m-20 -56.2 -37.32 69.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 0.0 110.657 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -168.11 -34.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.737 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.676 ' O ' ' N ' ' A' ' 299' ' ' HIS . 28.9 pt -69.54 -27.36 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 297' ' ' ILE . 0.0 OUTLIER 28.93 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.93 0.769 . . . . 0.0 110.828 -178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.802 ' CD2' ' H ' ' A' ' 300' ' ' VAL . 0.3 OUTLIER -49.85 -49.5 48.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.217 -179.355 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.802 ' H ' ' CD2' ' A' ' 299' ' ' HIS . 15.5 t 134.06 -48.99 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 124.561 1.163 . . . . 0.0 109.695 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 302' ' ' GLY . 25.7 Cg_exo -51.84 -30.18 37.47 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.196 1.264 . . . . 0.0 111.618 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.664 ' N ' ' NE2' ' A' ' 299' ' ' HIS . . . -47.06 -91.31 0.01 OUTLIER Glycine 0 C--N 1.333 0.416 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -58.15 -29.23 62.39 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 84.61 147.16 8.36 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.342 -0.929 . . . . 0.0 112.032 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.592 ' C ' HG23 ' A' ' 306' ' ' VAL . 23.0 t -176.59 -20.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.592 HG23 ' C ' ' A' ' 305' ' ' SER . 2.2 t 74.44 35.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.386 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.722 ' H ' HG11 ' A' ' 300' ' ' VAL . 77.7 mt-30 -79.03 -65.93 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.586 ' C ' HG23 ' A' ' 309' ' ' VAL . 24.4 pt -74.37 -19.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.586 HG23 ' C ' ' A' ' 308' ' ' ILE . 1.5 t 66.65 -28.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.45 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.614 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 20.9 p90 -108.37 133.37 52.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.744 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.441 ' O ' ' OXT' ' A' ' 312' ' ' PRO . 1.9 ptmm? -98.28 124.28 47.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.628 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.441 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 75.4 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 C-N-CA 121.075 1.183 . . . . 0.0 112.201 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 30.0 tptt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.596 ' ND1' ' OE1' ' A' ' 269' ' ' GLN . 85.8 t60 -91.97 147.14 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.241 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.62 ' CD ' ' H ' ' A' ' 269' ' ' GLN . 0.1 OUTLIER -63.57 146.15 96.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.268 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -57.58 150.15 62.66 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.865 1.71 . . . . 0.0 111.957 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -56.22 -33.89 61.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 274' ' ' LYS . . . 143.31 -39.64 1.29 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -72.19 9.55 5.41 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 272' ' ' GLY . 2.5 ttmp? 66.64 44.92 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.546 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.09 -36.1 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -113.1 144.13 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.53 -20.45 26.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.23 130.84 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.216 0.531 . . . . 0.0 110.663 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -87.14 143.68 27.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.574 ' CD ' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -51.9 -34.78 42.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.476 -179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.483 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER -58.78 -39.03 79.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.876 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.1 -30.13 70.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.354 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.47 ' OD2' ' NE2' ' A' ' 269' ' ' GLN . 65.4 t0 -77.61 116.67 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 0.0 110.934 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 285' ' ' SER . 54.7 mt -65.12 -38.12 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.338 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.8 m 152.08 57.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 71.79 -22.45 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.148 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 289' ' ' SER . 75.1 t -60.78 -28.68 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.016 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 290' ' ' LYS . 58.7 tt0 -45.05 -9.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 287' ' ' VAL . 32.1 t -35.02 -30.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.016 0.436 . . . . 0.0 109.961 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 288' ' ' GLN . 12.9 tptm -114.57 147.93 38.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 20.8 p -68.86 125.04 25.36 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.317 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . 99.18 -35.61 4.57 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 292' ' ' GLY . 2.4 m 153.7 -86.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.834 0.35 . . . . 0.0 110.095 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -149.06 31.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.56 ' OD2' ' NZ ' ' A' ' 290' ' ' LYS . 87.1 m-20 55.82 45.22 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 295' ' ' ASP . 81.7 m-20 -152.63 -15.72 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.006 0.432 . . . . 0.0 109.967 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 299' ' ' HIS . 13.1 pt -140.8 7.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -46.59 87.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.606 ' N ' ' O ' ' A' ' 297' ' ' ILE . 4.0 p80 -174.96 154.85 1.92 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.621 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 306' ' ' VAL . 1.6 t -58.85 -66.87 1.16 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.743 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 32.8 Cg_endo -52.01 105.21 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.756 1.637 . . . . 0.0 111.516 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 103.18 -1.0 47.17 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 100.19 131.76 7.48 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 178.66 -167.54 38.02 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.543 ' C ' HG23 ' A' ' 306' ' ' VAL . 91.7 p -63.24 -14.55 50.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.612 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 300' ' ' VAL . 2.6 t 75.83 75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -136.09 -69.96 0.48 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.454 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.977 ' O ' HD12 ' A' ' 308' ' ' ILE . 2.7 pp -110.36 131.57 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.27 0.557 . . . . 0.0 112.029 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.602 ' C ' ' H ' ' A' ' 311' ' ' LYS . 17.6 m -85.92 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.773 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -49.35 0.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.51 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.602 ' H ' ' C ' ' A' ' 309' ' ' VAL . 13.0 pttt 34.96 93.37 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.744 0.307 . . . . 0.0 111.242 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo . . . . . 0 C--N 1.309 -1.525 0 C-N-CA 122.11 1.874 . . . . 0.0 112.32 179.379 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 66.8 mttt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.466 ' CD2' ' OE1' ' A' ' 288' ' ' GLN . 1.4 t60 -58.8 -37.91 77.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.453 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -66.0 139.74 96.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.41 -23.99 76.47 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 120.225 0.617 . . . . 0.0 112.205 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.52 41.67 50.7 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.16 20.67 29.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 84.05 45.99 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.478 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.468 ' HG2' HG12 ' A' ' 275' ' ' VAL . 57.8 tttp -57.61 -48.33 79.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.576 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 276' ' ' GLN . 4.4 p 173.43 -23.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 275' ' ' VAL . 0.0 OUTLIER -55.08 -153.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.306 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.544 ' C ' ' H ' ' A' ' 279' ' ' ASN . 64.8 mt -57.88 -16.19 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.566 0.222 . . . . 0.0 110.771 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 278' ' ' ILE . 91.8 mt 65.1 -19.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.52 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 277' ' ' ILE . 74.9 m-20 -89.96 79.56 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.512 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.469 ' H ' ' HE3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -58.65 -24.62 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.333 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -54.88 -38.38 67.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.77 -35.87 81.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.274 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.13 127.05 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.783 HD12 ' N ' ' A' ' 284' ' ' LEU . 5.7 mp -70.84 -24.75 62.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 9.7 p 95.8 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.947 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 65.34 -52.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.752 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 289' ' ' SER . 9.4 p -56.89 -21.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 110.14 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 290' ' ' LYS . 62.1 tt0 -44.25 -13.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.108 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 287' ' ' VAL . 37.5 m -40.43 -23.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.569 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 288' ' ' GLN . 39.2 mmtm -55.58 -31.78 62.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 2.0 t 72.5 -60.02 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 179.02 -170.06 41.68 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 19.8 t 59.07 16.29 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.754 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 297' ' ' ILE . 84.0 mttt -146.18 -90.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.0 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.49 -43.16 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 22.2 m120 -85.54 -3.97 59.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.521 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.734 HD13 ' O ' ' A' ' 297' ' ' ILE . 0.2 OUTLIER -49.89 -26.31 2.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.41 ' O ' ' CA ' ' A' ' 304' ' ' GLY . 14.9 ptpt -71.01 18.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.453 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 296' ' ' ASN . 0.0 OUTLIER -104.14 148.11 26.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 302' ' ' GLY . 70.2 t -48.18 -43.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.87 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 300' ' ' VAL . 26.4 Cg_exo -46.49 -11.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 120.609 0.873 . . . . 0.0 111.304 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -156.62 32.58 0.57 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 86.67 86.18 1.07 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 300' ' ' VAL . . . -133.27 176.45 19.6 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.576 ' C ' HG23 ' A' ' 306' ' ' VAL . 43.0 p -87.93 10.6 18.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.406 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.576 HG23 ' C ' ' A' ' 305' ' ' SER . 2.7 t 79.75 82.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.947 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.54 ' CD ' ' N ' ' A' ' 307' ' ' GLN . 0.0 OUTLIER -123.33 -91.92 0.54 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.147 179.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 1.055 HD12 ' N ' ' A' ' 309' ' ' VAL . 2.7 pp -61.18 -47.63 92.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 1.055 ' N ' HD12 ' A' ' 308' ' ' ILE . 21.6 t 39.86 13.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.833 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.639 ' N ' ' O ' ' A' ' 308' ' ' ILE . 0.2 OUTLIER -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.142 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 310' ' ' TYR . 34.1 tttp 75.22 95.79 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.998 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.086 179.817 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.841 0.353 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -67.51 153.86 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.47 151.31 88.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.343 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.38 150.17 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.746 1.63 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.07 48.35 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.07 -37.03 36.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.57 177.81 45.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -114.41 121.65 44.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.172 0.511 . . . . 0.0 110.933 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 275' ' ' VAL . 7.5 p -132.13 -13.31 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.646 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 0.0 OUTLIER -138.91 176.25 8.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.694 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.646 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 31.9 mm -67.62 130.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.599 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 42.8 mm -70.73 92.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.362 0.601 . . . . 0.0 110.905 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.49 39.86 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.704 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 283' ' ' ASP . 30.9 mtmt -50.88 -39.16 53.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.734 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -59.66 -37.9 80.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.059 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 48.7 mt -72.91 -35.24 67.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.179 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 280' ' ' LYS . 46.1 p30 -113.01 170.78 7.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.256 0.55 . . . . 0.0 111.982 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 285' ' ' SER . 15.6 tp -153.43 64.91 0.75 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.414 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 43.82 -173.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.963 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -68.95 -16.81 63.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.294 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 284' ' ' LEU . 35.2 m -57.12 -11.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.713 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 290' ' ' LYS . 23.7 mt-30 -52.52 -41.92 63.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.294 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 288' ' ' GLN . 10.0 t 25.19 30.04 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 288' ' ' GLN . 52.4 mttm -143.68 138.41 28.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 110.988 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 89.2 m -98.73 -22.14 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -93.1 -74.73 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.331 -0.707 . . . . 0.0 111.331 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 53.0 m -116.24 150.34 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.022 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 296' ' ' ASN . 32.0 mmtp -99.4 135.75 40.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.992 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 295' ' ' ASP . 59.2 t0 51.68 6.54 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 294' ' ' LYS . 77.7 m-20 62.22 26.13 15.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.132 0.491 . . . . 0.0 110.639 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.761 ' C ' HD12 ' A' ' 297' ' ' ILE . 1.7 pp -113.46 -7.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.509 ' C ' ' CG ' ' A' ' 299' ' ' HIS . 50.3 tttp -101.11 116.47 32.9 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.265 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.544 ' H ' ' HA3' ' A' ' 304' ' ' GLY . 1.5 p80 162.27 165.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.82 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.53 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 0.2 OUTLIER -52.15 -67.55 0.52 Allowed Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 61.2 Cg_endo -52.53 101.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.05 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 101.39 1.95 53.74 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 299' ' ' HIS . . . 98.43 128.44 6.12 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.386 -0.685 . . . . 0.0 111.386 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.544 ' HA3' ' H ' ' A' ' 299' ' ' HIS . . . 170.85 -107.52 0.26 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 300' ' ' VAL . 9.3 m -133.15 -128.36 0.18 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 111.377 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.2 6.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.521 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 307' ' ' GLN . 13.0 pt20 -55.27 -40.41 70.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.372 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.681 HD12 ' C ' ' A' ' 308' ' ' ILE . 2.3 pp -128.78 -175.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.632 ' N ' HD12 ' A' ' 308' ' ' ILE . 11.0 p -171.55 -0.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.086 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.442 ' O ' ' C ' ' A' ' 311' ' ' LYS . 1.0 OUTLIER -85.87 28.78 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 310' ' ' TYR . 9.6 pttm 33.16 68.63 0.97 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.078 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.475 ' HD3' HD13 ' A' ' 308' ' ' ILE . 77.4 Cg_exo . . . . . 0 C--N 1.306 -1.681 0 C-N-CA 122.514 2.143 . . . . 0.0 112.184 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -69.1 149.83 48.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.191 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -62.55 147.68 91.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.26 155.58 50.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.827 1.685 . . . . 0.0 111.933 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -52.34 -16.58 3.53 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 99.79 0.8 56.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.81 23.16 1.02 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -91.13 -78.29 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.795 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 276' ' ' GLN . 9.2 p -176.05 -39.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.491 ' N ' HG13 ' A' ' 275' ' ' VAL . 96.5 mt-30 -67.4 9.24 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.778 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.485 ' H ' ' C ' ' A' ' 275' ' ' VAL . 91.6 mt -47.52 -41.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.829 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 2.3 pt -52.41 -35.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.888 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -85.49 0.14 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.568 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 16.2 ttmt -55.13 -50.96 67.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.459 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -64.85 -31.18 72.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 282' ' ' LEU . 3.1 mm? -68.1 -34.25 76.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 283' ' ' ASP . 50.2 p30 -106.6 155.52 19.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.161 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 286' ' ' ASN . 22.3 mt -109.22 153.31 23.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.081 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 287' ' ' VAL . 0.5 OUTLIER -56.75 73.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.029 0.442 . . . . 0.0 110.505 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 284' ' ' LEU . 2.2 p30 55.01 -6.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.632 ' H ' ' C ' ' A' ' 285' ' ' SER . 61.0 t -60.99 -27.03 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.467 ' CD ' ' H ' ' A' ' 284' ' ' LEU . 13.0 pt20 -87.64 -160.83 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.207 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.31 -51.21 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.136 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -97.47 155.33 16.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.157 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 74.2 m -53.74 -33.46 55.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.125 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . -71.24 0.1 33.82 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 292' ' ' GLY . 1.4 t 89.71 -167.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.45 -38.86 72.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.988 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 297' ' ' ILE . 61.3 t0 -166.09 72.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.897 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.601 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 74.8 m-20 39.3 20.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.313 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 295' ' ' ASP . 1.4 pp -60.65 -17.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.123 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.407 ' HG3' HE22 ' A' ' 307' ' ' GLN . 0.3 OUTLIER -68.47 -1.12 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.42 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.724 ' HD1' ' C ' ' A' ' 299' ' ' HIS . 0.1 OUTLIER -93.47 168.7 10.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.043 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 304' ' ' GLY . 0.0 OUTLIER -127.04 104.91 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.519 ' CD ' ' ND1' ' A' ' 299' ' ' HIS . 0.3 OUTLIER -68.25 -12.69 35.79 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 C-N-CA 120.488 0.792 . . . . 0.0 112.819 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -55.93 -28.96 54.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 304' ' ' GLY . . . -149.57 4.43 0.67 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 50.64 108.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 308' ' ' ILE . 73.9 m -66.76 160.72 25.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 110.331 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 6.8 p -53.66 -28.8 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.075 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.438 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 5.8 pt20 -61.04 -36.65 80.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.187 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.802 HD12 ' N ' ' A' ' 309' ' ' VAL . 2.9 pp -132.51 -152.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.802 ' N ' HD12 ' A' ' 308' ' ' ILE . 0.6 OUTLIER 166.27 -5.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -83.02 11.16 6.58 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 309' ' ' VAL . 0.0 OUTLIER 39.66 56.16 6.4 Favored Pre-proline 0 N--CA 1.435 -1.193 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.786 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.48 ' HD2' HD13 ' A' ' 308' ' ' ILE . 55.7 Cg_exo . . . . . 0 C--N 1.311 -1.419 0 C-N-CA 121.768 1.646 . . . . 0.0 112.43 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 268' ' ' HIS . 18.2 ttpp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.733 0.301 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.483 ' O ' ' O ' ' A' ' 267' ' ' LYS . 83.0 t60 57.16 146.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.95 146.13 77.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.993 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.33 -27.97 77.88 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.183 1.922 . . . . 0.0 112.338 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.24 -1.89 86.49 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.46 0.43 70.02 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 275' ' ' VAL . . . -90.69 -82.7 1.4 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.87 -33.3 73.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 275' ' ' VAL . 37.0 t 51.85 19.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.53 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -54.75 -39.14 68.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.222 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 279' ' ' ASN . 32.3 mm -67.22 -20.59 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.782 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 64.8 mt 64.63 -65.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.836 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 277' ' ' ILE . 33.6 m-20 -95.4 95.56 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 281' ' ' LYS . 4.8 ptpp? -61.41 -42.69 99.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.013 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.684 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.1 OUTLIER -59.88 -30.11 68.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.93 -36.4 79.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.503 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 284' ' ' LEU . 59.8 t0 -101.01 141.35 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 79.7 mt -102.73 146.91 27.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.009 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.603 ' C ' ' H ' ' A' ' 287' ' ' VAL . 44.8 m -55.72 -167.58 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -49.99 -3.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.664 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 285' ' ' SER . 76.2 t -57.76 -37.28 58.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 290' ' ' LYS . 9.9 pt20 -55.9 -38.65 70.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 15.4 t 41.87 11.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.497 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 288' ' ' GLN . 87.4 mttt -130.21 141.2 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 77.8 m -94.3 -20.35 19.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.936 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -101.15 -130.34 7.01 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.597 ' HB2' HG22 ' A' ' 297' ' ' ILE . 24.7 p -70.05 158.67 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.876 ' O ' HG23 ' A' ' 297' ' ' ILE . 36.9 pttt -166.83 -129.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.161 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.413 ' N ' ' HG3' ' A' ' 294' ' ' LYS . 88.9 m-20 -81.97 -3.9 55.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.576 ' H ' ' HG3' ' A' ' 294' ' ' LYS . 25.6 t30 -99.44 -26.88 13.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 294' ' ' LYS . 1.6 pt 12.94 -98.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.819 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 297' ' ' ILE . 93.5 mttt 35.34 29.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.524 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.729 ' CD2' ' HD3' ' A' ' 301' ' ' PRO . 0.1 OUTLIER -50.68 -61.67 2.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.129 -178.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.813 ' H ' ' CD ' ' A' ' 301' ' ' PRO . 77.5 t -154.28 -8.27 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.813 ' CD ' ' H ' ' A' ' 300' ' ' VAL . 59.5 Cg_endo -56.72 106.16 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 CA-C-N 120.393 1.176 . . . . 0.0 112.117 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.49 72.29 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.6 63.32 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.39 -25.0 29.6 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.0 m -60.58 -38.94 86.26 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 307' ' ' GLN . 39.2 t -66.95 -42.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.817 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 307' ' ' GLN . 0.0 OUTLIER 47.14 100.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.931 0.872 . . . . 0.0 109.779 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.606 ' C ' HG23 ' A' ' 309' ' ' VAL . 3.3 pt -124.59 20.77 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.057 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.606 HG23 ' C ' ' A' ' 308' ' ' ILE . 1.8 t 69.76 -50.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.66 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 308' ' ' ILE . 8.8 p90 -95.35 144.31 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.026 0.441 . . . . 0.0 110.657 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.574 ' HB3' ' CD2' ' A' ' 299' ' ' HIS . 0.0 OUTLIER -98.47 116.94 65.3 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.019 -178.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.313 -1.302 0 C-N-CA 121.274 1.316 . . . . 0.0 112.333 178.34 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 9.2 pttm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -72.05 155.81 39.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.405 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.93 147.72 98.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.486 ' HG3' ' H ' ' A' ' 278' ' ' ILE . 19.8 Cg_endo -59.2 157.12 31.47 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.543 1.495 . . . . 0.0 112.081 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -87.0 81.93 1.65 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 95.46 4.12 60.98 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.83 5.9 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 275' ' ' VAL . 55.1 mttp -54.93 -70.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 274' ' ' LYS . 49.6 t -161.82 -15.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 110.458 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 275' ' ' VAL . 58.9 mt-30 -56.14 -131.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 279' ' ' ASN . 75.4 mt -59.59 -35.78 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.486 ' H ' ' HG3' ' A' ' 270' ' ' PRO . 97.9 mt 62.79 -32.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.853 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 277' ' ' ILE . 8.2 m120 -71.99 58.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.874 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -49.37 -38.85 29.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.549 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.497 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 8.6 mptt -56.76 -28.31 60.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.34 -40.2 85.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.648 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -98.85 139.55 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 1.007 ' H ' HD22 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -91.96 -0.26 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.9 t 93.21 -171.11 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.746 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -50.98 -22.64 2.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 284' ' ' LEU . 4.8 m -61.55 -21.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.693 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.626 ' C ' ' H ' ' A' ' 290' ' ' LYS . 18.0 pt20 -53.63 -41.96 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.501 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 288' ' ' GLN . 1.5 t 59.82 -26.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.199 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 288' ' ' GLN . 43.6 tttp -90.67 148.74 22.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.827 0.346 . . . . 0.0 110.803 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.17 147.18 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 71.28 -125.95 12.6 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -117.02 148.05 41.81 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 297' ' ' ILE . 18.5 tttm -106.25 -53.5 2.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 294' ' ' LYS . 85.2 m-20 38.17 37.73 0.17 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 298' ' ' LYS . 37.5 t30 73.67 46.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.667 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 294' ' ' LYS . 11.1 tt 34.6 32.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.699 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ASN . 14.3 pttp -74.55 -0.61 18.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.529 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 301' ' ' PRO . 3.7 p80 -80.24 149.41 30.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.556 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 0.6 OUTLIER -55.78 -67.55 0.72 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.316 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.557 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 95.1 Cg_endo -51.6 108.27 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.87 1.713 . . . . 0.0 111.379 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 99.72 -1.04 56.7 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 299' ' ' HIS . . . 107.6 128.71 5.95 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 171.54 -169.89 42.88 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.574 ' HB2' HE22 ' A' ' 307' ' ' GLN . 24.9 m -71.61 -84.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.761 0.315 . . . . 0.0 110.851 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 306' ' ' VAL . 2.1 p 178.27 80.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.221 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.574 HE22 ' HB2' ' A' ' 305' ' ' SER . 0.1 OUTLIER -120.24 -100.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.928 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.787 HD13 ' H ' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -104.5 127.17 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.714 0.768 . . . . 0.0 112.347 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 311' ' ' LYS . 16.3 m -84.83 -7.29 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 1.2 t80 -43.3 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.805 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 309' ' ' VAL . 27.5 ttmt 56.21 65.65 4.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.003 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 C--N 1.304 -1.781 0 C-N-CA 122.656 2.238 . . . . 0.0 112.21 179.468 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 268' ' ' HIS . 48.6 mttp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 267' ' ' LYS . 0.0 OUTLIER -57.1 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.062 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.422 ' CB ' ' CD ' ' A' ' 270' ' ' PRO . 4.8 mt-30 -41.37 -39.62 2.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 269' ' ' GLN . 3.2 Cg_endo -83.84 91.99 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.689 1.593 . . . . 0.0 111.748 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.67 30.34 2.27 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.18 60.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -83.4 -171.13 47.21 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -55.32 -31.24 61.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.606 ' O ' ' N ' ' A' ' 277' ' ' ILE . 99.2 t -57.95 -12.82 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.923 0.392 . . . . 0.0 110.058 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.629 ' C ' ' H ' ' A' ' 278' ' ' ILE . 19.7 pt20 -44.2 -8.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.546 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 275' ' ' VAL . 37.4 mm -48.33 -3.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.629 ' H ' ' C ' ' A' ' 276' ' ' GLN . 8.2 mt 65.96 7.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.133 0.492 . . . . 0.0 110.277 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 281' ' ' LYS . 15.3 t-20 -57.2 -18.4 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 283' ' ' ASP . 0.0 OUTLIER -46.85 -1.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.176 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.623 ' H ' ' C ' ' A' ' 279' ' ' ASN . 23.4 mmtm -42.39 -31.84 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.142 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.82 -35.64 77.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 280' ' ' LYS . 60.2 t0 -75.22 139.47 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.973 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 285' ' ' SER . 13.5 mt -62.7 -29.13 70.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER 89.95 -134.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.78 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -58.39 -31.4 67.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.09 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.65 -32.26 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 290' ' ' LYS . 55.6 tt0 -51.28 -21.63 2.27 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.674 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.3 t 50.76 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.628 ' N ' ' O ' ' A' ' 288' ' ' GLN . 19.3 tttm -130.84 148.33 52.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.697 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' CYS . . . . . 0.43 ' HB2' HE21 ' A' ' 288' ' ' GLN . 52.8 t -97.88 140.57 32.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.898 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . 98.42 42.85 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER 163.16 107.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.622 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.56 ' C ' ' N ' ' A' ' 296' ' ' ASN . 64.8 tttt 44.97 18.05 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 293' ' ' SER . 61.4 m-20 52.5 8.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.56 ' N ' ' C ' ' A' ' 294' ' ' LYS . 79.7 m-20 -144.8 -65.72 0.34 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.795 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.491 ' CG2' ' O ' ' A' ' 296' ' ' ASN . 23.7 pt -159.31 50.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.523 ' HB2' ' N ' ' A' ' 294' ' ' LYS . 78.2 tttt -57.41 -27.0 61.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.456 ' CG ' ' HD2' ' A' ' 301' ' ' PRO . 0.1 OUTLIER -69.3 156.16 39.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.146 -178.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.637 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 84.5 t -74.45 -60.07 1.45 Allowed Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 45.9 Cg_endo -48.09 142.05 16.59 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.153 1.902 . . . . 0.0 112.262 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.84 18.15 38.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 85.54 26.67 34.94 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -86.67 -162.04 36.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.548 ' O ' HG13 ' A' ' 306' ' ' VAL . 19.1 m -55.49 -131.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.681 0.277 . . . . 0.0 111.168 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 305' ' ' SER . 18.6 m -159.58 26.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.863 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.477 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 0.0 OUTLIER -84.84 -70.87 0.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.636 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.987 ' O ' HD12 ' A' ' 308' ' ' ILE . 2.7 pp -113.94 134.65 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.484 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 311' ' ' LYS . 14.4 m -118.17 5.99 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.512 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 311' ' ' LYS . 2.8 p90 -70.29 20.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.073 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.557 ' H ' ' C ' ' A' ' 309' ' ' VAL . 9.7 pttp 32.31 98.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.595 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.484 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 94.2 Cg_exo . . . . . 0 N--CA 1.493 1.478 0 C-N-CA 121.652 1.568 . . . . 0.0 112.223 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 31.3 mttp . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.783 0.325 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 84.6 t60 -58.47 -36.67 74.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.61 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 268' ' ' HIS . 18.9 tt0 84.94 125.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.184 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -58.31 138.29 85.09 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.688 0.925 . . . . 0.0 112.16 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -133.48 40.32 1.61 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 103.16 -26.34 24.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -59.23 -35.38 84.23 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 61.59 37.0 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.415 ' HB ' ' NE2' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -115.49 2.65 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.415 ' NE2' ' HB ' ' A' ' 275' ' ' VAL . 2.9 mm-40 -110.67 170.35 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.188 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.0 123.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.625 ' C ' ' H ' ' A' ' 280' ' ' LYS . 46.7 mm -62.48 -25.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.488 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 281' ' ' LYS . 79.2 m-20 -67.13 23.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.322 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 278' ' ' ILE . 2.6 ptpt -38.75 -15.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.834 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 279' ' ' ASN . 6.4 mptt -47.97 -37.53 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 282' ' ' LEU . 7.6 mp -71.23 -34.33 70.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.061 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 280' ' ' LYS . 90.7 m-20 -91.07 128.74 37.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.932 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 285' ' ' SER . 0.4 OUTLIER -102.66 4.1 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.2 t 87.11 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.653 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -49.22 -24.78 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.391 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.17 -35.89 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.598 ' O ' ' N ' ' A' ' 290' ' ' LYS . 11.1 pt20 -58.15 -36.59 73.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.13 -68.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.309 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 288' ' ' GLN . 90.6 mttt -75.75 161.99 28.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.615 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 83.4 m -50.9 -36.09 36.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.549 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -92.32 -167.78 39.88 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 294' ' ' LYS . 21.8 t -62.36 -141.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.585 ' N ' ' OG ' ' A' ' 293' ' ' SER . 17.8 mmtm -53.44 -30.29 39.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -161.99 -120.93 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.6 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.623 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 35.6 p30 -83.19 0.05 47.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.923 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.785 HD12 ' H ' ' A' ' 297' ' ' ILE . 2.4 mp -59.31 -19.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 297' ' ' ILE . 4.3 pttm -41.24 -21.37 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.545 0.688 . . . . 0.0 109.416 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' HIS . . . . . 0.623 ' CD2' ' O ' ' A' ' 296' ' ' ASN . 1.2 p80 -86.67 -162.95 0.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.216 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 300' ' ' VAL . 1.7 p 172.35 74.44 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.958 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 303' ' ' GLY . 12.0 Cg_exo -31.32 -28.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.608 1.539 . . . . 0.0 113.205 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -66.39 4.14 2.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 168.08 7.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -87.42 -170.34 46.39 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.433 ' OG ' ' CG ' ' A' ' 307' ' ' GLN . 24.7 p -79.38 8.92 5.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.175 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.718 HG12 HG22 ' A' ' 309' ' ' VAL . 35.4 t 55.19 58.57 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.552 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 309' ' ' VAL . 62.4 mt-30 -82.2 -72.41 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.59 HD12 ' CD2' ' A' ' 299' ' ' HIS . 0.1 OUTLIER -72.13 -2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.09 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.718 HG22 HG12 ' A' ' 306' ' ' VAL . 2.0 t 33.97 40.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.536 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' TYR . . . . . 0.497 ' O ' ' O ' ' A' ' 311' ' ' LYS . 7.0 t80 -146.4 -14.33 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.686 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 310' ' ' TYR . 28.0 pttt 31.96 96.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.298 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.494 1.516 0 C-N-CA 121.612 1.542 . . . . 0.0 112.004 179.62 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.489 ' O ' ' CD2' ' A' ' 268' ' ' HIS . 19.2 t-160 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.028 0.442 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 19.8 mp0 -54.48 -34.54 23.6 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.934 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 32.4 Cg_exo -63.18 -8.78 15.15 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 118.624 0.544 . . . . 0.0 112.016 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.89 4.52 55.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 275' ' ' VAL . . . 165.91 120.92 0.54 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -51.9 -36.44 42.1 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -61.45 -34.44 75.42 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.7 t -111.25 129.45 66.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -118.31 132.2 56.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.402 . . . . 0.0 111.029 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 277' ' ' ILE . 84.7 mt -99.64 7.9 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.863 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.1 mm 70.12 -24.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.287 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.548 ' H ' ' C ' ' A' ' 277' ' ' ILE . 4.0 m120 -56.69 -22.28 33.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.02 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -48.85 -41.92 34.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -58.89 -38.12 78.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 57.8 mt -71.02 -35.5 72.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.698 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -79.84 140.47 36.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.029 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 285' ' ' SER . 48.5 mt -68.63 -26.45 65.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 21.8 p 100.26 -134.52 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.727 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.521 ' N ' ' OG ' ' A' ' 285' ' ' SER . 22.9 m120 -59.18 -32.27 69.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.794 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 270' ' ' PRO . 24.3 t60 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.781 0.324 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.463 HE21 ' HB2' ' A' ' 283' ' ' ASP . 0.0 OUTLIER -34.42 -33.82 0.1 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.139 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.459 ' N ' ' O ' ' A' ' 268' ' ' HIS . 6.4 Cg_endo -112.84 89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.171 1.247 . . . . 0.0 112.285 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -54.5 -38.36 62.82 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -66.08 -40.12 94.97 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.63 110.66 3.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -59.74 -37.31 78.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 275' ' ' VAL . 9.4 p -145.21 0.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -94.43 144.7 25.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 6.6 pt -99.25 123.81 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.497 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 279' ' ' ASN . 32.9 mm -117.0 106.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER 18.61 -112.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.752 0.657 . . . . 0.0 111.736 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 279' ' ' ASN . 10.9 mmtp 37.84 23.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 279' ' ' ASN . 23.2 tptp -55.46 -25.95 39.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.068 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.83 -28.69 61.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.463 ' HB2' HE21 ' A' ' 269' ' ' GLN . 92.0 m-20 -74.93 152.33 38.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.451 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 44.5 mt -95.33 155.42 16.74 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.651 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 284' ' ' LEU . 8.1 t -58.77 -142.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -12.67 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 110.101 179.785 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.901 0.381 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 144.42 57.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.327 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 272' ' ' GLY . 90.0 Cg_endo -57.22 -12.11 9.46 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.348 2.032 . . . . 0.0 112.174 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . -37.29 -25.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -97.81 -106.03 2.47 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -85.72 169.83 43.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -97.37 120.35 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 275' ' ' VAL . 50.3 t -150.56 -15.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.416 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 1.6 pp0? -137.83 172.8 12.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.642 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.598 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 59.5 mt -72.36 136.39 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.642 ' C ' ' H ' ' A' ' 280' ' ' LYS . 84.9 mt -53.86 -17.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.213 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 281' ' ' LYS . 42.1 t-20 -51.76 -1.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 278' ' ' ILE . 0.0 OUTLIER -38.11 -11.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 279' ' ' ASN . 10.6 mptt -45.17 -37.05 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.229 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 282' ' ' LEU . 6.8 mp -69.5 -30.42 68.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.215 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 280' ' ' LYS . 88.3 m-20 -92.67 140.63 29.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.188 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 285' ' ' SER . 74.1 mt -112.89 160.89 17.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.588 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 287' ' ' VAL . 1.0 OUTLIER -55.6 -155.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.263 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.533 ' N ' ' OG ' ' A' ' 285' ' ' SER . 45.9 t-20 -43.35 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 285' ' ' SER . 60.0 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.602 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 268' ' ' HIS . 17.6 t-160 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.112 0.482 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 3.2 mp0 -43.35 -40.9 6.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.026 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 7.6 Cg_endo -86.25 137.93 5.42 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 120.786 0.99 . . . . 0.0 111.853 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -102.69 -15.89 23.49 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.51 -38.23 86.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.84 -139.79 6.84 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 276' ' ' GLN . 41.6 mtmt -95.99 147.19 23.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 277' ' ' ILE . 2.1 t 61.84 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.345 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 274' ' ' LYS . 92.7 mm-40 -72.4 24.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.312 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 275' ' ' VAL . 93.3 mt -39.67 -26.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.96 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 276' ' ' GLN . 79.5 mt -51.6 -37.68 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.151 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.727 HD22 ' N ' ' A' ' 279' ' ' ASN . 0.6 OUTLIER -82.04 -1.1 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.026 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 277' ' ' ILE . 30.7 ttpt -54.61 -34.08 61.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.479 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.2 OUTLIER -56.09 -32.7 64.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.483 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 282' ' ' LEU . 9.7 mp -62.38 -37.04 84.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 85.9 m-20 -109.72 160.38 16.36 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.415 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 284' ' ' LEU . 2.9 mp -92.38 148.71 21.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.591 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.3 m -57.26 72.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.346 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 284' ' ' LEU . 29.4 m120 61.42 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.97 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.591 ' H ' ' C ' ' A' ' 285' ' ' SER . 20.8 m . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.587 ' O ' ' CD2' ' A' ' 268' ' ' HIS . 16.8 t-160 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.473 0.654 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.653 ' NE2' ' ND2' ' A' ' 286' ' ' ASN . 52.3 mt-30 -41.62 -36.66 1.11 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.969 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 271' ' ' GLY . 14.1 Cg_endo -100.62 143.41 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 118.965 0.666 . . . . 0.0 112.246 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . 33.1 -106.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.46 71.51 0.44 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 76.81 33.61 45.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.98 147.32 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.143 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.657 ' C ' ' H ' ' A' ' 277' ' ' ILE . 16.2 m -63.42 -9.19 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.164 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 278' ' ' ILE . 93.1 mt-30 -57.24 12.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.657 ' H ' ' C ' ' A' ' 275' ' ' VAL . 17.4 tt -42.87 -21.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.579 0.228 . . . . 0.0 110.812 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 276' ' ' GLN . 21.9 pt -53.98 -26.2 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.872 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.604 HD22 ' C ' ' A' ' 279' ' ' ASN . 0.4 OUTLIER -115.93 38.54 3.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.515 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -61.84 -18.94 61.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.732 -179.421 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.495 ' NZ ' HD21 ' A' ' 282' ' ' LEU . 0.0 OUTLIER -57.68 -23.58 52.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.724 -178.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.495 HD21 ' NZ ' ' A' ' 281' ' ' LYS . 84.0 mt -56.8 -37.89 71.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.58 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -127.59 116.45 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.44 11.14 5.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 87.1 p -44.21 -35.95 2.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.3 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.758 HD22 ' N ' ' A' ' 286' ' ' ASN . 0.0 OUTLIER -62.86 -42.42 99.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.073 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.708 ' H ' ' ND2' ' A' ' 286' ' ' ASN . 76.1 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.249 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.404 ' NE2' ' HD3' ' A' ' 280' ' ' LYS . 2.5 p-80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.535 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 0.5 OUTLIER -112.91 100.09 50.11 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.464 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -68.94 -18.78 40.77 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.801 1.667 . . . . 0.0 112.064 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.86 -34.75 4.59 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.58 -32.62 65.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.29 -63.34 3.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.3 -35.71 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 275' ' ' VAL . 34.2 m -91.84 129.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.775 0.321 . . . . 0.0 110.808 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.05 -31.24 69.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 279' ' ' ASN . 40.7 mt -140.89 -119.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.016 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 277' ' ' ILE . 69.2 mt 55.66 -74.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.014 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.782 HD22 ' N ' ' A' ' 279' ' ' ASN . 0.6 OUTLIER -76.48 2.32 14.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.404 ' HD3' ' NE2' ' A' ' 268' ' ' HIS . 31.2 ttpt -51.48 -27.07 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.645 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.21 -35.1 48.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 282' ' ' LEU . 10.0 mp -66.68 -32.83 74.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.233 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -82.96 119.59 24.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 1.034 ' H ' HD22 ' A' ' 284' ' ' LEU . 1.0 OUTLIER -70.72 -25.28 62.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.2 t 93.46 -139.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.216 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -57.09 -30.55 64.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.148 179.572 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 1.1 p80 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.705 0.288 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 0.0 OUTLIER 79.3 143.67 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 272' ' ' GLY . 60.7 Cg_endo -53.55 -36.73 81.48 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.29 1.993 . . . . 0.0 112.435 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.498 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 55.62 -78.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -56.78 -30.9 60.29 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 86.12 21.28 52.97 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -58.32 -41.88 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.818 HG13 ' H ' ' A' ' 276' ' ' GLN . 1.6 p 176.55 -97.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.425 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.818 ' H ' HG13 ' A' ' 275' ' ' VAL . 67.3 mm-40 37.39 -126.7 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 277' ' ' ILE . 4.2 mp -103.4 110.81 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.79 HD12 ' H ' ' A' ' 278' ' ' ILE . 3.2 mp -66.23 -29.55 47.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.651 HD22 ' H ' ' A' ' 282' ' ' LEU . 0.2 OUTLIER -74.4 69.38 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.904 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -55.28 -37.2 66.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 10.4 mptt -56.12 -30.42 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.131 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.651 ' H ' HD22 ' A' ' 279' ' ' ASN . 35.9 tp -61.67 -37.14 82.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -106.03 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 286' ' ' ASN . 23.7 mt -99.88 148.85 24.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.106 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.634 ' C ' ' H ' ' A' ' 287' ' ' VAL . 1.1 m -61.66 67.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.364 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 284' ' ' LEU . 42.9 t-20 60.94 -25.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.699 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.634 ' H ' ' C ' ' A' ' 285' ' ' SER . 8.4 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.778 0.323 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 271' ' ' GLY . 7.7 t60 . . . . . 0 CA--C 1.518 -0.262 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.498 ' O ' ' OD2' ' A' ' 283' ' ' ASP . 7.5 mt-30 -38.27 -39.72 0.78 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.974 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.06 -28.13 49.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.424 1.416 . . . . 0.0 112.575 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 268' ' ' HIS . . . 98.26 71.06 1.01 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 156.49 15.64 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 69.53 -59.19 0.67 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -72.38 146.29 47.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.683 0.278 . . . . 0.0 110.332 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.411 ' H ' HG12 ' A' ' 275' ' ' VAL . 3.1 p -69.71 128.76 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.15 0.5 . . . . 0.0 110.749 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -120.64 161.95 20.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.418 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.77 -17.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 85.6 mt -57.15 140.08 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.699 ' N ' ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -66.04 112.91 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 110.354 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -57.98 -34.02 69.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.776 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.731 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -57.82 -22.42 47.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.63 -36.94 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.328 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.498 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 39.0 m-20 -104.71 163.85 12.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.389 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 286' ' ' ASN . 24.6 mt -81.6 154.55 26.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.631 ' C ' ' H ' ' A' ' 287' ' ' VAL . 2.6 m -56.34 69.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.663 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 284' ' ' LEU . 14.4 m120 58.73 -22.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.631 ' H ' ' C ' ' A' ' 285' ' ' SER . 9.4 p . . . . . 0 C--N 1.328 -0.342 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.91 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.564 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 4.1 m170 . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.721 0.296 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.579 ' OE1' ' ND2' ' A' ' 286' ' ' ASN . 30.6 tt0 93.26 71.4 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.207 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -52.27 134.42 50.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.497 2.131 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -59.96 -32.22 74.67 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -168.67 21.85 0.09 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.16 35.68 33.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 275' ' ' VAL . 86.4 mttt -59.1 -39.54 82.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.35 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 274' ' ' LYS . 71.5 t -156.94 -41.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.376 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' H ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -65.54 163.61 15.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 110.579 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.536 ' C ' ' H ' ' A' ' 279' ' ' ASN . 68.3 mt -72.7 141.53 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.86 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 278' ' ' ILE . 48.9 mm -62.82 6.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 277' ' ' ILE . 87.0 m-20 -61.97 13.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.61 ' H ' ' C ' ' A' ' 278' ' ' ILE . 54.2 pttt -40.76 -37.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.667 0.27 . . . . 0.0 111.126 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.461 ' HZ2' ' CB ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -54.92 -30.92 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.427 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 279' ' ' ASN . 31.9 tp -57.02 -37.75 72.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.442 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.59 ' O ' ' ND2' ' A' ' 286' ' ' ASN . 44.1 t0 -149.95 33.6 0.67 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.841 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' LYS . 7.4 tt -57.94 -36.95 73.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 87.4 p -57.27 -24.01 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.081 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.707 HD22 ' H ' ' A' ' 287' ' ' VAL . 0.0 OUTLIER -53.32 -36.44 61.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.916 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.707 ' H ' HD22 ' A' ' 286' ' ' ASN . 54.7 t . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.789 0.328 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -63.3 148.27 93.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.185 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.98 151.29 58.71 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.855 1.703 . . . . 0.0 112.321 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.1 35.16 1.38 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 97.0 -0.19 60.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -114.05 -49.26 0.54 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 150.27 20.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.379 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 275' ' ' VAL . 10.1 p -133.89 3.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.874 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -57.68 -39.65 77.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.231 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 280' ' ' LYS . 55.2 mt -111.09 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.15 -38.42 82.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.763 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.607 HD22 ' C ' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -82.58 1.6 37.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.565 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.654 ' C ' ' H ' ' A' ' 282' ' ' LEU . 39.7 mtmt 40.03 -149.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 55.79 -19.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.089 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 280' ' ' LYS . 35.8 tp -64.67 -39.68 94.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 283' ' ' ASP . 51.8 p30 -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.7 mt -106.39 147.47 29.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.099 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.2 m -63.01 86.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 63.08 -29.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.397 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.614 ' H ' ' C ' ' A' ' 285' ' ' SER . 54.3 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.017 0.437 . . . . 0.0 110.029 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.624 ' O ' ' N ' ' A' ' 270' ' ' PRO . 71.8 t60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.42 0.152 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.4 OUTLIER -29.34 -30.58 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.949 -178.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.624 ' N ' ' O ' ' A' ' 268' ' ' HIS . 4.4 Cg_endo -112.26 122.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.082 1.188 . . . . 0.0 111.662 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' A' ' 282' ' ' LEU . . . -55.11 -27.84 47.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.39 -32.57 30.47 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.5 -82.71 1.55 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.4 -23.46 62.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.28 133.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -106.93 149.48 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.004 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 279' ' ' ASN . 16.4 mm 41.46 -120.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.407 ' N ' HG22 ' A' ' 277' ' ' ILE . 74.8 mt 38.89 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.128 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.841 HD22 ' H ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER -94.1 19.72 8.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.7 OUTLIER -40.73 -20.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.648 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.9 OUTLIER -54.87 -29.86 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.487 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 84.3 mt -58.05 -37.77 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.503 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.786 ' C ' HD13 ' A' ' 284' ' ' LEU . 92.4 m-20 -137.94 162.64 33.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.316 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 1.093 ' H ' HD22 ' A' ' 284' ' ' LEU . 0.0 OUTLIER -105.71 171.15 7.49 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 287' ' ' VAL . 35.8 m -45.84 172.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.577 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -45.69 -6.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.423 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 285' ' ' SER . 4.7 p . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.32 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.901 0.382 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.485 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 1.3 tt0 -82.6 138.63 44.12 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.836 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 272' ' ' GLY . 17.9 Cg_endo -59.9 -25.94 80.88 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 120.404 0.736 . . . . 0.0 112.283 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 45.34 -86.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -55.94 -32.97 59.8 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.7 76.18 0.55 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.514 ' C ' HG23 ' A' ' 275' ' ' VAL . 68.4 mttm -90.51 16.95 8.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 110.442 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.514 HG23 ' C ' ' A' ' 274' ' ' LYS . 2.4 t 73.06 3.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.626 ' C ' ' H ' ' A' ' 278' ' ' ILE . 26.1 mt-30 -74.16 32.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.468 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 279' ' ' ASN . 20.4 pt -48.77 -1.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.603 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.626 ' H ' ' C ' ' A' ' 276' ' ' GLN . 15.4 mm -43.82 -12.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.828 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 277' ' ' ILE . 6.8 t-20 101.15 28.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.922 0.764 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.406 ' HZ1' HG21 ' A' ' 278' ' ' ILE . 1.2 mptt -57.48 -11.91 2.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.331 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -48.46 -30.87 5.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 72.2 mt -62.6 -29.7 70.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 110.028 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -80.17 151.24 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 285' ' ' SER . 75.1 mt -97.82 161.37 13.78 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 287' ' ' VAL . 22.6 t -51.45 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 286' ' ' ASN . 0.7 OUTLIER -44.3 -12.65 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.748 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 285' ' ' SER . 6.3 p . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.926 0.393 . . . . 0.0 110.249 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.596 ' ND1' ' OE1' ' A' ' 269' ' ' GLN . 85.8 t60 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.62 ' H ' ' CD ' ' A' ' 269' ' ' GLN . 0.1 OUTLIER -63.57 146.15 96.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.268 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -57.58 150.15 62.66 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.865 1.71 . . . . 0.0 111.957 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -56.22 -33.89 61.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 274' ' ' LYS . . . 143.31 -39.64 1.29 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -72.19 9.55 5.41 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 272' ' ' GLY . 2.5 ttmp? 66.64 44.92 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.546 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.438 ' HB ' HE21 ' A' ' 276' ' ' GLN . 63.9 t -62.09 -36.1 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.438 HE21 ' HB ' ' A' ' 275' ' ' VAL . 0.9 OUTLIER -113.1 144.13 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.53 -20.45 26.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.23 130.84 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.216 0.531 . . . . 0.0 110.663 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -87.14 143.68 27.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.574 ' CD ' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -51.9 -34.78 42.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.476 -179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.483 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER -58.78 -39.03 79.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.876 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.1 -30.13 70.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.354 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.47 ' OD2' ' NE2' ' A' ' 269' ' ' GLN . 65.4 t0 -77.61 116.67 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 0.0 110.934 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 285' ' ' SER . 54.7 mt -65.12 -38.12 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.338 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.8 m 152.08 57.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.79 -22.45 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.148 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 285' ' ' SER . 75.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.016 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -66.0 139.74 96.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.41 -23.99 76.47 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 120.225 0.617 . . . . 0.0 112.205 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.52 41.67 50.7 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.16 20.67 29.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 84.05 45.99 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.478 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.468 ' HG2' HG12 ' A' ' 275' ' ' VAL . 57.8 tttp -57.61 -48.33 79.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.576 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.649 HG13 ' NE2' ' A' ' 276' ' ' GLN . 4.4 p 173.43 -23.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.649 ' NE2' HG13 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -55.08 -153.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.306 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.544 ' C ' ' H ' ' A' ' 279' ' ' ASN . 64.8 mt -57.88 -16.19 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.566 0.222 . . . . 0.0 110.771 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 278' ' ' ILE . 91.8 mt 65.1 -19.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.52 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 277' ' ' ILE . 74.9 m-20 -89.96 79.56 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.512 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.469 ' HE3' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -58.65 -24.62 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.333 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -54.88 -38.38 67.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.77 -35.87 81.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.274 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.13 127.05 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.783 ' N ' HD12 ' A' ' 284' ' ' LEU . 5.7 mp -70.84 -24.75 62.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 9.7 p 95.8 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.947 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 65.34 -52.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.752 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 285' ' ' SER . 9.4 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 110.14 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.47 151.31 88.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.343 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.38 150.17 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.746 1.63 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.07 48.35 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.07 -37.03 36.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.57 177.81 45.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -114.41 121.65 44.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.172 0.511 . . . . 0.0 110.933 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 275' ' ' VAL . 7.5 p -132.13 -13.31 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.613 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 1.6 pp0? -138.91 176.25 8.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.613 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 31.9 mm -67.62 130.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.599 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.448 ' HA ' HE22 ' A' ' 276' ' ' GLN . 42.8 mm -70.73 92.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.362 0.601 . . . . 0.0 110.905 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.49 39.86 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.704 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 283' ' ' ASP . 30.9 mtmt -50.88 -39.16 53.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.734 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -59.66 -37.9 80.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.059 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 48.7 mt -72.91 -35.24 67.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.179 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 280' ' ' LYS . 46.1 p30 -113.01 170.78 7.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.256 0.55 . . . . 0.0 111.982 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 285' ' ' SER . 15.6 tp -153.43 64.91 0.75 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.414 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 43.82 -173.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.963 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -68.95 -16.81 63.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.294 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 284' ' ' LEU . 35.2 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.713 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.803 0.335 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.55 147.68 91.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.26 155.58 50.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.827 1.685 . . . . 0.0 111.933 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -52.34 -16.58 3.53 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 99.79 0.8 56.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.81 23.16 1.02 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -91.13 -78.29 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.795 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 276' ' ' GLN . 9.2 p -176.05 -39.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.491 ' N ' HG13 ' A' ' 275' ' ' VAL . 96.5 mt-30 -67.4 9.24 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.778 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.485 ' H ' ' C ' ' A' ' 275' ' ' VAL . 91.6 mt -47.52 -41.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.829 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.46 HD12 HD21 ' A' ' 279' ' ' ASN . 2.3 pt -52.41 -35.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.888 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.711 HD22 ' N ' ' A' ' 279' ' ' ASN . 0.8 OUTLIER -85.49 0.14 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.568 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 16.2 ttmt -55.13 -50.96 67.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.459 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -64.85 -31.18 72.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 282' ' ' LEU . 3.1 mm? -68.1 -34.25 76.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 283' ' ' ASP . 50.2 p30 -106.6 155.52 19.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.161 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 286' ' ' ASN . 22.3 mt -109.22 153.31 23.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.081 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 287' ' ' VAL . 0.5 OUTLIER -56.75 73.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.029 0.442 . . . . 0.0 110.505 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 55.01 -6.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.632 ' H ' ' C ' ' A' ' 285' ' ' SER . 61.0 t . . . . . 0 CA--C 1.515 -0.365 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.871 0.367 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 146.13 77.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.993 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.33 -27.97 77.88 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.183 1.922 . . . . 0.0 112.338 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.24 -1.89 86.49 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.46 0.43 70.02 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 275' ' ' VAL . . . -90.69 -82.7 1.4 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.87 -33.3 73.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 275' ' ' VAL . 37.0 t 51.85 19.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.53 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -54.75 -39.14 68.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.222 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 279' ' ' ASN . 32.3 mm -67.22 -20.59 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.782 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.444 HG22 ' ND2' ' A' ' 279' ' ' ASN . 64.8 mt 64.63 -65.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.836 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 277' ' ' ILE . 2.5 m120 -95.4 95.56 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 281' ' ' LYS . 4.8 ptpp? -61.41 -42.69 99.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.013 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.684 ' H ' ' CD ' ' A' ' 281' ' ' LYS . 0.1 OUTLIER -59.88 -30.11 68.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.93 -36.4 79.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.503 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 284' ' ' LEU . 59.8 t0 -101.01 141.35 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 79.7 mt -102.73 146.91 27.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.009 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.603 ' C ' ' H ' ' A' ' 287' ' ' VAL . 44.8 m -55.72 -167.58 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -49.99 -3.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.664 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 285' ' ' SER . 76.2 t . . . . . 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.774 0.321 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.93 147.72 98.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.486 ' HG3' ' H ' ' A' ' 278' ' ' ILE . 19.8 Cg_endo -59.2 157.12 31.47 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.543 1.495 . . . . 0.0 112.081 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -87.0 81.93 1.65 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 95.46 4.12 60.98 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.83 5.9 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 275' ' ' VAL . 55.1 mttp -54.93 -70.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 274' ' ' LYS . 49.6 t -161.82 -15.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 110.458 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 275' ' ' VAL . 30.3 mt-30 -56.14 -131.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 279' ' ' ASN . 75.4 mt -59.59 -35.78 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.486 ' H ' ' HG3' ' A' ' 270' ' ' PRO . 97.9 mt 62.79 -32.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.853 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 277' ' ' ILE . 8.2 m120 -71.99 58.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.874 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -49.37 -38.85 29.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.549 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.497 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 8.6 mptt -56.76 -28.31 60.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.34 -40.2 85.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.648 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -98.85 139.55 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 1.007 ' H ' HD22 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -91.96 -0.26 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.9 t 93.21 -171.11 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.746 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.603 HD22 ' C ' ' A' ' 286' ' ' ASN . 0.2 OUTLIER -50.98 -22.64 2.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 284' ' ' LEU . 4.8 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.693 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 269' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.422 ' CB ' ' CD ' ' A' ' 270' ' ' PRO . 4.4 mt-30 -41.37 -39.62 2.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 269' ' ' GLN . 3.2 Cg_endo -83.84 91.99 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.689 1.593 . . . . 0.0 111.748 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.67 30.34 2.27 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.18 60.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -83.4 -171.13 47.21 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -55.32 -31.24 61.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.606 ' O ' ' N ' ' A' ' 277' ' ' ILE . 99.2 t -57.95 -12.82 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.923 0.392 . . . . 0.0 110.058 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.629 ' C ' ' H ' ' A' ' 278' ' ' ILE . 19.7 pt20 -44.2 -8.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.546 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 275' ' ' VAL . 37.4 mm -48.33 -3.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.629 ' H ' ' C ' ' A' ' 276' ' ' GLN . 8.2 mt 65.96 7.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.133 0.492 . . . . 0.0 110.277 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 281' ' ' LYS . 15.3 t-20 -57.2 -18.4 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 283' ' ' ASP . 0.0 OUTLIER -46.85 -1.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.176 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.623 ' H ' ' C ' ' A' ' 279' ' ' ASN . 23.4 mmtm -42.39 -31.84 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.142 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.82 -35.64 77.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 280' ' ' LYS . 60.2 t0 -75.22 139.47 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.973 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 285' ' ' SER . 13.5 mt -62.7 -29.13 70.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER 89.95 -134.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.78 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -31.4 67.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.09 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 84.6 t60 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.563 0.22 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 268' ' ' HIS . 18.9 tt0 84.94 125.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.184 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -58.31 138.29 85.09 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.688 0.925 . . . . 0.0 112.16 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -133.48 40.32 1.61 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 103.16 -26.34 24.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -59.23 -35.38 84.23 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 61.59 37.0 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.415 ' HB ' ' NE2' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -115.49 2.65 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.415 ' NE2' ' HB ' ' A' ' 275' ' ' VAL . 2.9 mm-40 -110.67 170.35 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.188 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.0 123.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.625 ' C ' ' H ' ' A' ' 280' ' ' LYS . 46.7 mm -62.48 -25.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.488 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 281' ' ' LYS . 79.2 m-20 -67.13 23.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.322 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 278' ' ' ILE . 2.6 ptpt -38.75 -15.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.834 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 279' ' ' ASN . 6.4 mptt -47.97 -37.53 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 282' ' ' LEU . 7.6 mp -71.23 -34.33 70.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.061 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 280' ' ' LYS . 90.7 m-20 -91.07 128.74 37.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.932 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 285' ' ' SER . 0.4 OUTLIER -102.66 4.1 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.2 t 87.11 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.653 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -49.22 -24.78 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.391 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' A' ' 280' ' ' LYS . 54.4 mttp . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' A' ' 268' ' ' HIS . 19.2 t-160 -98.36 -12.85 21.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.709 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 19.8 mp0 -54.48 -34.54 23.6 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.934 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 32.4 Cg_exo -63.18 -8.78 15.15 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 118.624 0.544 . . . . 0.0 112.016 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.89 4.52 55.57 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 275' ' ' VAL . . . 165.91 120.92 0.54 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -51.9 -36.44 42.1 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -61.45 -34.44 75.42 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 272' ' ' GLY . 37.7 t -111.25 129.45 66.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -118.31 132.2 56.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.402 . . . . 0.0 111.029 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 277' ' ' ILE . 84.7 mt -99.64 7.9 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.863 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.1 mm 70.12 -24.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.287 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.548 ' H ' ' C ' ' A' ' 277' ' ' ILE . 4.0 m120 -56.69 -22.28 33.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.02 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.632 ' CD ' ' N ' ' A' ' 267' ' ' LYS . 32.9 ttpt -48.85 -41.92 34.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 5.3 mtpp -58.89 -38.12 78.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 57.8 mt -71.02 -35.5 72.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.698 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -79.84 140.47 36.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.029 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 285' ' ' SER . 48.5 mt -68.63 -26.45 65.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 21.8 p 100.26 -134.52 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.727 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.521 ' N ' ' OG ' ' A' ' 285' ' ' SER . 22.9 m120 -59.18 -32.27 69.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.39 -34.95 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.631 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.8 tt0 -57.75 -36.05 71.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 288' ' ' GLN . 7.6 t 33.17 -85.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.919 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' A' ' 288' ' ' GLN . 69.2 mttt -59.91 165.96 2.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.314 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 76.5 m -51.37 -31.97 24.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.221 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -127.97 -178.13 15.2 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.679 ' H ' ' CG1' ' A' ' 297' ' ' ILE . 6.2 t -68.63 -171.92 0.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.788 0.328 . . . . 0.0 110.31 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -60.17 138.99 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.198 0.523 . . . . 0.0 110.919 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 58.58 40.73 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.946 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 298' ' ' LYS . 18.3 m120 53.5 46.72 25.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.45 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.679 ' CG1' ' H ' ' A' ' 293' ' ' SER . 57.4 mt 49.87 6.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.31 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 296' ' ' ASN . 49.6 mtmt 51.97 22.88 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.998 0.428 . . . . 0.0 109.899 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.755 ' C ' HD11 ' A' ' 308' ' ' ILE . 2.3 p80 -88.81 10.62 20.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.055 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.657 HG21 HE21 ' A' ' 307' ' ' GLN . 96.5 t -25.64 111.87 0.21 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.257 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -87.5 -23.05 1.47 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.517 1.478 . . . . 0.0 111.493 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 306' ' ' VAL . . . 171.32 -84.52 0.08 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -50.33 -28.26 13.56 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.445 ' O ' ' OG ' ' A' ' 305' ' ' SER . . . -53.16 -38.1 55.72 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 304' ' ' GLY . 3.0 m 173.88 -5.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 110.512 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 302' ' ' GLY . 4.7 t 51.28 81.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.789 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.657 HE21 HG21 ' A' ' 300' ' ' VAL . 39.9 mt-30 -137.36 -75.64 0.41 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.755 HD11 ' C ' ' A' ' 299' ' ' HIS . 11.7 pt -70.39 -27.42 31.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.346 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.413 HG22 ' C ' ' A' ' 308' ' ' ILE . 34.2 m 37.75 41.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.916 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.631 ' O ' ' CG ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -149.63 51.69 0.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.458 0.647 . . . . 0.0 111.401 179.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -9.18 108.69 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.349 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo . . . . . 0 C--N 1.305 -1.738 0 C-N-CA 121.58 1.52 . . . . 0.0 112.4 178.053 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.723 0.296 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 270' ' ' PRO . 24.3 t60 -88.41 -35.05 17.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.765 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.463 HE21 ' HB2' ' A' ' 283' ' ' ASP . 0.0 OUTLIER -34.42 -33.82 0.1 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.139 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.459 ' N ' ' O ' ' A' ' 268' ' ' HIS . 6.4 Cg_endo -112.84 89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.171 1.247 . . . . 0.0 112.285 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -54.5 -38.36 62.82 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -66.08 -40.12 94.97 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.63 110.66 3.69 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -59.74 -37.31 78.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 275' ' ' VAL . 9.4 p -145.21 0.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.552 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -94.43 144.7 25.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 6.6 pt -99.25 123.81 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.497 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 279' ' ' ASN . 32.9 mm -117.0 106.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER 18.61 -112.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.752 0.657 . . . . 0.0 111.736 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 279' ' ' ASN . 10.9 mmtp 37.84 23.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 279' ' ' ASN . 23.2 tptp -55.46 -25.95 39.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.068 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 67.0 mt -56.83 -28.69 61.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.463 ' HB2' HE21 ' A' ' 269' ' ' GLN . 92.0 m-20 -74.93 152.33 38.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.451 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 44.5 mt -95.33 155.42 16.74 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.651 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 284' ' ' LEU . 8.1 t -58.77 -142.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -12.67 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.76 -35.39 72.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 110.101 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 283' ' ' ASP . 7.3 tt0 -52.12 -14.32 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.615 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 29.9 t -47.42 -29.26 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.623 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 292' ' ' GLY . 53.7 mttm -55.48 -29.82 59.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.013 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 290' ' ' LYS . 5.2 t 30.77 33.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.135 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 290' ' ' LYS . . . -165.91 -79.38 0.04 OUTLIER Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 295' ' ' ASP . 29.2 m -55.49 -31.17 61.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.665 -0.268 . . . . 0.0 111.547 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -45.93 -12.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.094 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 293' ' ' SER . 54.2 t0 -46.34 -37.68 7.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.43 ' H ' ' H ' ' A' ' 297' ' ' ILE . 35.6 p-10 -179.87 16.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 297' ' ' ILE . 85.5 mt 62.02 52.04 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.513 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.421 ' CE ' HE22 ' A' ' 307' ' ' GLN . 16.4 ptmt -77.73 20.41 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.917 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.674 ' NE2' HG23 ' A' ' 297' ' ' ILE . 0.5 OUTLIER -99.97 149.83 23.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.268 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.597 ' O ' ' N ' ' A' ' 302' ' ' GLY . 74.7 t -63.54 -36.57 23.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 300' ' ' VAL . 52.2 Cg_exo -45.85 -10.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 CA-C-N 119.648 0.91 . . . . 0.0 111.689 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -150.37 -32.99 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 299' ' ' HIS . . . 169.48 96.02 0.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -156.06 -166.39 15.92 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 307' ' ' GLN . 23.0 t -125.55 92.98 3.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t 40.76 14.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.262 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' A' ' 305' ' ' SER . 2.7 tt0 -115.24 115.62 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.538 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.655 ' CG2' ' H ' ' A' ' 311' ' ' LYS . 1.1 mp -131.99 146.2 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.0 111.431 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.558 HG23 ' OG ' ' A' ' 293' ' ' SER . 76.1 t -71.16 -28.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.307 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.562 ' OH ' ' NZ ' ' A' ' 290' ' ' LYS . 1.1 p90 -138.9 -7.08 1.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.655 ' H ' ' CG2' ' A' ' 308' ' ' ILE . 25.3 mttm 62.94 112.36 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.495 1.57 0 C-N-CA 121.039 1.16 . . . . 0.0 112.233 -178.805 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -113.25 150.37 32.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.537 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 144.42 57.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.327 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 272' ' ' GLY . 90.0 Cg_endo -57.22 -12.11 9.46 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.348 2.032 . . . . 0.0 112.174 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . -37.29 -25.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -97.81 -106.03 2.47 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -85.72 169.83 43.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -97.37 120.35 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 275' ' ' VAL . 50.3 t -150.56 -15.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.416 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 1.6 pp0? -137.83 172.8 12.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.642 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.598 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 59.5 mt -72.36 136.39 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.642 ' C ' ' H ' ' A' ' 280' ' ' LYS . 84.9 mt -53.86 -17.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.213 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 281' ' ' LYS . 42.1 t-20 -51.76 -1.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.666 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 278' ' ' ILE . 0.0 OUTLIER -38.11 -11.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 279' ' ' ASN . 10.6 mptt -45.17 -37.05 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.229 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 282' ' ' LEU . 6.8 mp -69.5 -30.42 68.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.215 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 280' ' ' LYS . 88.3 m-20 -92.67 140.63 29.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.188 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 285' ' ' SER . 74.1 mt -112.89 160.89 17.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.588 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 287' ' ' VAL . 1.0 OUTLIER -55.6 -155.67 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.263 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.533 ' N ' ' OG ' ' A' ' 285' ' ' SER . 45.9 t-20 -43.35 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 289' ' ' SER . 60.0 t -52.33 -7.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.602 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 286' ' ' ASN . 98.8 mm-40 -41.2 -14.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.619 ' N ' ' O ' ' A' ' 287' ' ' VAL . 12.5 t -45.5 -21.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.464 ' N ' ' C ' ' A' ' 288' ' ' GLN . 16.1 pttp -75.34 136.0 40.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.911 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 78.8 m -84.27 -38.9 19.91 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -101.12 -76.08 1.18 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.53 ' O ' ' C ' ' A' ' 294' ' ' LYS . 3.7 p -164.67 -28.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 296' ' ' ASN . 55.8 mttp 13.99 -130.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.988 0.805 . . . . 0.0 111.944 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.463 ' O ' ' CG ' ' A' ' 296' ' ' ASN . 79.8 m-20 44.81 10.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.128 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.582 ' N ' ' O ' ' A' ' 294' ' ' LYS . 1.9 m120 -177.98 -65.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.918 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.61 ' O ' ' N ' ' A' ' 299' ' ' HIS . 31.5 pt -90.68 54.62 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.363 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 297' ' ' ILE . 82.6 tttt -37.49 88.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.497 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.61 ' N ' ' O ' ' A' ' 297' ' ' ILE . 0.3 OUTLIER -131.73 156.09 46.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.234 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 305' ' ' SER . 2.7 t -85.3 -53.48 0.46 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 56.9 Cg_endo -46.06 144.56 6.11 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.244 1.296 . . . . 0.0 111.906 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 100.2 15.94 29.03 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 96.96 18.71 28.64 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -81.7 -169.15 42.16 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.756 ' O ' HG13 ' A' ' 300' ' ' VAL . 4.4 m -60.16 -172.28 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 111.037 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.04 30.88 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.751 0.31 . . . . 0.0 110.944 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -65.77 -122.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.669 ' N ' HD13 ' A' ' 308' ' ' ILE . 0.2 OUTLIER -61.22 -24.67 34.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.914 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 309' ' ' VAL . 5.2 p 25.22 36.86 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 123.521 0.513 . . . . 0.0 112.315 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.615 ' CD2' ' O ' ' A' ' 310' ' ' TYR . 1.6 p90 -96.69 15.92 20.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.859 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 312' ' ' PRO . 24.7 tttt 67.72 62.87 0.72 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.944 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 311' ' ' LYS . 54.0 Cg_exo . . . . . 0 C--N 1.307 -1.611 0 C-N-CA 122.248 1.965 . . . . 0.0 112.288 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 59.5 tttm . . . . . 0 C--O 1.231 0.109 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 268' ' ' HIS . 17.6 t-160 -93.05 -22.35 19.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 109.993 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 270' ' ' PRO . 3.2 mp0 -43.35 -40.9 6.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.026 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 269' ' ' GLN . 7.6 Cg_endo -86.25 137.93 5.42 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 120.786 0.99 . . . . 0.0 111.853 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -102.69 -15.89 23.49 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.51 -38.23 86.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.84 -139.79 6.84 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 276' ' ' GLN . 41.6 mtmt -95.99 147.19 23.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 277' ' ' ILE . 2.1 t 61.84 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.345 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 274' ' ' LYS . 92.7 mm-40 -72.4 24.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.312 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 275' ' ' VAL . 93.3 mt -39.67 -26.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.96 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 276' ' ' GLN . 79.5 mt -51.6 -37.68 20.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.151 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.727 HD22 ' N ' ' A' ' 279' ' ' ASN . 0.6 OUTLIER -82.04 -1.1 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.026 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 277' ' ' ILE . 30.7 ttpt -54.61 -34.08 61.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.479 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.2 OUTLIER -56.09 -32.7 64.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.483 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 282' ' ' LEU . 9.7 mp -62.38 -37.04 84.22 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 85.9 m-20 -109.72 160.38 16.36 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.415 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.836 HD12 ' N ' ' A' ' 284' ' ' LEU . 2.9 mp -92.38 148.71 21.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.591 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.3 m -57.26 72.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.346 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 284' ' ' LEU . 29.4 m120 61.42 -29.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.97 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.591 ' H ' ' C ' ' A' ' 285' ' ' SER . 20.8 m -59.03 -7.3 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 286' ' ' ASN . 38.6 tt0 -46.82 -28.89 1.7 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.247 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 68.0 p -53.26 -19.78 3.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.211 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.504 ' C ' ' SG ' ' A' ' 291' ' ' CYS . 18.8 ptmt -54.09 -18.74 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.264 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . 0.504 ' SG ' ' C ' ' A' ' 290' ' ' LYS . 1.3 p 34.48 62.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.944 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 76.18 -117.94 5.19 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 3.1 p -35.78 118.53 0.5 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.266 0.555 . . . . 0.0 112.482 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 45.6 tttp 179.11 -73.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.02 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -94.17 -70.08 0.72 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -150.32 -0.57 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.78 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 299' ' ' HIS . 6.3 mm -69.96 -4.82 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -44.49 -12.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.923 0.392 . . . . 0.0 110.565 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.919 ' O ' HG13 ' A' ' 300' ' ' VAL . 2.8 p80 -75.11 -173.36 1.95 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.573 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 299' ' ' HIS . 1.9 m -178.13 80.66 0.23 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.623 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.505 ' HG2' ' H ' ' A' ' 311' ' ' LYS . 8.3 Cg_exo -41.43 136.54 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.108 1.205 . . . . 0.0 111.956 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.72 5.48 62.94 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 175.42 -7.63 0.03 OUTLIER Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -83.98 -171.29 47.67 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 307' ' ' GLN . 0.1 OUTLIER -71.82 18.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 306' ' ' VAL . 13.8 p 41.86 20.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.869 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 305' ' ' SER . 3.1 pt20 -60.08 -42.61 94.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.9 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -124.32 164.23 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 309' ' ' VAL . 5.7 p -129.9 98.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.586 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 0.0 OUTLIER 168.35 -20.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.006 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.505 ' H ' ' HG2' ' A' ' 301' ' ' PRO . 19.5 tttt 66.26 68.99 0.6 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 111.129 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.408 ' HG2' ' HE2' ' A' ' 299' ' ' HIS . 80.7 Cg_exo . . . . . 0 C--N 1.306 -1.691 0 C-N-CA 122.14 1.893 . . . . 0.0 112.115 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.45 ' CG ' ' H ' ' A' ' 268' ' ' HIS . 16.2 tptp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.793 0.33 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 268' ' ' HIS . 16.8 t-160 -87.23 -17.97 31.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.473 0.654 . . . . 0.0 109.326 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.653 ' NE2' ' ND2' ' A' ' 286' ' ' ASN . 52.3 mt-30 -41.62 -36.66 1.11 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.969 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' A' ' 271' ' ' GLY . 14.1 Cg_endo -100.62 143.41 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 118.965 0.666 . . . . 0.0 112.246 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 270' ' ' PRO . . . 33.1 -106.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.46 71.51 0.44 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 76.81 33.61 45.9 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.98 147.32 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 111.143 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.657 ' C ' ' H ' ' A' ' 277' ' ' ILE . 16.2 m -63.42 -9.19 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.164 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 278' ' ' ILE . 93.1 mt-30 -57.24 12.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.657 ' H ' ' C ' ' A' ' 275' ' ' VAL . 17.4 tt -42.87 -21.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.579 0.228 . . . . 0.0 110.812 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 276' ' ' GLN . 21.9 pt -53.98 -26.2 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.872 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.604 ' C ' HD22 ' A' ' 279' ' ' ASN . 0.4 OUTLIER -115.93 38.54 3.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.515 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -61.84 -18.94 61.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.732 -179.421 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.495 ' NZ ' HD21 ' A' ' 282' ' ' LEU . 0.0 OUTLIER -57.68 -23.58 52.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.724 -178.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.495 HD21 ' NZ ' ' A' ' 281' ' ' LYS . 84.0 mt -56.8 -37.89 71.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.58 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -127.59 116.45 20.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.44 11.14 5.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.433 ' HA ' HE21 ' A' ' 288' ' ' GLN . 87.1 p -44.21 -35.95 2.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.3 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.758 HD22 ' N ' ' A' ' 286' ' ' ASN . 0.0 OUTLIER -62.86 -42.42 99.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.073 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.708 ' H ' ' ND2' ' A' ' 286' ' ' ASN . 76.1 t -72.63 -35.61 51.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.249 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 290' ' ' LYS . 61.5 mt-30 -55.74 -42.84 75.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.593 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 288' ' ' GLN . 5.8 t 22.3 35.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.902 0.751 . . . . 0.0 112.785 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 288' ' ' GLN . 80.1 mttt -146.25 141.61 27.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 111.051 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 71.9 m -70.09 -38.38 75.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.775 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -164.49 93.54 0.11 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.33 -31.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.092 0.472 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 296' ' ' ASN . 65.1 tttm -137.39 123.14 19.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.39 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 297' ' ' ILE . 60.4 t0 60.6 -68.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.617 ' C ' ' H ' ' A' ' 298' ' ' LYS . 92.5 m-20 -70.84 12.35 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.536 ' H ' ' C ' ' A' ' 295' ' ' ASP . 0.7 OUTLIER -47.01 -4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.351 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.617 ' H ' ' C ' ' A' ' 296' ' ' ASN . 52.6 mttp 64.84 36.48 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.449 ' CG ' ' HD2' ' A' ' 301' ' ' PRO . 0.2 OUTLIER -125.8 153.27 44.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.367 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.684 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 62.1 t -103.77 -25.8 0.21 Allowed Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 0.5 OUTLIER -48.53 140.01 22.33 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 CA-C-N 119.331 0.797 . . . . 0.0 111.774 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.62 11.62 57.88 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.46 49.09 4.78 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -91.93 -114.58 2.02 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.4 ' N ' HG13 ' A' ' 300' ' ' VAL . 26.0 m -101.51 -116.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.646 0.26 . . . . 0.0 110.819 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 306' ' ' VAL . 6.2 p -163.59 8.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.754 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.441 HE22 ' HA ' ' A' ' 298' ' ' LYS . 16.6 pt20 -61.52 -44.63 96.71 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.052 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 310' ' ' TYR . 1.8 pp -128.91 168.73 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.772 0.32 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.432 ' N ' HD12 ' A' ' 308' ' ' ILE . 1.5 t -124.32 -23.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.78 ' O ' HD13 ' A' ' 308' ' ' ILE . 43.9 p90 -88.31 130.28 35.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.95 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.21 131.54 58.81 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 N--CA 1.489 1.257 0 C-N-CA 121.021 1.147 . . . . 0.0 112.296 178.781 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.79 0.329 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.404 ' NE2' ' HD3' ' A' ' 280' ' ' LYS . 2.5 p-80 -103.1 157.5 16.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.535 ' N ' ' CD ' ' A' ' 269' ' ' GLN . 0.5 OUTLIER -112.91 100.09 50.11 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.464 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -68.94 -18.78 40.77 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.801 1.667 . . . . 0.0 112.064 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.86 -34.75 4.59 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -57.58 -32.62 65.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.29 -63.34 3.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.3 -35.71 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.661 0.267 . . . . 0.0 110.905 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 275' ' ' VAL . 34.2 m -91.84 129.04 43.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.775 0.321 . . . . 0.0 110.808 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.05 -31.24 69.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 279' ' ' ASN . 40.7 mt -140.89 -119.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.016 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 277' ' ' ILE . 69.2 mt 55.66 -74.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.014 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.782 HD22 ' N ' ' A' ' 279' ' ' ASN . 0.6 OUTLIER -76.48 2.32 14.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.404 ' HD3' ' NE2' ' A' ' 268' ' ' HIS . 31.2 ttpt -51.48 -27.07 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.645 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.21 -35.1 48.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 282' ' ' LEU . 10.0 mp -66.68 -32.83 74.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.233 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -82.96 119.59 24.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.694 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 1.034 ' H ' HD22 ' A' ' 284' ' ' LEU . 1.0 OUTLIER -70.72 -25.28 62.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.2 t 93.46 -139.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.216 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -57.09 -30.55 64.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.7 -32.45 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.148 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.615 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.4 tt0 -52.36 -40.55 62.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 288' ' ' GLN . 18.9 t 11.42 52.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.175 0.922 . . . . 0.0 112.375 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 288' ' ' GLN . 23.3 mtpp 58.26 58.67 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.384 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 288' ' ' GLN . 93.3 m -37.97 -34.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -137.5 -34.24 0.2 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 294' ' ' LYS . 1.0 OUTLIER 173.51 9.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 293' ' ' SER . 14.9 tptp 92.41 -48.13 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 296' ' ' ASN . 53.8 p30 -67.58 -23.02 65.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.642 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 63.9 t30 -55.25 -36.23 65.83 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.836 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 297' ' ' ILE . 0.2 OUTLIER -63.41 -33.57 62.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -102.37 45.79 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.378 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.682 ' HB2' HD11 ' A' ' 308' ' ' ILE . 0.0 OUTLIER -111.78 132.67 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.473 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 302' ' ' GLY . 42.4 t -34.57 -49.89 1.0 Allowed Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.595 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.497 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 9.1 Cg_endo -60.33 81.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 120.778 0.985 . . . . 0.0 110.31 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 106.76 1.38 36.82 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 299' ' ' HIS . . . 123.72 121.91 2.67 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 170.79 -172.78 44.41 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.2 m -86.88 -79.63 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 0.0 110.7 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 306' ' ' VAL . 3.6 p -179.87 7.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.348 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -52.91 -43.93 66.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.764 HD12 ' C ' ' A' ' 308' ' ' ILE . 1.7 pp -131.13 167.69 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.529 ' N ' HD12 ' A' ' 308' ' ' ILE . 11.4 p -161.31 -4.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.22 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -53.78 -8.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 309' ' ' VAL . 21.5 ttmt 68.19 64.48 0.63 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo . . . . . 0 C--N 1.306 -1.696 0 C-N-CA 122.513 2.142 . . . . 0.0 112.148 179.875 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.857 0.36 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -64.52 -23.58 67.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 0.0 OUTLIER 79.3 143.67 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 272' ' ' GLY . 60.7 Cg_endo -53.55 -36.73 81.48 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.29 1.993 . . . . 0.0 112.435 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.498 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 55.62 -78.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -56.78 -30.9 60.29 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 86.12 21.28 52.97 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -58.32 -41.88 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.818 HG13 ' H ' ' A' ' 276' ' ' GLN . 1.6 p 176.55 -97.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.425 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.818 ' H ' HG13 ' A' ' 275' ' ' VAL . 67.3 mm-40 37.39 -126.7 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 277' ' ' ILE . 4.2 mp -103.4 110.81 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.79 HD12 ' H ' ' A' ' 278' ' ' ILE . 3.2 mp -66.23 -29.55 47.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.651 HD22 ' H ' ' A' ' 282' ' ' LEU . 0.2 OUTLIER -74.4 69.38 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.904 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -55.28 -37.2 66.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 10.4 mptt -56.12 -30.42 62.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.131 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.651 ' H ' HD22 ' A' ' 279' ' ' ASN . 35.9 tp -61.67 -37.14 82.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.343 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -106.03 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.431 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 286' ' ' ASN . 23.7 mt -99.88 148.85 24.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.106 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.634 ' C ' ' H ' ' A' ' 287' ' ' VAL . 1.1 m -61.66 67.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.364 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 288' ' ' GLN . 42.9 t-20 60.94 -25.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.699 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.634 ' H ' ' C ' ' A' ' 285' ' ' SER . 8.4 p -50.68 -8.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.778 0.323 . . . . 0.0 110.19 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 286' ' ' ASN . 88.7 mt-30 -40.57 -18.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.357 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 287' ' ' VAL . 25.4 t -48.41 -9.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 288' ' ' GLN . 41.1 mttp -51.41 -29.73 16.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.681 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 2.2 t 63.72 -67.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.679 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 290' ' ' LYS . . . -161.84 127.6 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.699 ' H ' ' CD2' ' A' ' 299' ' ' HIS . 31.9 m 30.44 97.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -138.75 -79.87 0.33 Allowed 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.164 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.61 -50.84 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 297' ' ' ILE . 28.8 t30 -176.67 -13.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.607 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.639 ' O ' ' N ' ' A' ' 299' ' ' HIS . 46.6 pt -57.31 -24.63 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 297' ' ' ILE . 55.3 pttt 27.21 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.874 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.699 ' CD2' ' H ' ' A' ' 293' ' ' SER . 0.3 OUTLIER -68.14 169.03 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.153 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.652 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 93.9 t -80.27 -53.31 0.92 Allowed Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 52.5 Cg_endo -50.09 141.96 28.94 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.554 1.503 . . . . 0.0 112.269 -177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.22 57.14 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.25 21.12 57.64 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 305' ' ' SER . . . -81.63 -158.92 22.83 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 306' ' ' VAL . 28.4 t -49.98 -170.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 111.102 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.525 ' N ' ' OG ' ' A' ' 305' ' ' SER . 17.0 m -119.38 23.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.21 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.559 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 3.7 pt20 -85.19 -104.93 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 111.79 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 308' ' ' ILE . 0.0 OUTLIER -90.24 136.51 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.302 0.572 . . . . 0.0 112.306 -178.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 309' ' ' VAL . 13.8 p -107.8 -5.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.509 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 308' ' ' ILE . 15.8 p90 -60.4 -11.0 5.56 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.959 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 72.1 tttt 67.41 104.38 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo . . . . . 0 C--N 1.31 -1.485 0 C-N-CA 122.035 1.824 . . . . 0.0 112.191 178.303 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 271' ' ' GLY . 7.7 t60 -72.59 -32.23 65.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.498 ' O ' ' OD2' ' A' ' 283' ' ' ASP . 7.5 mt-30 -38.27 -39.72 0.78 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.974 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.06 -28.13 49.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.424 1.416 . . . . 0.0 112.575 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 268' ' ' HIS . . . 98.26 71.06 1.01 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 156.49 15.64 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 69.53 -59.19 0.67 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -72.38 146.29 47.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.683 0.278 . . . . 0.0 110.332 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.411 ' H ' HG12 ' A' ' 275' ' ' VAL . 3.1 p -69.71 128.76 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.15 0.5 . . . . 0.0 110.749 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -120.64 161.95 20.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.418 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.77 -17.81 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 85.6 mt -57.15 140.08 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.699 ' N ' ' ND2' ' A' ' 279' ' ' ASN . 0.2 OUTLIER -66.04 112.91 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 110.354 -178.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -57.98 -34.02 69.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.776 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.731 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -57.82 -22.42 47.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 15.8 tp -55.63 -36.94 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.328 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.498 ' OD2' ' O ' ' A' ' 269' ' ' GLN . 39.0 m-20 -104.71 163.85 12.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.389 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 286' ' ' ASN . 24.6 mt -81.6 154.55 26.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.631 ' C ' ' H ' ' A' ' 287' ' ' VAL . 2.6 m -56.34 69.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.663 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 284' ' ' LEU . 14.4 m120 58.73 -22.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.631 ' H ' ' C ' ' A' ' 285' ' ' SER . 9.4 p -58.64 -22.26 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.91 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 290' ' ' LYS . 1.4 pt20 -51.12 -112.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.01 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.51 ' O ' ' OG ' ' A' ' 293' ' ' SER . 43.9 t 36.11 -89.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 288' ' ' GLN . 11.9 ptmm? -63.17 -37.59 87.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.404 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . 0.547 ' O ' ' N ' ' A' ' 296' ' ' ASN . 7.2 m -77.42 -80.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.45 5.01 57.72 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.025 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -135.07 25.47 3.57 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.733 0.766 . . . . 0.0 111.534 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 10.6 tptp -170.49 -53.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.748 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -93.15 -74.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.066 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.547 ' N ' ' O ' ' A' ' 291' ' ' CYS . 83.9 m-20 -58.08 -32.6 68.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.788 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.488 ' C ' ' N ' ' A' ' 299' ' ' HIS . 0.0 OUTLIER -50.8 -20.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.922 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.456 ' HE2' HE22 ' A' ' 307' ' ' GLN . 54.0 pttt -50.8 -13.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.585 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.623 ' ND1' ' C ' ' A' ' 299' ' ' HIS . 1.4 p80 -89.29 -170.71 2.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.001 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 300' ' ' VAL . 1.9 p 176.39 80.46 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.06 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.448 ' HG2' ' H ' ' A' ' 311' ' ' LYS . 20.3 Cg_exo -40.37 136.58 1.66 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.371 1.38 . . . . 0.0 111.877 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 92.36 5.93 64.94 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.423 ' H ' ' H ' ' A' ' 304' ' ' GLY . . . 175.02 -6.59 0.03 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -83.06 -169.93 45.37 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 18.7 p -70.11 5.35 1.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.0 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 304' ' ' GLY . 2.2 t 59.3 13.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.456 HE22 ' HE2' ' A' ' 298' ' ' LYS . 11.6 pt20 -60.38 -38.88 85.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 110.003 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.551 HD11 ' CE1' ' A' ' 299' ' ' HIS . 2.3 pp -129.11 168.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.883 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 18.0 m -127.44 4.23 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.1 OUTLIER -91.38 -7.67 50.15 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.092 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 310' ' ' TYR . 12.4 pttt 35.59 64.99 1.99 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 110.694 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 98.5 Cg_exo . . . . . 0 C--N 1.307 -1.644 0 C-N-CA 122.309 2.006 . . . . 0.0 112.33 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.745 0.307 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.564 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 4.1 m170 -134.07 177.41 7.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.608 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.649 ' NE2' HE22 ' A' ' 288' ' ' GLN . 30.6 tt0 93.26 71.4 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.207 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -52.27 134.42 50.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.497 2.131 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -59.96 -32.22 74.67 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -168.67 21.85 0.09 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.16 35.68 33.49 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 275' ' ' VAL . 86.4 mttt -59.1 -39.54 82.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.35 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 274' ' ' LYS . 71.5 t -156.94 -41.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.376 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.594 ' CD ' ' H ' ' A' ' 276' ' ' GLN . 0.0 OUTLIER -65.54 163.61 15.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 110.579 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.536 ' C ' ' H ' ' A' ' 279' ' ' ASN . 68.3 mt -72.7 141.53 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.86 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 278' ' ' ILE . 48.9 mm -62.82 6.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 277' ' ' ILE . 87.0 m-20 -61.97 13.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.131 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.61 ' H ' ' C ' ' A' ' 278' ' ' ILE . 54.2 pttt -40.76 -37.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.667 0.27 . . . . 0.0 111.126 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.461 ' HZ2' ' CB ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -54.92 -30.92 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.427 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 279' ' ' ASN . 31.9 tp -57.02 -37.75 72.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.442 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.59 ' O ' ' ND2' ' A' ' 286' ' ' ASN . 44.1 t0 -149.95 33.6 0.67 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.841 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.56 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 7.4 tt -57.94 -36.95 73.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 289' ' ' SER . 87.4 p -57.27 -24.01 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.081 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.707 HD22 ' H ' ' A' ' 287' ' ' VAL . 0.0 OUTLIER -53.32 -36.44 61.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.916 -178.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.707 ' H ' HD22 ' A' ' 286' ' ' ASN . 54.7 t -75.76 -53.66 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.649 HE22 ' NE2' ' A' ' 269' ' ' GLN . 0.4 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.706 -178.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.609 ' N ' ' O ' ' A' ' 285' ' ' SER . 3.6 t 67.33 -8.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 110.102 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 288' ' ' GLN . 38.2 tptt -118.98 132.47 56.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.82 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . 0.716 ' CB ' HD22 ' A' ' 296' ' ' ASN . 50.9 t -127.7 141.08 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 111.149 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 91.6 11.48 60.64 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.709 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 294' ' ' LYS . 26.8 t -167.01 6.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.303 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 296' ' ' ASN . 85.4 mttt -158.86 126.81 5.08 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.4 t70 59.57 -69.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.716 HD22 ' CB ' ' A' ' 291' ' ' CYS . 87.2 m-20 -49.17 -28.51 4.5 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.584 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 294' ' ' LYS . 2.5 pp -49.89 -11.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 109.995 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 296' ' ' ASN . 1.0 OUTLIER -56.62 -14.65 3.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.894 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.584 ' ND1' ' C ' ' A' ' 299' ' ' HIS . 4.0 p80 -67.77 -165.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 300' ' ' VAL . 2.3 p 173.58 78.39 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.231 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 311' ' ' LYS . 6.3 Cg_exo -40.04 133.74 1.9 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 121.376 1.384 . . . . 0.0 111.784 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.42 1.56 66.34 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -171.16 -16.96 0.02 OUTLIER Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -80.6 -174.9 48.72 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.857 ' H ' HE22 ' A' ' 307' ' ' GLN . 69.7 m -76.66 8.93 3.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.999 0.428 . . . . 0.0 110.187 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 306' ' ' VAL . 16.6 t 63.39 26.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.695 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.857 HE22 ' H ' ' A' ' 305' ' ' SER . 0.0 OUTLIER -60.44 -44.31 95.93 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.669 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.651 HD13 ' H ' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -123.57 167.42 17.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.27 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.86 9.75 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.898 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -106.22 3.86 28.25 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.025 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 310' ' ' TYR . 6.7 ptmt 34.12 56.16 1.79 Allowed Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.644 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.441 ' C ' ' O ' ' A' ' 311' ' ' LYS . 90.4 Cg_exo . . . . . 0 C--N 1.307 -1.642 0 C-N-CA 122.666 2.244 . . . . 0.0 112.394 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 53.3 tttp . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.756 0.312 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -81.78 143.62 31.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -63.3 148.27 93.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.185 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.98 151.29 58.71 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.855 1.703 . . . . 0.0 112.321 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.1 35.16 1.38 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 97.0 -0.19 60.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -114.05 -49.26 0.54 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 150.27 20.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.379 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 275' ' ' VAL . 10.1 p -133.89 3.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.874 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -57.68 -39.65 77.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.231 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 280' ' ' LYS . 55.2 mt -111.09 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.15 -38.42 82.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.763 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.607 ' C ' HD22 ' A' ' 279' ' ' ASN . 0.3 OUTLIER -82.58 1.6 37.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.565 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.654 ' C ' ' H ' ' A' ' 282' ' ' LEU . 39.7 mtmt 40.03 -149.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 55.79 -19.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.089 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 280' ' ' LYS . 35.8 tp -64.67 -39.68 94.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 283' ' ' ASP . 51.8 p30 -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.7 mt -106.39 147.47 29.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.099 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 287' ' ' VAL . 3.2 m -63.01 86.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 63.08 -29.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.397 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.614 ' H ' ' C ' ' A' ' 285' ' ' SER . 54.3 t -57.49 -26.6 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.017 0.437 . . . . 0.0 110.029 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.547 ' C ' ' N ' ' A' ' 290' ' ' LYS . 2.3 pt20 -44.19 -10.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.234 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.593 ' N ' ' O ' ' A' ' 287' ' ' VAL . 8.7 t -46.4 -19.79 0.09 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.547 ' N ' ' C ' ' A' ' 288' ' ' GLN . 48.8 mttm -81.47 145.89 30.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.668 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 79.9 m -61.04 -31.51 71.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.701 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -132.7 -73.7 0.1 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 7.2 t 174.49 75.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.479 ' H ' ' HD3' ' A' ' 290' ' ' LYS . 67.2 mttm -54.3 -30.94 52.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.861 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -51.51 -43.2 62.19 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.797 ' O ' HG22 ' A' ' 297' ' ' ILE . 15.5 m120 -92.17 -30.71 15.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 296' ' ' ASN . 19.8 tt 120.06 63.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 125.238 1.586 . . . . 0.0 109.61 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.542 ' C ' ' O ' ' A' ' 297' ' ' ILE . 10.2 ptmm? 1.17 66.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.809 0.693 . . . . 0.0 112.633 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.605 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 0.5 OUTLIER -126.5 135.97 52.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.794 179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 302' ' ' GLY . 94.0 t -50.74 -34.28 11.44 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 121.47 -0.769 . . . . 0.0 112.026 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 300' ' ' VAL . 46.9 Cg_exo -45.15 -12.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 CA-C-N 119.025 0.688 . . . . 0.0 111.697 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -143.72 30.35 1.95 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.95 14.25 79.8 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 299' ' ' HIS . . . -89.04 -168.75 44.09 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 299' ' ' HIS . 14.5 m -69.68 159.8 32.81 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.5 p -63.66 -7.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.128 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 297' ' ' ILE . 12.5 pt20 -46.18 -23.58 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.772 0.32 . . . . 0.0 111.505 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 308' ' ' ILE . 0.0 OUTLIER -42.78 154.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.179 0.514 . . . . 0.0 110.816 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 308' ' ' ILE . 14.4 m -133.76 -13.56 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.525 ' O ' ' O ' ' A' ' 311' ' ' LYS . 47.4 p90 -106.39 -10.8 16.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 310' ' ' TYR . 9.8 pttp 31.66 97.29 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 122.966 0.166 . . . . 0.0 111.045 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo . . . . . 0 N--CA 1.491 1.344 0 C-N-CA 120.937 1.091 . . . . 0.0 112.212 -178.896 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.406 ' O ' ' CD ' ' A' ' 270' ' ' PRO . 62.6 mttp . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.584 0.23 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.624 ' O ' ' N ' ' A' ' 270' ' ' PRO . 71.8 t60 -64.75 -13.53 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.214 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.4 OUTLIER -29.34 -30.58 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.949 -178.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.624 ' N ' ' O ' ' A' ' 268' ' ' HIS . 4.4 Cg_endo -112.26 122.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.082 1.188 . . . . 0.0 111.662 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' A' ' 282' ' ' LEU . . . -55.11 -27.84 47.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.39 -32.57 30.47 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.5 -82.71 1.55 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.4 -23.46 62.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 110.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.28 133.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -106.93 149.48 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.004 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 279' ' ' ASN . 16.4 mm 41.46 -120.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.407 ' N ' HG22 ' A' ' 277' ' ' ILE . 74.8 mt 38.89 -83.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.128 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.841 HD22 ' H ' ' A' ' 279' ' ' ASN . 0.0 OUTLIER -94.1 19.72 8.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 283' ' ' ASP . 0.7 OUTLIER -40.73 -20.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.648 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 279' ' ' ASN . 0.9 OUTLIER -54.87 -29.86 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.487 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 84.3 mt -58.05 -37.77 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.503 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.786 ' C ' HD13 ' A' ' 284' ' ' LEU . 92.4 m-20 -137.94 162.64 33.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.316 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 1.093 ' H ' HD22 ' A' ' 284' ' ' LEU . 0.0 OUTLIER -105.71 171.15 7.49 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 287' ' ' VAL . 35.8 m -45.84 172.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.577 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -45.69 -6.63 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.423 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 285' ' ' SER . 4.7 p -51.39 -25.92 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.32 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 290' ' ' LYS . 97.2 mt-30 -36.12 -77.15 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 33.3 t 43.33 11.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.161 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 288' ' ' GLN . 59.9 mttp -135.45 131.41 36.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 77.6 m -72.73 -32.29 65.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.74 -49.45 55.16 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.934 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.467 ' O ' ' CG1' ' A' ' 297' ' ' ILE . 70.0 m -85.73 18.07 3.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.88 -77.86 0.53 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.78 -43.48 98.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.155 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.613 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 64.5 m-20 -92.71 2.01 56.97 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.829 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.518 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 0.4 OUTLIER -52.37 -19.76 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.515 ' HZ3' HG22 ' A' ' 297' ' ' ILE . 37.8 mmtm -83.02 1.69 38.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.657 ' CE1' HD11 ' A' ' 308' ' ' ILE . 0.0 OUTLIER -54.3 -121.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.195 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 300' ' ' VAL . 2.8 p -175.63 31.97 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.994 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.544 ' C ' ' N ' ' A' ' 303' ' ' GLY . 14.2 Cg_exo 19.25 -120.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 113.871 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 301' ' ' PRO . . . 44.16 21.41 0.24 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.544 ' N ' ' C ' ' A' ' 301' ' ' PRO . . . 151.18 -36.61 0.88 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.23 94.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.625 ' O ' HG13 ' A' ' 306' ' ' VAL . 14.1 t 171.8 -125.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 305' ' ' SER . 11.8 m -161.56 61.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.206 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 309' ' ' VAL . 91.1 mm-40 -110.54 -112.84 0.32 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.925 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.8 HD12 ' H ' ' A' ' 309' ' ' VAL . 0.6 OUTLIER -59.7 -31.38 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.8 ' H ' HD12 ' A' ' 308' ' ' ILE . 33.3 t 46.33 45.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.306 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.615 ' O ' ' CG ' ' A' ' 310' ' ' TYR . 0.8 OUTLIER -175.25 33.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.125 0.488 . . . . 0.0 110.276 178.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 310' ' ' TYR . 14.8 pttm 34.43 77.91 0.35 Allowed Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.102 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.491 1.34 0 C-N-CA 121.387 1.391 . . . . 0.0 112.35 -178.008 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 69.0 tttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.793 0.33 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -110.83 159.79 17.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.719 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.485 ' HG3' ' H ' ' A' ' 271' ' ' GLY . 1.3 tt0 -82.6 138.63 44.12 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.836 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 272' ' ' GLY . 17.9 Cg_endo -59.9 -25.94 80.88 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 120.404 0.736 . . . . 0.0 112.283 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 269' ' ' GLN . . . 45.34 -86.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 270' ' ' PRO . . . -55.94 -32.97 59.8 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.7 76.18 0.55 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.514 ' C ' HG23 ' A' ' 275' ' ' VAL . 68.4 mttm -90.51 16.95 8.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 110.442 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.514 HG23 ' C ' ' A' ' 274' ' ' LYS . 2.4 t 73.06 3.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.626 ' C ' ' H ' ' A' ' 278' ' ' ILE . 26.1 mt-30 -74.16 32.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.468 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 279' ' ' ASN . 20.4 pt -48.77 -1.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.603 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.626 ' H ' ' C ' ' A' ' 276' ' ' GLN . 15.4 mm -43.82 -12.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.828 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 277' ' ' ILE . 6.8 t-20 101.15 28.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.922 0.764 . . . . 0.0 110.535 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.406 ' HZ1' HG21 ' A' ' 278' ' ' ILE . 1.2 mptt -57.48 -11.91 2.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.331 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -48.46 -30.87 5.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 72.2 mt -62.6 -29.7 70.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 0.0 110.028 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.409 ' HB3' HE22 ' A' ' 288' ' ' GLN . 91.3 m-20 -80.17 151.24 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.717 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 285' ' ' SER . 75.1 mt -97.82 161.37 13.78 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.176 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 287' ' ' VAL . 22.6 t -51.45 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 286' ' ' ASN . 0.7 OUTLIER -44.3 -12.65 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.748 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 285' ' ' SER . 6.3 p -61.48 -27.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.926 0.393 . . . . 0.0 110.249 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.5 tt0 -53.63 -30.3 42.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.596 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 288' ' ' GLN . 1.0 OUTLIER 35.75 -89.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.609 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 288' ' ' GLN . 65.8 mmtt -88.65 151.46 22.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 86.9 m -56.97 -30.85 64.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.574 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -172.72 92.51 0.09 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.643 ' C ' ' H ' ' A' ' 295' ' ' ASP . 24.1 t -179.96 110.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.642 0.258 . . . . 0.0 110.798 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt 61.78 -25.51 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.579 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.643 ' H ' ' C ' ' A' ' 293' ' ' SER . 78.7 m-20 -56.2 -37.32 69.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.333 . . . . 0.0 110.657 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -168.11 -34.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.737 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.676 ' O ' ' N ' ' A' ' 299' ' ' HIS . 28.9 pt -69.54 -27.36 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 297' ' ' ILE . 0.0 OUTLIER 28.93 30.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.93 0.769 . . . . 0.0 110.828 -178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.802 ' CD2' ' H ' ' A' ' 300' ' ' VAL . 0.3 OUTLIER -49.85 -49.5 48.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.217 -179.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.802 ' H ' ' CD2' ' A' ' 299' ' ' HIS . 15.5 t 134.06 -48.99 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 124.561 1.163 . . . . 0.0 109.695 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 302' ' ' GLY . 25.7 Cg_exo -51.84 -30.18 37.47 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.196 1.264 . . . . 0.0 111.618 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.664 ' N ' ' NE2' ' A' ' 299' ' ' HIS . . . -47.06 -91.31 0.01 OUTLIER Glycine 0 C--N 1.333 0.416 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -58.15 -29.23 62.39 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 84.61 147.16 8.36 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.342 -0.929 . . . . 0.0 112.032 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.592 ' C ' HG23 ' A' ' 306' ' ' VAL . 23.0 t -176.59 -20.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.592 HG23 ' C ' ' A' ' 305' ' ' SER . 2.2 t 74.44 35.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.386 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.722 ' H ' HG11 ' A' ' 300' ' ' VAL . 77.7 mt-30 -79.03 -65.93 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.586 ' C ' HG23 ' A' ' 309' ' ' VAL . 24.4 pt -74.37 -19.74 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.586 HG23 ' C ' ' A' ' 308' ' ' ILE . 1.5 t 66.65 -28.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.45 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.614 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 20.9 p90 -108.37 133.37 52.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.744 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.441 ' O ' ' OXT' ' A' ' 312' ' ' PRO . 1.9 ptmm? -98.28 124.28 47.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.628 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.441 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 75.4 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 C-N-CA 121.075 1.183 . . . . 0.0 112.201 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 30.0 tptt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.596 ' ND1' ' OE1' ' A' ' 269' ' ' GLN . 85.8 t60 -91.97 147.14 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.241 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.62 ' CD ' ' H ' ' A' ' 269' ' ' GLN . 0.1 OUTLIER -63.57 146.15 96.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.268 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -57.58 150.15 62.66 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.865 1.71 . . . . 0.0 111.957 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -56.22 -33.89 61.97 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 274' ' ' LYS . . . 143.31 -39.64 1.29 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -72.19 9.55 5.41 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 272' ' ' GLY . 2.5 ttmp? 66.64 44.92 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.546 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.438 ' HB ' HE21 ' A' ' 276' ' ' GLN . 63.9 t -62.09 -36.1 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.438 HE21 ' HB ' ' A' ' 275' ' ' VAL . 0.9 OUTLIER -113.1 144.13 43.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 179.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.53 -20.45 26.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.23 130.84 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.216 0.531 . . . . 0.0 110.663 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -87.14 143.68 27.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.574 ' CD ' ' H ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -51.9 -34.78 42.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.476 -179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.483 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.9 OUTLIER -58.78 -39.03 79.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.876 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.1 -30.13 70.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.354 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.47 ' OD2' ' NE2' ' A' ' 269' ' ' GLN . 65.4 t0 -77.61 116.67 18.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 0.0 110.934 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 285' ' ' SER . 54.7 mt -65.12 -38.12 89.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.338 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 2.8 m 152.08 57.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.79 -22.45 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.148 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 289' ' ' SER . 75.1 t -60.78 -28.68 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.016 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.5 tt0 -45.05 -9.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 287' ' ' VAL . 32.1 t -35.02 -30.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.016 0.436 . . . . 0.0 109.961 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 288' ' ' GLN . 12.9 tptm -114.57 147.93 38.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.676 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 20.8 p -68.86 125.04 25.36 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.317 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . 99.18 -35.61 4.57 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 292' ' ' GLY . 2.4 m 153.7 -86.86 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.834 0.35 . . . . 0.0 110.095 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -149.06 31.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.592 ' O ' ' ND2' ' A' ' 296' ' ' ASN . 87.1 m-20 55.82 45.22 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.936 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 295' ' ' ASP . 29.0 m120 -152.63 -15.72 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.006 0.432 . . . . 0.0 109.967 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 299' ' ' HIS . 13.1 pt -140.8 7.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.456 ' HZ2' ' HG2' ' A' ' 298' ' ' LYS . 22.1 ttpp -46.59 87.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.606 ' N ' ' O ' ' A' ' 297' ' ' ILE . 4.0 p80 -174.96 154.85 1.92 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.621 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 306' ' ' VAL . 1.6 t -58.85 -66.87 1.16 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.743 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 32.8 Cg_endo -52.01 105.21 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.756 1.637 . . . . 0.0 111.516 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 103.18 -1.0 47.17 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 100.19 131.76 7.48 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 178.66 -167.54 38.02 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.543 ' C ' HG23 ' A' ' 306' ' ' VAL . 91.7 p -63.24 -14.55 50.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.612 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 300' ' ' VAL . 2.6 t 75.83 75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 308' ' ' ILE . 2.2 pt20 -136.09 -69.96 0.48 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.454 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.977 ' O ' HD12 ' A' ' 308' ' ' ILE . 2.7 pp -110.36 131.57 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.27 0.557 . . . . 0.0 112.029 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.602 ' C ' ' H ' ' A' ' 311' ' ' LYS . 17.6 m -85.92 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.773 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -49.35 0.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.51 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.602 ' H ' ' C ' ' A' ' 309' ' ' VAL . 13.0 pttt 34.96 93.37 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.744 0.307 . . . . 0.0 111.242 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo . . . . . 0 C--N 1.309 -1.525 0 C-N-CA 122.11 1.874 . . . . 0.0 112.32 179.379 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 66.8 mttt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.43 ' CE1' HE22 ' A' ' 288' ' ' GLN . 23.2 t-160 -58.8 -37.91 77.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 110.453 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -66.0 139.74 96.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.41 -23.99 76.47 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 120.225 0.617 . . . . 0.0 112.205 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.52 41.67 50.7 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 94.16 20.67 29.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 84.05 45.99 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.478 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.468 ' HG2' HG12 ' A' ' 275' ' ' VAL . 57.8 tttp -57.61 -48.33 79.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.576 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.649 HG13 ' NE2' ' A' ' 276' ' ' GLN . 4.4 p 173.43 -23.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.649 ' NE2' HG13 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -55.08 -153.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.306 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.544 ' C ' ' H ' ' A' ' 279' ' ' ASN . 64.8 mt -57.88 -16.19 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.566 0.222 . . . . 0.0 110.771 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 278' ' ' ILE . 91.8 mt 65.1 -19.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.52 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 277' ' ' ILE . 74.9 m-20 -89.96 79.56 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.512 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.469 ' H ' ' HE3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -58.65 -24.62 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.333 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -54.88 -38.38 67.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.77 -35.87 81.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.274 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.13 127.05 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.737 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.783 HD12 ' N ' ' A' ' 284' ' ' LEU . 5.7 mp -70.84 -24.75 62.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.218 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 9.7 p 95.8 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.947 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 65.34 -52.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.752 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 289' ' ' SER . 9.4 p -56.89 -21.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 110.14 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 290' ' ' LYS . 7.7 tt0 -44.25 -13.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.108 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 287' ' ' VAL . 37.5 m -40.43 -23.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.569 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 288' ' ' GLN . 39.2 mmtm -55.58 -31.78 62.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.705 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 2.0 t 72.5 -60.02 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 179.02 -170.06 41.68 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 19.8 t 59.07 16.29 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.754 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 297' ' ' ILE . 84.0 mttt -146.18 -90.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.0 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.49 -43.16 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 299' ' ' HIS . 22.2 m120 -85.54 -3.97 59.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.521 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.734 HD13 ' O ' ' A' ' 297' ' ' ILE . 0.2 OUTLIER -49.89 -26.31 2.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.41 ' O ' ' CA ' ' A' ' 304' ' ' GLY . 14.9 ptpt -71.01 18.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.453 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 296' ' ' ASN . 0.0 OUTLIER -104.14 148.11 26.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 302' ' ' GLY . 70.2 t -48.18 -43.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.87 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 300' ' ' VAL . 26.4 Cg_exo -46.49 -11.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 120.609 0.873 . . . . 0.0 111.304 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -156.62 32.58 0.57 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 86.67 86.18 1.07 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 300' ' ' VAL . . . -133.27 176.45 19.6 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.754 ' N ' HE22 ' A' ' 307' ' ' GLN . 43.0 p -87.93 10.6 18.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.406 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.671 ' H ' HE22 ' A' ' 307' ' ' GLN . 2.7 t 79.75 82.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.947 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.754 HE22 ' N ' ' A' ' 305' ' ' SER . 0.0 OUTLIER -123.33 -91.92 0.54 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.147 179.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 1.055 HD12 ' N ' ' A' ' 309' ' ' VAL . 2.7 pp -61.18 -47.63 92.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 1.055 ' N ' HD12 ' A' ' 308' ' ' ILE . 21.6 t 39.86 13.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.833 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.639 ' N ' ' O ' ' A' ' 308' ' ' ILE . 0.2 OUTLIER -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.142 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 310' ' ' TYR . 34.1 tttp 75.22 95.79 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.998 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.086 179.817 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.841 0.353 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -67.51 153.86 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.47 151.31 88.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.343 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.38 150.17 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.746 1.63 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.07 48.35 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -51.07 -37.03 36.09 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -88.57 177.81 45.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -114.41 121.65 44.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.172 0.511 . . . . 0.0 110.933 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 275' ' ' VAL . 7.5 p -132.13 -13.31 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.613 ' NE2' ' O ' ' A' ' 277' ' ' ILE . 1.6 pp0? -138.91 176.25 8.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.613 ' O ' ' NE2' ' A' ' 276' ' ' GLN . 31.9 mm -67.62 130.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.599 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.448 ' HA ' HE22 ' A' ' 276' ' ' GLN . 42.8 mm -70.73 92.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.362 0.601 . . . . 0.0 110.905 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.49 39.86 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.704 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 283' ' ' ASP . 30.9 mtmt -50.88 -39.16 53.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.734 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -59.66 -37.9 80.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.059 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 48.7 mt -72.91 -35.24 67.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.179 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 280' ' ' LYS . 46.1 p30 -113.01 170.78 7.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.256 0.55 . . . . 0.0 111.982 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.765 ' N ' HE21 ' A' ' 288' ' ' GLN . 15.6 tp -153.43 64.91 0.75 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.414 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 43.82 -173.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.963 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -68.95 -16.81 63.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.294 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 284' ' ' LEU . 35.2 m -57.12 -11.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.713 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.765 HE21 ' N ' ' A' ' 284' ' ' LEU . 92.2 mt-30 -52.52 -41.92 63.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.294 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 288' ' ' GLN . 10.0 t 25.19 30.04 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 288' ' ' GLN . 52.4 mttm -143.68 138.41 28.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 110.988 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 89.2 m -98.73 -22.14 16.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -93.1 -74.73 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.331 -0.707 . . . . 0.0 111.331 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 53.0 m -116.24 150.34 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.022 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 296' ' ' ASN . 32.0 mmtp -99.4 135.75 40.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.992 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 295' ' ' ASP . 59.2 t0 51.68 6.54 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 294' ' ' LYS . 77.7 m-20 62.22 26.13 15.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.132 0.491 . . . . 0.0 110.639 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.761 ' C ' HD12 ' A' ' 297' ' ' ILE . 1.7 pp -113.46 -7.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.509 ' C ' ' CG ' ' A' ' 299' ' ' HIS . 50.3 tttp -101.11 116.47 32.9 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.265 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.544 ' H ' ' HA3' ' A' ' 304' ' ' GLY . 1.5 p80 162.27 165.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.82 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.53 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 0.2 OUTLIER -52.15 -67.55 0.52 Allowed Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.316 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 61.2 Cg_endo -52.53 101.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.05 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 101.39 1.95 53.74 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 299' ' ' HIS . . . 98.43 128.44 6.12 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.386 -0.685 . . . . 0.0 111.386 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.544 ' HA3' ' H ' ' A' ' 299' ' ' HIS . . . 170.85 -107.52 0.26 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 300' ' ' VAL . 9.3 m -133.15 -128.36 0.18 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 111.377 -179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.2 6.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.521 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 307' ' ' GLN . 13.0 pt20 -55.27 -40.41 70.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.372 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.681 HD12 ' C ' ' A' ' 308' ' ' ILE . 2.3 pp -128.78 -175.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.632 ' N ' HD12 ' A' ' 308' ' ' ILE . 11.0 p -171.55 -0.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.086 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.442 ' O ' ' C ' ' A' ' 311' ' ' LYS . 1.0 OUTLIER -85.87 28.78 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 310' ' ' TYR . 9.6 pttm 33.16 68.63 0.97 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.078 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.475 ' HD3' HD13 ' A' ' 308' ' ' ILE . 77.4 Cg_exo . . . . . 0 C--N 1.306 -1.681 0 C-N-CA 122.514 2.143 . . . . 0.0 112.184 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -69.1 149.83 48.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.191 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.55 147.68 91.99 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.431 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.26 155.58 50.72 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.827 1.685 . . . . 0.0 111.933 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -52.34 -16.58 3.53 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 99.79 0.8 56.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.81 23.16 1.02 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -91.13 -78.29 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.795 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 276' ' ' GLN . 9.2 p -176.05 -39.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.491 ' N ' HG13 ' A' ' 275' ' ' VAL . 96.5 mt-30 -67.4 9.24 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.778 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.485 ' H ' ' C ' ' A' ' 275' ' ' VAL . 91.6 mt -47.52 -41.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.829 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.46 HD12 HD21 ' A' ' 279' ' ' ASN . 2.3 pt -52.41 -35.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.888 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.711 HD22 ' N ' ' A' ' 279' ' ' ASN . 0.8 OUTLIER -85.49 0.14 53.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.568 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.479 ' O ' ' OD1' ' A' ' 283' ' ' ASP . 16.2 ttmt -55.13 -50.96 67.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.459 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.0 OUTLIER -64.85 -31.18 72.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 282' ' ' LEU . 3.1 mm? -68.1 -34.25 76.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 283' ' ' ASP . 50.2 p30 -106.6 155.52 19.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.161 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 286' ' ' ASN . 22.3 mt -109.22 153.31 23.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.081 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 287' ' ' VAL . 0.5 OUTLIER -56.75 73.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.029 0.442 . . . . 0.0 110.505 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER 55.01 -6.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.632 ' H ' ' C ' ' A' ' 285' ' ' SER . 61.0 t -60.99 -27.03 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.467 ' CD ' ' H ' ' A' ' 284' ' ' LEU . 13.0 pt20 -87.64 -160.83 0.65 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.207 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.31 -51.21 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.136 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -97.47 155.33 16.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.157 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 74.2 m -53.74 -33.46 55.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.125 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.546 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . -71.24 0.1 33.82 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 292' ' ' GLY . 1.4 t 89.71 -167.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.45 -38.86 72.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.988 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 297' ' ' ILE . 61.3 t0 -166.09 72.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.897 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.601 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 74.8 m-20 39.3 20.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.313 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 295' ' ' ASP . 1.4 pp -60.65 -17.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.123 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.407 ' HG3' HE22 ' A' ' 307' ' ' GLN . 0.3 OUTLIER -68.47 -1.12 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.42 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.724 ' HD1' ' C ' ' A' ' 299' ' ' HIS . 0.1 OUTLIER -93.47 168.7 10.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.043 -179.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 304' ' ' GLY . 0.0 OUTLIER -127.04 104.91 22.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.519 ' CD ' ' ND1' ' A' ' 299' ' ' HIS . 0.3 OUTLIER -68.25 -12.69 35.79 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 C-N-CA 120.488 0.792 . . . . 0.0 112.819 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -55.93 -28.96 54.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 304' ' ' GLY . . . -149.57 4.43 0.67 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 50.64 108.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 308' ' ' ILE . 73.9 m -66.76 160.72 25.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 110.331 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 6.8 p -53.66 -28.8 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.075 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.438 ' HG2' ' H ' ' A' ' 307' ' ' GLN . 5.8 pt20 -61.04 -36.65 80.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.187 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.802 HD12 ' N ' ' A' ' 309' ' ' VAL . 2.9 pp -132.51 -152.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.802 ' N ' HD12 ' A' ' 308' ' ' ILE . 0.6 OUTLIER 166.27 -5.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 310' ' ' TYR . 0.0 OUTLIER -83.02 11.16 6.58 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 309' ' ' VAL . 0.0 OUTLIER 39.66 56.16 6.4 Favored Pre-proline 0 N--CA 1.435 -1.193 0 CA-C-N 113.376 -1.738 . . . . 0.0 109.786 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.48 ' HD2' HD13 ' A' ' 308' ' ' ILE . 55.7 Cg_exo . . . . . 0 C--N 1.311 -1.419 0 C-N-CA 121.768 1.646 . . . . 0.0 112.43 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 268' ' ' HIS . 18.2 ttpp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.733 0.301 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.483 ' O ' ' O ' ' A' ' 267' ' ' LYS . 83.0 t60 57.16 146.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.606 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 146.13 77.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.993 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -57.33 -27.97 77.88 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.183 1.922 . . . . 0.0 112.338 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.24 -1.89 86.49 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 92.46 0.43 70.02 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 275' ' ' VAL . . . -90.69 -82.7 1.4 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.87 -33.3 73.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 275' ' ' VAL . 37.0 t 51.85 19.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.53 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 -54.75 -39.14 68.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.222 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 279' ' ' ASN . 32.3 mm -67.22 -20.59 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.782 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.444 HG22 ' ND2' ' A' ' 279' ' ' ASN . 64.8 mt 64.63 -65.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.836 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 277' ' ' ILE . 2.5 m120 -95.4 95.56 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 281' ' ' LYS . 4.8 ptpp? -61.41 -42.69 99.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.013 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.684 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 0.1 OUTLIER -59.88 -30.11 68.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.93 -36.4 79.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.503 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 284' ' ' LEU . 59.8 t0 -101.01 141.35 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 285' ' ' SER . 79.7 mt -102.73 146.91 27.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.009 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.603 ' C ' ' H ' ' A' ' 287' ' ' VAL . 44.8 m -55.72 -167.58 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -49.99 -3.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.664 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 285' ' ' SER . 76.2 t -57.76 -37.28 58.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 290' ' ' LYS . 9.9 pt20 -55.9 -38.65 70.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 15.4 t 41.87 11.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.497 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 288' ' ' GLN . 87.4 mttt -130.21 141.2 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 77.8 m -94.3 -20.35 19.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.936 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -101.15 -130.34 7.01 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.597 ' HB2' HG22 ' A' ' 297' ' ' ILE . 24.7 p -70.05 158.67 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.876 ' O ' HG23 ' A' ' 297' ' ' ILE . 36.9 pttt -166.83 -129.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.161 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.413 ' N ' ' HG3' ' A' ' 294' ' ' LYS . 88.9 m-20 -81.97 -3.9 55.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.576 ' H ' ' HG3' ' A' ' 294' ' ' LYS . 25.6 t30 -99.44 -26.88 13.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.876 HG23 ' O ' ' A' ' 294' ' ' LYS . 1.6 pt 12.94 -98.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.819 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 297' ' ' ILE . 93.5 mttt 35.34 29.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.524 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.757 ' H ' ' CD2' ' A' ' 299' ' ' HIS . 0.2 OUTLIER -50.68 -61.67 2.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.129 -178.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.813 ' H ' ' CD ' ' A' ' 301' ' ' PRO . 77.5 t -154.28 -8.27 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.813 ' CD ' ' H ' ' A' ' 300' ' ' VAL . 59.5 Cg_endo -56.72 106.16 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 CA-C-N 120.393 1.176 . . . . 0.0 112.117 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.49 72.29 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 94.22 3.6 63.32 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.39 -25.0 29.6 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.0 m -60.58 -38.94 86.26 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 307' ' ' GLN . 39.2 t -66.95 -42.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.817 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 307' ' ' GLN . 0.0 OUTLIER 47.14 100.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.931 0.872 . . . . 0.0 109.779 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.606 ' C ' HG23 ' A' ' 309' ' ' VAL . 3.3 pt -124.59 20.77 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.057 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.606 HG23 ' C ' ' A' ' 308' ' ' ILE . 1.8 t 69.76 -50.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.66 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 308' ' ' ILE . 8.8 p90 -95.35 144.31 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.026 0.441 . . . . 0.0 110.657 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.47 116.94 65.3 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.019 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.313 -1.302 0 C-N-CA 121.274 1.316 . . . . 0.0 112.333 178.34 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 9.2 pttm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -72.05 155.81 39.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.405 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.93 147.72 98.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.486 ' HG3' ' H ' ' A' ' 278' ' ' ILE . 19.8 Cg_endo -59.2 157.12 31.47 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.543 1.495 . . . . 0.0 112.081 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -87.0 81.93 1.65 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 95.46 4.12 60.98 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.83 5.9 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 275' ' ' VAL . 55.1 mttp -54.93 -70.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 274' ' ' LYS . 49.6 t -161.82 -15.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.883 0.373 . . . . 0.0 110.458 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.498 ' O ' ' O ' ' A' ' 275' ' ' VAL . 30.3 mt-30 -56.14 -131.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 279' ' ' ASN . 75.4 mt -59.59 -35.78 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.486 ' H ' ' HG3' ' A' ' 270' ' ' PRO . 97.9 mt 62.79 -32.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.853 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 277' ' ' ILE . 8.2 m120 -71.99 58.06 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.874 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -49.37 -38.85 29.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.549 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.497 ' CD ' ' H ' ' A' ' 281' ' ' LYS . 8.6 mptt -56.76 -28.31 60.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.34 -40.2 85.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.648 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -98.85 139.55 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 1.007 ' H ' HD22 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -91.96 -0.26 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.9 t 93.21 -171.11 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.746 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.603 HD22 ' C ' ' A' ' 286' ' ' ASN . 0.2 OUTLIER -50.98 -22.64 2.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 284' ' ' LEU . 4.8 m -61.55 -21.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.693 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.626 ' C ' ' H ' ' A' ' 290' ' ' LYS . 2.4 pt20 -53.63 -41.96 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.501 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 288' ' ' GLN . 1.5 t 59.82 -26.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.199 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 288' ' ' GLN . 43.6 tttp -90.67 148.74 22.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.827 0.346 . . . . 0.0 110.803 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 38.6 t -75.17 147.18 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 71.28 -125.95 12.6 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -117.02 148.05 41.81 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 297' ' ' ILE . 18.5 tttm -106.25 -53.5 2.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 294' ' ' LYS . 85.2 m-20 38.17 37.73 0.17 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 298' ' ' LYS . 37.5 t30 73.67 46.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.667 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 294' ' ' LYS . 11.1 tt 34.6 32.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.699 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.595 ' O ' ' NE2' ' A' ' 307' ' ' GLN . 14.3 pttp -74.55 -0.61 18.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.529 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 301' ' ' PRO . 3.7 p80 -80.24 149.41 30.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.556 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 0.6 OUTLIER -55.78 -67.55 0.72 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.316 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.557 ' O ' ' CE1' ' A' ' 299' ' ' HIS . 95.1 Cg_endo -51.6 108.27 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.87 1.713 . . . . 0.0 111.379 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 99.72 -1.04 56.7 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 299' ' ' HIS . . . 107.6 128.71 5.95 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 171.54 -169.89 42.88 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.9 m -71.61 -84.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.761 0.315 . . . . 0.0 110.851 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.654 ' N ' HE22 ' A' ' 307' ' ' GLN . 2.1 p 178.27 80.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.221 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.654 HE22 ' N ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -120.24 -100.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.928 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.787 HD13 ' H ' ' A' ' 308' ' ' ILE . 0.1 OUTLIER -104.5 127.17 59.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.714 0.768 . . . . 0.0 112.347 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 311' ' ' LYS . 16.3 m -84.83 -7.29 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 310' ' ' TYR . 1.2 t80 -43.3 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.805 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 309' ' ' VAL . 27.5 ttmt 56.21 65.65 4.06 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.003 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 C--N 1.304 -1.781 0 C-N-CA 122.656 2.238 . . . . 0.0 112.21 179.468 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 268' ' ' HIS . 48.6 mttp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.639 ' H ' ' CD2' ' A' ' 268' ' ' HIS . 0.1 OUTLIER -57.1 -149.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.062 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.422 ' CB ' ' CD ' ' A' ' 270' ' ' PRO . 4.4 mt-30 -41.37 -39.62 2.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 269' ' ' GLN . 3.2 Cg_endo -83.84 91.99 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.689 1.593 . . . . 0.0 111.748 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.67 30.34 2.27 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.18 60.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -83.4 -171.13 47.21 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -55.32 -31.24 61.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.606 ' O ' ' N ' ' A' ' 277' ' ' ILE . 99.2 t -57.95 -12.82 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.923 0.392 . . . . 0.0 110.058 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.629 ' C ' ' H ' ' A' ' 278' ' ' ILE . 19.7 pt20 -44.2 -8.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.546 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.606 ' N ' ' O ' ' A' ' 275' ' ' VAL . 37.4 mm -48.33 -3.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.629 ' H ' ' C ' ' A' ' 276' ' ' GLN . 8.2 mt 65.96 7.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.133 0.492 . . . . 0.0 110.277 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 281' ' ' LYS . 15.3 t-20 -57.2 -18.4 15.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.721 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 283' ' ' ASP . 0.0 OUTLIER -46.85 -1.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.176 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.623 ' H ' ' C ' ' A' ' 279' ' ' ASN . 23.4 mmtm -42.39 -31.84 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.142 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.82 -35.64 77.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 280' ' ' LYS . 60.2 t0 -75.22 139.47 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.973 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 285' ' ' SER . 13.5 mt -62.7 -29.13 70.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.0 OUTLIER 89.95 -134.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.78 -179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -31.4 67.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.09 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.65 -32.26 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 290' ' ' LYS . 6.8 tt0 -51.28 -21.63 2.27 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.674 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 17.3 t 50.76 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.628 ' N ' ' O ' ' A' ' 288' ' ' GLN . 19.3 tttm -130.84 148.33 52.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.697 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 52.8 t -97.88 140.57 32.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.898 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 293' ' ' SER . . . 98.42 42.85 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 295' ' ' ASP . 0.8 OUTLIER 163.16 107.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.622 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.56 ' C ' ' N ' ' A' ' 296' ' ' ASN . 64.8 tttt 44.97 18.05 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 293' ' ' SER . 61.4 m-20 52.5 8.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.56 ' N ' ' C ' ' A' ' 294' ' ' LYS . 79.7 m-20 -144.8 -65.72 0.34 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.795 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.491 ' CG2' ' O ' ' A' ' 296' ' ' ASN . 23.7 pt -159.31 50.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.523 ' HB2' ' N ' ' A' ' 294' ' ' LYS . 78.2 tttt -57.41 -27.0 61.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.456 ' CG ' ' HD2' ' A' ' 301' ' ' PRO . 0.3 OUTLIER -69.3 156.16 39.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.146 -178.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.637 ' N ' ' CD ' ' A' ' 301' ' ' PRO . 84.5 t -74.45 -60.07 1.45 Allowed Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 300' ' ' VAL . 45.9 Cg_endo -48.09 142.05 16.59 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.153 1.902 . . . . 0.0 112.262 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 93.84 18.15 38.61 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 85.54 26.67 34.94 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -86.67 -162.04 36.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.548 ' O ' HG13 ' A' ' 306' ' ' VAL . 19.1 m -55.49 -131.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.681 0.277 . . . . 0.0 111.168 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 305' ' ' SER . 18.6 m -159.58 26.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.863 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.477 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 1.7 pt20 -84.84 -70.87 0.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.636 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.987 ' O ' HD12 ' A' ' 308' ' ' ILE . 2.7 pp -113.94 134.65 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.484 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 311' ' ' LYS . 14.4 m -118.17 5.99 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.512 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 311' ' ' LYS . 2.8 p90 -70.29 20.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.073 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.557 ' H ' ' C ' ' A' ' 309' ' ' VAL . 9.7 pttp 32.31 98.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.595 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.484 ' OXT' ' O ' ' A' ' 311' ' ' LYS . 94.2 Cg_exo . . . . . 0 N--CA 1.493 1.478 0 C-N-CA 121.652 1.568 . . . . 0.0 112.223 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 31.3 mttp . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.783 0.325 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.545 ' O ' ' CB ' ' A' ' 269' ' ' GLN . 84.6 t60 -58.47 -36.67 74.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.61 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 268' ' ' HIS . 18.9 tt0 84.94 125.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.184 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -58.31 138.29 85.09 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.688 0.925 . . . . 0.0 112.16 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -133.48 40.32 1.61 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 103.16 -26.34 24.19 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -59.23 -35.38 84.23 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 61.59 37.0 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.693 0.282 . . . . 0.0 111.063 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.415 ' HB ' ' NE2' ' A' ' 276' ' ' GLN . 0.2 OUTLIER -115.49 2.65 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.415 ' NE2' ' HB ' ' A' ' 275' ' ' VAL . 2.9 mm-40 -110.67 170.35 8.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.188 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.0 123.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.625 ' C ' ' H ' ' A' ' 280' ' ' LYS . 46.7 mm -62.48 -25.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.488 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 281' ' ' LYS . 79.2 m-20 -67.13 23.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.775 0.322 . . . . 0.0 110.837 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 278' ' ' ILE . 2.6 ptpt -38.75 -15.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.834 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 279' ' ' ASN . 6.4 mptt -47.97 -37.53 14.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 282' ' ' LEU . 7.6 mp -71.23 -34.33 70.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.061 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 280' ' ' LYS . 90.7 m-20 -91.07 128.74 37.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.932 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 285' ' ' SER . 0.4 OUTLIER -102.66 4.1 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 284' ' ' LEU . 1.2 t 87.11 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.653 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -49.22 -24.78 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.391 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.17 -35.89 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.598 ' O ' ' N ' ' A' ' 290' ' ' LYS . 2.8 pt20 -58.15 -36.59 73.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.157 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.13 -68.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.309 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 288' ' ' GLN . 90.6 mttt -75.75 161.99 28.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.615 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' CYS . . . . . . . . . . . . . 83.4 m -50.9 -36.09 36.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.549 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -92.32 -167.78 39.88 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 294' ' ' LYS . 21.8 t -62.36 -141.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.585 ' N ' ' OG ' ' A' ' 293' ' ' SER . 17.8 mmtm -53.44 -30.29 39.79 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -161.99 -120.93 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.6 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.623 ' O ' ' CD2' ' A' ' 299' ' ' HIS . 35.6 p30 -83.19 0.05 47.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.923 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.785 HD12 ' H ' ' A' ' 297' ' ' ILE . 2.4 mp -59.31 -19.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.2 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 297' ' ' ILE . 4.3 pttm -41.24 -21.37 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.545 0.688 . . . . 0.0 109.416 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' HIS . . . . . 0.623 ' CD2' ' O ' ' A' ' 296' ' ' ASN . 1.2 p80 -86.67 -162.95 0.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.216 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 300' ' ' VAL . 1.7 p 172.35 74.44 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.958 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 303' ' ' GLY . 12.0 Cg_exo -31.32 -28.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.608 1.539 . . . . 0.0 113.205 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -66.39 4.14 2.98 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 178.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . 168.08 7.33 0.03 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 300' ' ' VAL . . . -87.42 -170.34 46.39 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.433 ' OG ' ' CG ' ' A' ' 307' ' ' GLN . 24.7 p -79.38 8.92 5.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.175 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.718 HG12 HG22 ' A' ' 309' ' ' VAL . 35.4 t 55.19 58.57 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.552 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 309' ' ' VAL . 62.4 mt-30 -82.2 -72.41 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.59 HD12 ' CD2' ' A' ' 299' ' ' HIS . 0.1 OUTLIER -72.13 -2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.09 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.718 HG22 HG12 ' A' ' 306' ' ' VAL . 2.0 t 33.97 40.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.536 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' TYR . . . . . 0.497 ' O ' ' O ' ' A' ' 311' ' ' LYS . 7.0 t80 -146.4 -14.33 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.686 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 310' ' ' TYR . 28.0 pttt 31.96 96.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.298 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.494 1.516 0 C-N-CA 121.612 1.542 . . . . 0.0 112.004 179.62 . . . . . . . . 0 0 . 1 stop_ save_